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Personalized cancer medicine is a cancer care paradigm in which diagnostic and 
therapeutic strategies are customized for individual patients.  Microsystems that are created 
by Micro-Electro-Mechanical Systems (MEMS) technology and integrate various 
diagnostic and therapeutic methods on a single chip hold great potential to enable 
personalized cancer medicine. Toward ultimate realization of such microsystems, this 
thesis focuses on developing critical functional building blocks that perform genetic 
variation identification (single-nucleotide polymorphism (SNP) genotyping) and specific, 
efficient and flexible cell manipulation on microfluidic surfaces. 
For the identification of genetic variations, we first present a bead-based approach to 
detect single-base mutations by performing single-base extension (SBE) of SNP specific 
primers on solid surfaces. Successful genotyping of the SNP on exon 1 of HBB gene 
demonstrates the potential of the device for simple, rapid, and accurate detection of SNPs. 
In addition, a multi-step solution-based approach, which integrates SBE with mass-tagged 
dideoxynucleotides and solid-phase purification of extension products, is also presented. 
Rapid, accurate and simultaneous detection of 4 loci on a synthetic template demonstrates 
the capability of multiplex genotyping with reduced consumption of samples and reagents. 
For cell manipulation, we first present a microfluidic device for cell purification with 
surface-immobilized aptamers, exploiting the strong temperature dependence of the 
affinity binding between aptamers and cells. Further, we demonstrate the feasibility of 
  
using aptamers to specifically separate target cells from a heterogeneous solution and 
employing environmental changes to retrieve purified cells. Moreover, spatially specific 
capture and selective temperature-mediated release of cells on design-specified areas is 
presented, which demonstrates the ability to establish cell arrays on pre-defined regions 
and to collect only specifically selected cell groups for downstream analysis. 
We also investigate tunable microfluidic trapping of cells by exploiting the large 
compliance of elastomers to create an array of cell-trapping microstructures, whose 
dimensions can be mechanically modulated by inducing uniform strain via the application 
of external force. Cell trapping under different strain modulations has been studied, and 
capture of a predetermined number of cells, from single cells to multiple cells, has been 
achieved. 
In addition, to address the lack of aptamers for targets of interest, which is a major 
hindrance to aptamer-based cell manipulation, we present a microfluidic device for 
synthetically isolating cell-targeting aptamers from a randomized single-strand DNA 
(ssDNA) library, integrating cell culturing with affinity selection and amplification of cell-
binding ssDNA. Multi-round aptamer isolation on a single chip has also been realized by 
using pressure-driven flow. 
Finally, some perspectives on future work are presented, and strategies and notable 
issues are discussed for further development of MEMS/microfluidics-based devices for 
personalized cancer medicine. 
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Chapter 1. Introduction 
1.1. Microelectromechanical Systems and Microfluidics for Biomedical 
Applications 
Microelectromechanical systems (MEMS) are systems that integrate small-scale 
electrical and mechanical components (with feature size ranging from submicrometers to 
hundreds of micrometers) to accomplish specific objectives. Microfluidics focuses on a 
special class of MEMS technology that processes or manipulates small-volume fluids  
(10-6 L to 10-18 L) geometrically constrained to channels with dimensions of tens to 
hundreds of micrometres [1], employing knowledge from the field of engineering, physics, 
chemistry, nanotechnology and biotechnology. Typically, a microfluidic system will 
integrate methods for sample and reagent introduction, fluid movement and mixing, 
analytical reactions, and product detection into a single device [1]. The development of 
microfabrication technologies for MEMS and traditional semiconductor manufacturing has, 
likewise, led to the rapid development of microfluidics over past 20 years. This can be seen 
in the diversity of functional components that have been realized onto a single chip, such 
as valves [2, 3], mixers [4-6] and pumps [7]. Compared with conventional platforms, 
microfluidics offers a number of advantages, such as very low sample and reagent 
consumption, high resolution and sensitivity in separations and detections, low cost, fast 
analysis, and small device footprint [8]. Microfluidics were first employed to the field of 
molecular analysis, initially for chemical sensing [9]. Now, microfluidics are widely 
applied to a broad range of applications such as chemical analysis [10, 11], cell biology 
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[12-14], genetic analysis [15-18], biosensing [19-21], and drug discovery [22, 23]. 
Microfluidics is the critical technology for lab-on-a-chip systems. 
Lab-on-a-chip micro systems, which are also referred to as micro total analysis 
systems (µTAS), are chip-format devices that integrate various processes and functions, 
including sample preparation, reactions and detections for biological and chemical analysis 
(Figure 1.1) [24]. Such systems typically consist of subsystems that accomplish a variety 
of functions that involve fluidic, chemical, mechanical and electrical operations. The 
ultimate objective of this research is to develop integrated microsystems for personalized 
cancer medicine, which is a healthcare paradigm that allows physicians to tailor cancer 
treatment strategies for individual patients based on the exclusive patient-specific 
characteristics of a disease. These unique characteristics can be revealed by evidence such 
as identification of genetic variations, and cellular and pathological responses to 
pharmaceutical drug candidates [25]. As conventional methods are still time-, labor-, and 
resource-consuming, MEMS-based microfluidic systems, which are able to effectively and 
efficiently produce patient- and disease-specific information at multiple levels and thus 
identify the nature of cancer for each patient, become ideal platforms to realize 





Figure 1.1: Lab-on-a-chip: Miniaturizing and integrating laboratory processes onto a 
single chip [24]. 
1.2. Personalized Cancer Medicine 
Personalized cancer medicine is a cancer care paradigm in which diagnostic and 
therapeutic strategies are customized for individual patients. Different from traditional 
diagnostics and therapeutics, which rely on medical history and laboratory evaluation to 
determine a generic treatment scheme for patients with similar symptoms, personalized 
medicine utilizes patient-specific genetic, proteomic, cellular, clinical and environmental 
information to tailor a unique treatment approach for each individual cancer patient [25]. 
For example, to make an optimized medical decision toward each patient, genetic and 
cellular analyses are commonly employed to identify patient-specific characteristics of 
cancer. Advances in large-scale genomic, proteomic, and cellomic technology have led to 
vast improvements in the understanding and application of personalized medicine to cancer 
diagnosis and therapy. For example, the fine interrogation of genetic variations in DNA 
has revealed their impact on phenotypic differences, disease development, and drug 
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response, leading to a more efficient process for drug discovery [26]. However, due to the 
heterogeneity of the diseases at the pathological and cellular level, knowing only the 
genetic makeup of cancer is not sufficient to determine the outcome of a cancer treatment 
strategy [27]. For the same pharmaceutical drug, differences in the pathological and 
cellular level responses will also contribute to different therapy results. Therefore, drug 
candidates, chosen according to genetic information, also need to be further selected based 
on toxicity, side effects, and effectiveness. Since it is often not feasible to treat patients 
with multiple drugs, as there is potential for harmful toxicity and side effects, it is critical 
to use the most effective drug, which can be determined by drug screening using isolated 
cancer cells or tissues directly from the patient. This procedure will contribute to the 
optimization of  treatment for an individual patient, which is the final goal of personalized 
cancer medicine. 
1.3. Microfluidic Genetic Analysis and Cell Manipulation 
Microfluidic technologies have been explored in a broad range of bioanalytical 
applications [28]. In particular, microfluidic genetic analysis and cell manipulation have 
been enabling applications such as genetic variation interrogation and cell-based drug 
screening, which are highly desired capabilities in personalized cancer medicine. This 
section provides a brief overview of related work in the literature on microfluidic 
approaches to genetic analysis and cell manipulation. 
1.3.1. Microfluidic Genetic Analysis 
The successful sequencing of the human genome [29-31] has offered opportunities to 
elucidate the genetic bases of evolution, biological functions and diseases [32, 33]. The 
5 
 
increasing demand of genome-related research requires fast, high-throughput, sensitive and 
reliable analytical methods, but traditional genetic analysis systems may not be able to 
satisfy these requirements. A fully integrated microfluidic system has the capability to 
integrate all the analytical steps onto a single chip at pL-nL volumes [34], and thus 
eliminates most of the substantial manual labor, which increases the assay speed and 
throughput, decreases reagent and sample consumption, and reduces the instrument size 
[9, 35]. Therefore, microfluidic genetic analysis systems have been developed rapidly in 
the last ten years, addressing bioanalytical challenges, such as DNA sequencing, SNP 
genotyping, gene expression analysis, and pathogen detection, thus enabling large-scale 
and point-of-care applications [15]. 
1.3.1.1. Microfluidic DNA Sequencing 
Deoxyribonucleic acid (DNA), which encodes the genetic instructions used in the 
development and functioning of living organisms, is a long double helical polymer made 
from repeating deoxyribonucleotides, each containing a base, a sugar and a phosphate 
group [36]. In the DNA replication process, a new strand of DNA molecules is synthesized 
from deoxyribonucleoside 5’-trisphosphates (dNTPs), using the original strand as the 
template. Briefly, the 3’-hydroxyl group of the sugar in one nucleotide binds to the 5’-
phosphate group of the sugar in the adjacent nucleotide by a phosphodiester bond, 
generating the DNA molecules with a phosphate group on the 5’-terminal of the sugar unit 
(5’-end) and a free hydroxyl group at the 3’-terminal of the sugar unit (3’- end). The sugars 
and phosphate groups support the DNA structure, and the bases carry the genetic 
information. There are four different bases, adenine (A), guanine (G), thymine (T) and 
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cytosine (C), with thymine replaced by uridine in ribonucleic acid (RNA) [37]. Since the 
introduction of the dideoxyribonucleotide chain terminator sequencing method (Figure 
1.2) by Sanger, in which primer extensions terminate randomly with labeled 
dideoxyribonucleotide to generate different fragments to interrogate the terminating bases, 
DNA sequencing has revolutionized biological sciences and become one of the most 
powerful technologies in biology [38, 39]. To reduce the cost and increase throughput of 
Sanger sequencing, next-generation DNA sequencing techniques have also been evolving 
rapidly, such as massively parallel signature sequencing (MPSS) [40], polony sequencing 
[41], and DNA nanoball sequencing [42], amongst others. 
 
Figure 1.2: Schematic of Sanger sequencing process [43]. 
Driven by the ambitious goal of DNA sequencing, microfluidic devices have been 
developed to improve the Sanger biochemistry to provide longer reads and higher 
throughput, leading to significant breakthroughs. For example, microchip capillary 
electrophoresis (µCE) devices have realized ultrafast separation of 600 bases in 6.5 min 
[44] and extremely high-throughput analysis of 768 samples simultaneously [45]. A fully 
integrated platform has also been reported in 2006 [46], in which a nanoliter-scale device 
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incorporated all three Sanger sequencing steps, thermal cycling, sample purification, and 
capillary electrophoresis, into a 4-inch glass wafer (Figure 1.3). The integrated device can 
complete the sequencing of 1 fmole DNA template in less than 30 min with 99% accuracy. 
 
Figure 1.3: A fully integrated microfluidic device for Sanger DNA sequencing [46].  
1.3.1.2. Microfluidic SNP Genotyping 
Single nucleotide polymorphisms (SNPs) are genetic variations in a DNA sequence 
occurring when single nucleotides in the genome differ between members of a biological 
species. SNPs are the most abundant type of genetic variations, which includes 
substitutions, insertions and deletions of individual bases, and happen at specific locations 
in the genome. SNPs are found in more than 1% of the population [47], occur every 100 to 
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300 bases in the human genome, and have more than 10 million entries in public databases 
[48]. 
Although direct DNA sequencing is the most straightforward method to discover and 
analyze SNPs, when analyzing known SNP targets, sequencing methods are expensive, 
complex and usually unnecessary. Therefore, a number of alternative SNP genotyping 
technologies have been developed and used to analyze highly targeted SNPs, such as 
enzymatic cleavage, allele specific hybridization, allele specific ligation or cleavage, and 
allele specific primer extension [49, 50]. 
Enzymatic Cleavage. Polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) is a simple and convenient laboratory technique for SNP 
detection [51]. It utilizes DNA sequence-specific restriction endonucleases to identify 
DNA polymorphisms [52]. DNA restriction enzyme can recognize PCR-amplified specific 
sequences and catalyze endonucleolytic cleavages, generating fragments with known 
lengths. The individual base variations inhibit the cleavage and thus result in DNA 
fragments of different lengths (Figure 1.4A). Thermostable flap endonucleases (FEN) are 
sensitive to sequence mismatches and structure-specific in DNA cleavages [53]. Invader® 
Assays employ FEN to cleave a three-dimensional complex formed by the hybridization 
of allele-specific overlapping oligonucleotides to target DNA with a polymorphic site, 
followed by detection of cleavage products by different methods, such fluorescence 
resonance energy transfer (FRET) (Figure 1.4B) [54]. While it is highly accurate, this 
method is generally time-consuming and difficult to multiplex (i.e., to detect multiple SNPs 




Figure 1.4: Schematic of (A) PCR-RFLP assay [37] and (B) Invasive cleavage assay [54]. 
Allele Specific Hybridization. Single base discrimination can be realized by utilizing 
thermal stability differences of perfectly matched and mismatched target-probe pairs. The 
effectiveness of this method mostly depends on the length, sequence and GC content of the 
probe, secondary structure of the target, and hybridization condition. According to this 
principle, a number of SNP genotyping approaches have been developed. For example, 
Affymetrix® Human SNP Array is based on allelic discrimination by direct hybridization 
of genomic DNA (gDNA) to arrays containing locus- and allele-specific oligonucleotides 
[50, 55]. Briefly, gDNAs are first digested and amplified, and the resulting products are 
then fragmented, labeled, and hybridized to the DNA array with surface-bound probes 
under controlled conditions. The array is finally imaged, and the genotypes can be 
determined according to the hybridization signal (Figure 1.5). However, due to insufficient 




Figure 1.5: Schematic of SNP genotyping by DNA microarray hybridization [56].  
Allele Specific Ligation or Cleavage. This method combines the hybridization of 
probes specific to the target DNA sequence and the specificity of the ligase enzyme to 
distinguish mismatched nucleotides. The DNA ligase will only join the two 
oligonucleotides together through the formation of a phosphodiester bond when they 
hybridize to a single-strand DNA (ssDNA) with prefect matching [57]. Usually, three 
oligonucleotide probes are employed, one of which binds to the template adjacent to the 
SNP site. The other two probes are allele specific and target the SNP site. The ligation 
reaction happens only if the allele specific probe perfectly matches the SNP site. The 
products can then be detected by various methods, such as using fluorescently and 
radioactively labeled probes (Figure 1.6A). In another example, TaqMan® Assay, two 
allele specific probes are labeled with different reporter dyes at 5’ end and with non-
11 
 
fluorescent quenchers at 3’ end. When the forward primers extend, the Taq polymerase 
enzyme degrades the nucleotide at the 5’ end of the perfectly matched probes, and thus 
releases the 5’ bound reporter dyes, exhibiting corresponding fluorescence (Figure 1.6B) 
[58]. However, the slow reaction speed and limited number of modified probes restricts its 
applications [49]. 
 
Figure 1.6: Schematic of SNP genotyping by ligation. (A) A ligation assay based on 
fluorescent/radioactive detection [57] ; (B) TaqMan® Assay [58].  
Allele Specific Primer Extension. This method is a robust and flexible emerging 
method that involves allele-specific incorporation of nucleotides in primer extensions with 
a DNA template [49, 50].  Briefly, the primer anneals to the target DNA template with its 
3’ end adjacent to the SNP site, and then extends by polymerase enzyme. The 
discrimination between different incorporated nucleotides can be achieved by different 
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methods, such as fluorescence (Figure 1.7A), and mass spectrometry (Figure 1.7B). For 
the fluorescence-based approach, the primers are labeled with fluorescent dyes by 
incorporating fluorescently tagged nucleotides, which can be used to determine the base at 
the SNP site, such as Illumina® Infinium Assays [59]. For the mass spectrometry-based 
approach, the extended primers are analyzed by mass spectrometry to identify the 
nucleotides incorporated according to different molecular weights, such as Sequenom® 
iPlex Assays [60]. While rapid, accurate and capable of multiplexing, it requires 
complicated design of primer and fluorescent-tagged or mass-tagged nucleotide. 
 
Figure 1.7: Allele specific primer extension. (A) Fluorescence based detection [59]; (B) 
Mass spectrometry based detection [61]. 
Microfluidics technology has enabled fast, low-cost and automated SNP detection 
with improved sensitivity, resolution, accuracy, efficiency and throughput, as well as 
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minimized sample consumption [62]. The SNP genotyping methods described above have 
been implemented in microfluidic systems, leading to significant improvements. For 
example, enzymatic cleavage has been integrated with µCE to determine an SNP site in a 
p53 suppressor gene from clinical samples in ~100s, which is 10 and 50 times faster than 
using traditional capillary and slab gel electrophoresis, respectively [63]. By incorporating 
allele specific hybridization methods, a fully integrated microfluidic device has also been 
reported, which is comprised of a microfluidic channel, a DNA chip platform, and a 
photodetector for the discrimination (Figure 1.8) [64], and can achieve SNP detection 
without DNA extraction, purification and PCR in less than 1 hour. 
 
Figure 1.8: A fully integrated microfluidic device for SNP genotyping [64]. 
1.3.1.3. Microfluidic Gene Expression Analysis 
Gene expression is the process that interprets the genetic information (genes) stored in 
DNA to functional gene products, such as protein, and is the most fundamental procedure 
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through which genotype of an organism influences the phenotype. Genes are expressed by 
transcribing gDNA to RNA, which may then be translated to protein. Because of the 
random fluctuations and complex molecular switches [65, 66], the messenger RNA 
(mRNA) production level may differ, even for genetically identical cells. Although we can 
consider RNA as a mediator between gene and protein, it is still the focus and a valuable 
component in the study of organism growth and development [67]. Due to instability of 
RNA, reverse transcription PCR (RT-PCR) of mRNA becomes an important tool for gene 
expression analysis, which has also been significantly improved by integrating RT-PCR 
and other functional units into the microfluidic platforms [15]. 
For example, by integrating single-cell lysis, mRNA isolation and complementary 
DNA (cDNA) synthesis, a multilayer PDMS microsystem has been reported [68]. In this 
work, the employment of on-chip microvalaves and micrpumps led to accurate fluid 
control, the use of a 450 pL reaction volume enhanced the reaction efficiency, and the 
enclosed structures reduced the risk of degradation and contamination. Expanding on this 
technology, an improved and fully integrated microfluidic device has been established to 
perform high-precision qRT-PCR analysis from 300 cells in parallel [69] (Figure 1.9A). 
Compared with previous work, a more efficient single cell capturing strategy, on-chip 
amplification and fluorescence-based real-time detection have been incorporated in a 
single microfluidic device, extensively increasing the throughput and sensitivity. In 
addition, the CE device has also been integrated with single-cell capture, RT-PCR and 
post-PCR purification to be capable of analyzing gene expression [70] (Figure 1.9B). As 
low as 11 copies of mRNA in each reactor has been detected in this device. 
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Figure 1.9: Integrated microdevice for gene expression analysis of single cells. (i) A 
fluorescence-based approach [69]; (ii) a CE-based approach [70]. 
1.3.2. Microfluidic Cell Manipulation 
Sample preparation, which plays a very important role in the quality of results, is often 
the most tedious step in any assay. As biological problems and analytical methods become 
more and more complicated, there is a rapidly growing need for systems that can reliably 
reproduce and prepare samples with high purity, high throughput and high recovery [71]. 
Recently, cell and microparticle manipulation in microfluidic systems have drawn 
significant attention as potential biological and chemical sample preparation platforms for 
their advantages of fast assay period, minimal reactant consumption and high throughput 
[72, 73]. 
In principle, microfluidic cell manipulation involves applying differential forces on 
target cells to guide them along prescribed paths [72]. According to the way forces are 
applied to cells, the separation method can be divided into 5 categories: geometry based 
methods, electrokinetic methods, acoustic methods, optic methods, and affinity based 
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methods. The details of these microfluidic cell manipulation methods will be reviewed in 
the sections below, with particular focus on affinity-based methods. 
1.3.2.1. Geometry-Based Cell Manipulation 
Geometry-based cell manipulation relies on the difference in cell size or volume to 
separate cells [74]. The most straightforward method is filtration. For example, an array of 
closely packed micropillars (Figure 1.10A) [75] or microsieves (Figure 1.10B) [76] with 
designed dimensions can be employed to separate cells. In such devices, solutions with 
different types of cells can be introduced into the main channels; small cells will be carried 
with the bulk fluid and pass through the intervals between pillars or the slits under the 
sieves, leaving larger cells entrapped in the main channels.  A second geometry based cell 
manipulation method utilizes the nature of laminar flow in the microfluidic channel. In a 
micropost array with a lateral displacement, the direction of cell movement depends on the 
location of the cell’s center. Therefore, smaller cells maintain their position in the flow, 
while larger cells move to the right (Figure 1.11A) [77].  Similarly, in another 
hydrodynamic approach, cells are pinched to a sidewall as they move along their center 
streamlines, which are linearly expanded along with the chamber expansion, and thus 
separated accordingly (Figure 1.11B) [78]. A third method exploits particle equilibration 
in the channel. In a spiral microchannel, the shear gradient induced Inertial Lift Force (FL), 
generated in a plane Poiseuille flow, drives the suspended particles away from the 
microchannel center, and Dean Drag Force (FD) moves the particles away from the channel 
sidewall. Both of them depend on the particle diameter (d), and the ratio of FL and FD on 
particle size ( 3
L D/F F d ) determines the position of a particle (Figure 1.12) [79]. A forth 
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method relies on physical barriers, such as microwells [80, 81] and microcups [82, 83], to 
restrict cells to some specific locations. The microstructures are designed according to the 
size of target cells, which fall down to the wells (Figure 1.13A) or are trapped in the cup 
(Figure 1.13B) when passing by the microstructures with carrier fluids. Although 
geometry-based cell manipulation does not require any chemicals or any kind of external 
force to drive cells, it can only be applied to cells with a particular size or volume. 
 
Figure 1.10: Different filtration based cell manipulation using (A) micropillar array [75] 
and (B) microsieves [76]. 
 
Figure 1.11: Cell manipulation according to the nature of laminar flow in a microchamber. 
(A) Example of using a micropost array with lateral displacement [77]. (B) Example of a 




Figure 1.12: Schematic of the spiral microparticle separator based on equilibrium between 
Lift Force (FL) and Drag Force (FD) at different positions for different particle sizes [79]. 
 
Figure 1.13: Principle of (A) microwell [81] and (B) microcup based cell trapping [83]. 
1.3.2.2. Electrokinetic Cell Manipulation 
Electrokinetic cell manipulation depends on the phenomenon of dielectrophoresis 
(DEP), in which dielectric particles are polarized when placed in a non-uniform electric 
field [84, 85]. This polarization does not require the particle to be charged, and, overall, 
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the particles should be electrically neutral. The magnitude of the dielectric force generated 
on polarized particles depends on the electrical properties of the media and particles, the 
geometry of particles, and the electrical field frequency. Therefore, at a given electrical 
field frequency, different DEP forces will be induced on particles of different electrical 
properties, leading to selective manipulation of particles. 
The phenomenon of DEP was first investigated by Pohl in 1951 [86]. For a 
homogeneous spherical particle in a conducting dielectric media, the DEP force applied 
onto the particle is 
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particles are attracted to the electric field intensity 
minima, and negative DEP (n-DEP) happens [84]. 
Based on this principle, a variety of devices have been designed for cell manipulation. 
For example, platelets are the smallest cells in blood and as such, have significantly 
different electrical properties than other cells. Therefore, A DEP-activated cell sorter 
device has been reported to perform size-based fractionation of blood samples and 
enrichment of platelets in a continuous flow [87]. Because the DEP force on a particle has 
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a cubic dependence on its radius, whereas the hydrodynamic drag force under laminar flow 
conditions only has a linear dependence, the ratio between DEP force and drag force has a 
quadric dependence on cell radius. In addition, DEP force can be tuned by controlling the 
applied voltages, and the drag force can be modulated by altering the flow rate, so that the 
two forces can also be changed independently. By adjusting both flow rate and applied 
voltage, cells with different radii will have different deflections in the microfluidic channel, 
and thus can be separated (Figure 1.14). In another example, target cells are tagged with 
polystyrene beads through an antibody and antigen interaction, whereas non-target cells 
are not tagged [88]. After introducing an external electrical field, the dielectrophoretically 
labeled cells (bead bound target cells) move along the electrical field gradient. However, 
the non-labeled cells (non-target cells) are not affected. Therefore, the target cells are 
directed to the collecting channel under the combination of hydrodynamic force and 
dielectric force, and non-target cells are simply carried to the waste channel by the flow 
(Figure 1.15). 
 
Figure 1.14: Operation principle of electrokinetic based cell manipulations according to 
different cell size: the larger cells experience a larger DEP force than the smaller cells 




Figure 1.15: Operation principle of electrokinetic based cell manipulation according to 
dielectrophoretical labeling [88]: (A) cells are only deflected into the collection stream only 
if they are dielectrophoretically labeled. (B) Schematic of device. 
1.3.2.3. Acoustic Cell Manipulation 
Acoustic cell manipulation depends on the acoustic forces generated in an acoustic 
standing wave field [89], in which particles move toward either the pressure node or the 
anti-node (Figure 1.16), depending on the properties of particles, such as density and 
compressibility. According to this principle, a variety of microfluidic devices have been 
designed to separate cells of different size or density [89-91]. For example, a method of 
free flow acoustophoresis has been reported to separate micrometer-sized or smaller 
particles into multiple fractions in a continuous flow mode [90]. The acoustic standing 
wave generated by an ultrasonic transducer induces lateral displacement in the laminar 
flow of the microchannel, leading to a particle gradient developed across the channel 
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(Figure 1.17A). By using several outlets, particles of different size can be collected 
(Figure 1.17B).  
 
Figure 1.16: Particles positioned, by the acoustic forces, in (A) the pressure nodal plane 
(B) the pressure anti-nodal plane of a standing wave [89]. 
 
Figure 1.17: (A) Particles are moved to the center of the channel at a rate determined by 
their acoustic properties. (B) Fractions of separated particles are collected at five 
consecutive outlets. [90] 
1.3.2.4. Optic Cell Manipulation 
Optic cell manipulation depends on the attractive or repulsive forces generated by a 
highly focused laser beam. It was first used to move micrometer-sized dielectric particles 
in water and air [92], after which it was employed in a series of different experiments from 
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the cooling and trapping of neutral atoms [93] to manipulating live bacteria and viruses 
[94, 95]. Optical forces consist of two components: a scattering force and a gradient force 
[96]. The scattering force is responsible for moving microparticles along the direction of 
light propagation, and the gradient force is responsible for suspending microparticles. A 
typical experimental setup for optic cell manipulation is shown in Figure 1.18 [96]. 
 
Figure 1.18: Layout of a typical cell manipulation implementation [96]. 
According to this principle, multiple microfluidic devices have been reported to 
achieve active cell manipulation [97-100]. For example, combining refractive multiple 
optical tweezers, microfluidics, and optical microscopy, contact-free immobilization of 
more than 200 yeast cells into a high-density array have been demonstrated, where the cell 
array can be moved to any specific region during operation (Figure 1.19) [97]. In another 
example, optical force has been used for rapid and active control of cell routing on a 
microfluidic chip. Cells were aligned to a narrow stream by hydrodynamic focusing, passed 
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through an analysis region and optical switch region, and flowed out to a waste channel. 
Cells identified to be target cells causes the optical switch to be activated, which deflects 
cell to the target output channel (Figure 1.20) [101].  
 
Figure 1.19: Optical cell trapping in a microfluidic device [97]. 
 
Figure 1.20: Layout of a microfluidic sorting junction and optical switch [101]. 
25 
 
1.3.2.5. Affinity-Based Cell Manipulation 
Affinity based cell manipulation is based on a highly specific interaction, such as the 
interaction between antigen and antibody, or receptor and ligand, and it enables target 
recognition. However, the application of affinity methods has some limitations. First, the 
interaction between probes and target cells must be much greater than the interaction 
between probes and non-target cells. Secondly, the immobilization of probes onto a 
substrate must be stable. Finally, a large effective probe area is required to enable high 
capture efficiency.  
Antibodies are immunoglobulin found on the B cell membrane surface or in blood and 
other bodily fluids, and are used by the immune system to recognize and counteract foreign 
objects, such as bacteria and viruses. Antibodies distinguish cell types by the proteins they 
express. The general structures of all antibodies are very similar, and only a small region 
at the amino terminal end (paratope) is tremendously variable [102]. This allows the 
immune system to recognize an equally wide diversity of antigens [103]. The antibodies 
bind to unique parts of antigens, called epitopes, with a highly specific interaction [104], 
which allows antibodies to identify and bind only with their unique antigens in the midst 
of millions of different molecules that make up an organism. It enables specific cell 
recognition followed by manipulation. 
Surface functionalization is used to immobilize cell-specific probes onto the substrate 
surface. Silanization is the most common method to modify various molecular functional 
groups to a silicon-based surface [105]. After cleaning, the surface is treated with some 
form of energy to generate hydroxyl groups. These reactive molecular groups can provide 
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a surface onto which other chemical groups can be attached. This process is usually 
accomplished by exposing the hydroxyl-functionalized surface to the silanization agent 
dissolved in a solvent (Figure 1.21). 
 
Figure 1.21: Basic process of silanization [105]. 
Figure 1.22 details how to immobilize a peptide, DNA, or protein on the 
polydimethylsiloxane (PDMS) surface, a silicon-based material, after silanization. 
Modification of PDMS-based microfluidic channels starts with the solution-phase 
oxidation reaction of PDMS surfaces (1), which is carried out by continuously passing a 
mixture of H2O/H2O2/HCl (in a volume ratio of 5:1:1) through the microchannels for 5 
min. After purging the microchannels with deionized (DI) water and dry air, the 
hydrophilic silanol-covered PDMS surfaces (2) were obtained. The silanol-covered PDMS 
microchannels (2) were reacted with (3-aminopropyl) trimethoxy silane (5) to generate the 
amino-grafted PDMS surfaces (6). The surface-grafted amino groups were converted to 
the isothiocyanate groups by introducing a 0.5% (v/v) thiophosgen solution in MeCN to 
the microchannels (6). Again, after purging with DI water and dry air, the isothiocyanate-
grafted PDMS microchannels (7) were then subjected to attachment reactions with a 
variety of amino-terminated biomolecules, including tripeptide RGD (arginine-glycine-
aspartic acid), ssDNA and PSCA (prostate stem cell antigen) protein to produce the RGD-
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grafted PDMS surfaces (8), the DNA-grafted PDMS surfaces (9), and the PSCA-grafted 
PDMS surfaces (10), respectively [106].  
 
Figure 1.22: Immobilization of peptide, DNA, or protein on PDMS surface [106]. 
Cell capture efficiency most strongly depends on the effective area of cell-specific 
probe functionalized surface and the shear stress applied on cell surface [107, 108]. 
Biomaterial surface topography has shown to influence protein adsorption to material 
surface. Nanoparticles can be applied to increase the amount of probes in a certain area 
(Figure 1.23). For example, selectins are a family of cell adhesion molecules, which can 
be used to capture and separate CD34+ hematopoetic stem and progenitor cells and human 
leukemia HL60 cells from peripheral blood. Compared with direct immobilization, more 
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HL60 cells were captured on the selectins modified surface using nanoparticles as mediated 
layer (Figure 1.24) [107]. 
 
Figure 1.23: Basic principle of increasing effective area using nanoparticles [107]. 
 
Figure 1.24: Example of nanoparticles to increase cell capture efficiency [107]. 
Shear stress is another important factor that affects capture efficiency. In order to 
optimize the required shear stress, the Hele-Shaw chamber (Figure 1.25) can be used to 
investigate dynamic cell attachment behavior at different shear stresses by creating a linear 
shear gradient [109]. By employing Anti-CD5 and anti-CD19 antibodies as cell capture 
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probes, more MOLT-3 and Raji cells were captured at lower shear stresses, respectively 
(Figure 1.26) [108].  
 
Figure 1.25: (a) Hele-Shaw chamber and (b) generated linear shear stress [109]. 
 
Figure 1.26: Number of cells captured under different shear stress on (a) anti-CD5 surface 
and (b) anti-CD19 surface [108]. 
According to this principle, antiepithelial cell adhesion molecule (anti-EpCAM) 
antibodies have been successfully immobilized onto the inner surface of a circulating tumor 
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cell chip (CTC-chip) containing an array of 78,000 silicon microposts with 970 mm2 of 
surface area (Figure 1.27) [110]. This CTC-chip was able to purify spiked non-small-cell 
lung cancer (NSCLC) cells (NCI-H1650) in whole blood with concentration ranging from 
50 to 50,000 cells/mL, and was also capable of purifying CTCs from whole blood samples 
donated by cancer patients, with analyzed volumes ranging from 0.9 to 5.1 mL. This work 
demonstrates that with proper design considerations, affinity-based methods can capture 
viable CTCs from whole blood sample without any preprocessing steps, and can be used 
in basic biological research and clinical diagnostics. 
 
Figure 1.27: Microfluidic device for CTC isolation. a, experimental setup; b, a silicon-
based CTC chip; c, whole blood sample flowing through the CTC chip; d, Scanning 
electron microscope (SEM) micrograph of a captured NCI-H1650 lung cancer cell [110]. 
Unfortunately, antibodies generally have limited stability, are expensive and time-
consuming to develop [111]. Aptamers, which are oligonucleotide or peptide molecules 
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that bind to a specific target molecule, such as small molecules [112, 113], peptides [114], 
amino acids [115, 116], proteins [116], cells [117, 118], viruses [119, 120], or  bacteria 
[121, 122], are good alternatives to antibodies. Compared with antibodies, aptamers 
provide a lot of advantages, such as the ability to control properties, synthetic 
reproducibility, biocompatibility, enhanced stability and flexible terminal modification 
[123], and thus are ideal specific probes for affinity-based cell manipulation, although 
conventional platform for developing cell-targeting aptamers are still labor-, time- and 
resource-intensive [124]. 
1.3.3. Microfluidic Aptamer Development 
Aptamers are isolated from a large random sequence pool of single-stranded 
oligonucleotides (ssDNA or ssRNA) through an in vitro process known as systematic 
evolution of ligands by exponential enrichment (SELEX) [125-127]. A typical SELEX 
process for ssDNA aptamer development (Figure 1.28) starts from incubating a random 
ssDNA library of 1013-1015 different sequences with the target. The unbound and weakly 
bound ssDNA is removed, leaving strongly bound ssDNA binding to the target (selection). 
The strongly bound ssDNA is then eluted and amplified via PCR (amplification). The 
amplified double strand DNA is subsequently separated into ssDNA, which is used for the 
next selection process. This iteration is repeated several times until the amplified ssDNA 




Figure 1.28: A typical SELEX process [128]. 
Conventional SELEX for Aptamer Development: As discussed above, a typical 
SELEX process includes two major steps, selection and amplification, which have been 
extensively explored in the field of biological research. Conventional SELEX platforms, 
therefore, combine different selection and amplification methods to realize the 
development of aptamers for a large number of target molecules. 
Most current conventional SELEX processes utilize PCR to amplify the isolated 
sequences. Due to the designable known priming regions, PCR can rapidly and easily 
duplicate the separated ssDNA sequence at low cost. 
The selection process commonly employs one of two separation methods: solution-
based methods and solid-phase-based methods. For solution-based methods, target 
molecules are incubated with an ssDNA library in solution, which allows maximal binding 
efficiency between them. Then, the binding oligomers are separated from non-binding 
strands, using capillary electrophoresis [129], gel electrophoresis [130], centrifugation 
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[131], or electrophoretic mobility shift [132], and then used for amplification. For the solid-
phase-based method, target molecules are immobilized in agarose or sepharose matrix in 
an affinity column [133]. The strong binding strands capture the targets, and thus remain 
in the column. The weak binding oligomers are removed during washing. The captured 
strands are then eluted by changing the environmental condition, and collected to be 
amplified.  
These methods are labor- and time-intensive, requiring tedious pipetting steps for both 
selection and amplification processes, and thus cost a large amount of time and effort to 
successfully develop an aptamer for a single target [134]. Therefore, researchers have been 
investigating the integration of all necessary procedures using robotic workstations for 
sample and reagent dispensing [135, 136], and thus trying to eliminate human intervention 
during iterations. However, these automatic workstations consist of a number of expensive 
equipment, and require a large amount of reagents. Therefore, it is highly desired to 
develop a miniaturized system that can implement the whole SELEX procedure.  
Microfluidic SELEX for Aptamer Development: Microfluidics, which provides 
better efficiency, shorter assay duration and automated reactions, has been recently 
investigated to address issues in conventional SELEX described above.   
Hybarger and coworkers first reported a microfluidic SELEX system consisting of 
fused-silica microlines with surface immobilized proteins for isolation of target-binding 
strands, and a conventional thermal cycler for strand amplification (Figure 1.29) [137]. 
Although the system required extensive manual assembly, it proved the possibility of 
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performing SELEX in an integrated device and minimizing tedious manual sample transfer 
steps. 
 
Figure 1.29: The first integrated microfluidic SELEX system prototype [137]. 
Since PCR in a microdevice has been well investigated since 1994 [138], researchers 
primarily explored the development of microfluidic device for target-binding strand 
selection [124, 139-141]. For example, Soh and coworkers developed a continuous flow 
magnetic actuated cell separation (CMACS) system to isolate weak- and un-bound 
oligomers (Figure 1.30) [139]. In their approach, targets were immobilized on magnetic 
beads, which were then incubated with random ssDNA library, leading to surface-bound 
strong binders and free weak binders. The magnetic beads were then guided to the center 
of the microfluidic channel through a localized magnetic field generated by surface-
patterned ferromagnets. Due to the highly efficient washing provided by the continuous 
flow, this method could generate ssDNA aptamers with strong binding affinity in only a 




Figure 1.30: The CMACS system to isolate weak- and un-bound oligomers [139]. 
Recently, researchers have been working on the development of fully integrated 
microfluidic SELEX systems that can perform all necessary procedures without any human 
interference [142-146]. For example, Lee and coworkers immobilized target molecules on 
magnetic beads, which were retained in a single microfluidic chamber by a ferromagnet 
located beneath the chamber (Figure 1.31) [142]. The reagents, samples and products were 
pneumatically introduced into and sucked out of the microchamber during different stages 
of the SELEX process. However, the selection condition was restricted to using PCR buffer 
and it was unclear how to separate and collect amplified ssDNA after the amplification 
procedure. The use of unpurified/not well purified ssDNA significantly decreases the 





Figure 1.31: A magnetic bead based microfluidic system for integrated SELEX [142]. 
1.4. Objective and Significance 
The completion of the Human Genome Project has enabled greater understanding of 
the roles of genes in human development and physiology. Applying these advances to 
cancer care, genetically based diagnosis can be attained by identifying genetic variations 
that may directly contribute to disease development of individual patients, thereby 
achieving one of major goals of personalized medicine [25]. On the other hand, genetic 
information alone may not be sufficient for personalized medicine. Diseases that are 
identical at the molecular level may differ at the cellular level; a drug that is effective for 
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one patient may not be effective for another patient with the identical genotype [27]. Thus, 
we envision that personalized medicine could be enabled by microsystems which combine 
genetic analysis and drug effect screening of cancer cells for individual patients. Such 
microsystems would accept whole blood samples or other body fluids from individual 
patients, purify and retrieve tumor cells, and then identify genetic variation and perform 
anti-cancer drug screening. 
This thesis addresses the development of MEMS-based microfluidic devices toward 
personalized cancer medicine. Focusing on SNP genotyping, cell array formation, specific 
enrichment and nondestructive retrieval of cells using aptamers, and synthetic isolation of 
cell-targeting aptamers on microfluidic surfaces, these devices provide critical analytical 
capabilities required by genetic variation identification and cell manipulation at the 
individual patient level, and can hence be used as building blocks to ultimately realize fully 
integrated microsystems for personalized cancer diagnostics and therapeutics. 
1.5. Contributions of Thesis Research 
Allele-specific primer extension based SNP genotyping: Two microfluidic 
approaches have been developed to achieve high-throughput and multiplexed SNP 
genotyping. The bead-based approach uses solid-phase-based reactions in a single 
microchamber, in which all the reactions, including polymerase chain reaction (PCR), 
allele specific single base extension (SBE) and desalting, are performed. The easy design, 
fabrication and operation of the microfluidic device enable high-throughput detection of 
SNPs. Meanwhile, the solution-based approach integrates SBE, solid-phase purification 
(SPP), chemical cleavage and reverse-phase desalting onto a single microfluidic device. 
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Along with the employment of mass-tagged dideoxynucleotides, the multiplexing 
capability has been significantly improved. This microfluidic device is amenable to 
parallelization, and can be ultimately produced in array format to allow simultaneous 
analysis of samples from a large number of different sources, such as different patients. 
Aptameric specific cell capture and temperature-mediated cell release: We 
employed aptamers to achieve specific cell capture on microfluidic surfaces. More 
importantly, the microfluidic device has been designed to investigate the temperature 
dependence of binding affinity between aptamers and cells, which allows for 
nondestructive retrieval of target cells, eliminating the use of potentially harsh chemicals. 
In addition, the aptamer-cell binding reaction is reversible, making the aptamer-
functionalized surface regenerative and this capture and release strategy highly repeatable. 
The studies presented in this thesis elucidate, for the first time, the temperature dependence 
of aptamer-cell binding affinity in microfluidic devices for applications such as cell 
purification.   
Mechanically tunable cell trapping: To realize controllable cell trapping, we, for the 
first time, exploited the large compliance of elastomers to establish a tunable cell trapping 
microchip. The dimensions of these microstructures can be mechanically modulated by 
simply inducing uniformly distributed strain via the application of an external force on the 
chip, so as to precisely control the number of cells captured at the single and individual cell 
level. 
Development of cell-specific aptamers: To synthetically isolate cell-targeting 
aptamers from a randomized ssDNA library, we developed a microfluidic device that 
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integrates cell culturing with affinity selection of cell-binding ssDNA, which is then 
amplified by bead-based PCR. The on-chip cell culturing provides an ideal approach for 
cell membrane protein regeneration, as well as restraining cells in the selection chamber. 
The bead-based PCR significantly facilitates the ssDNA separation after the amplification 
process, eliminating the contamination of complementary strands. In addition, transfer 
between the selection and amplification chambers using pneumatic controlled pressure-
driven flow realizes multi-round aptamer isolation on a single chip, as well as reducing 
potential damage to cells caused by electrical fields in our previous work. 
1.6. Organization of Thesis 
In this thesis, we focus on the development of key technologies for microfluidic cell 
manipulation, genetic analysis, and selection of aptamers specific to cells. Following this 
introduction, Chapter 2 develops a bead-based genotyping approach to detect single-base 
mutations associated with sickle cell anemia, in a single chamber. Chapter 3 designs, 
fabricates and optimizes an integrated microsystem for multiplex SNP genotyping. 
Compared with the bead-based approach developed in Chapter 2, this multi-step solution-
based approach utilizes the mass-tagged dideoxyribonucleotides for SBE and integrates the 
functions of sample purification and desalting on solid-phase surfaces, and thus has an 
improved single-to-noise ratio and enhanced multiplexing capability. Chapter 4 
investigates the temperature response of binding affinity between surface-immobilized 
aptamers and cells, which demonstrates the feasibility of using aptamers to specifically 
separate target cells from a heterogeneous solution and employing environmental changes 
to retrieve purified cells. Based on this technique, Chapter 5 explores the spatially specific 
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capture and selective temperature-mediated release of cells using the same aptamers, which 
provides the potential to establish cell arrays on pre-defined regions and to only collect 
interested cell groups for downstream analysis. Chapter 6 presents a tunable microfluidic 
device for physically modulated cell trapping, which enables the trapping of various 
numbers of cells using a unique device. Chapter 7 describes the design and some 
preliminary results for a hydrodynamic based SELEX platform for cell-specific aptamer 
development, in which multiple rounds of SELEX have been successfully performed. 




Chapter 2. Microfluidic Genotyping of Single-Nucleotide 
Polymorphisms: a Bead-Based Approach 
In this chapter, a bead-based single-nucleotide polymorphism (SNP) genotyping 
device is presented. Polymerase chain reaction (PCR), allele specific single-base extension 
(SBE), and desalting on microbeads are performed in a single microchamber situated on a 
temperature control chip, which is coupled with matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) to analyze the SBE product. 
Experimental results from genotyping of the SNP on exon 1 of HBB gene, which causes 
sickle cell anemia, demonstrate the potential of the device for rapid, accurate, multiplexed 
and high-throughput detection of SNPs. The work presented in this chapter has resulted in 
a peer-reviewed conference proceeding [147] and a journal publication [148]. 
2.1. Introduction 
Genetic mutations take many forms, ranging from chromosome anomalies to single-
base substitutions [149]. Among them, SNPs, which are single nucleotide variations in the 
genome between different individuals, are the most common form, occurring 
approximately once every 1000 bases [150]. SNPs can be used as genetic markers to 
identify genes associated with complex disease [151, 152]. Therefore, accurate 
identification of SNPs is of great utility to disease diagnosis and prognosis [153-155]. 
Genotyping of SNPs can be based on enzymatic cleavage, allele specific hybridization, 
allele specific ligation or cleavage, and allele specific primer extension [49]. Enzymatic 
cleavage, illustrated in Invader® Assays [52, 53], utilize thermostable flap endonucleases 
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(FEN) and fluorescence resonance energy transfer (FRET) to recognize and detect SNP by 
the annealing of allele-specific overlapping oligonucleotides to the target DNA. While it is 
highly accurate, this method is generally time-consuming and difficult to multiplex (i.e., to 
detect multiple SNPs in one reaction). Allele-specific hybridization, used for example in 
the Affymetrix® Human SNP Array [55], is based on matched or mismatched probes 
annealing to the target DNA sequence adjacent to the SNP site [155]. This method allows 
detection of up to 2 million SNPs simultaneously, but it requires labor-intensive genomic 
DNA (gDNA) digestion, fractionation and amplification, and is prone to unspecific binding 
that leads to false positives [156]. Allele-specific ligation or cleavage combines the 
hybridization of probes specific to the target DNA sequence and the specificity of the ligase 
enzyme (e.g., SNPlexTM Assay [157]) or 5’ nuclease (TaqMan® Assay [157]) to distinguish 
matched or mismatched nucleotides. These assays have a very high level of specificity, but 
their applicability is hindered by slow reaction speeds and the limited number of modified 
probes available [49]. Allele-specific primer extension, which involves allele-specific 
incorporation of nucleotides during primer extension [49, 50], is an emerging SNP 
genotyping method that offers flexibility and robustness. The discrimination between 
different incorporated nucleotides is based on either fluorescence (e.g., Illumina® Infinium 
Assays [158]) or mass spectrometry (e.g., Sequenom® iPlex Assays [60]). While rapid, 
accurate and capable of multiplexing, they require complicated design of primers and 
fluorescent-tagged or mass-tagged nucleotides [159, 160]. There is hence a strong need for 
new genotyping platforms to address these issues. 
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Microfluidics technology can potentially enable fast, low-cost, and automated SNP 
detection with improved sensitivity, resolution, accuracy, efficiency and throughput, as 
well as minimized sample consumption [62]. The aforementioned genotyping principles 
have been implemented in microfluidic systems to generate modified DNA indicative of 
SNPs, which is then detected by methods such as electrophoresis and bioluminescence [62, 
161]. Electrophoresis, in which an applied electric field separates DNA fragments by 
charge-to-mass ratio, provides high accuracy with reduced buffer and sample consumption, 
but has limited potential in high throughput and multiplexed genotyping [63]. 
Alternatively, bioluminescent methods utilize fluorescent probes to provide either high 
sample throughput [162-165] or high accuracy [166] along with enhanced sensitivities and 
reduced time, sample and reactant consumption, but are limited by false positives and an 
inability to multiplex. Therefore, more research is needed to develop microfluidic SNP 
detection systems that offer improved accuracy, ability to multiplex, and increased 
throughput. 
This chapter presents a bead-based SNP genotyping approach using solid-phase based 
reactions in a single microchamber on a temperature control chip. PCR, allele specific SBE 
and desalting on microbeads are performed in the single microchamber, and are coupled 
with MALDI-TOF MS to identify SBE products. The use of SBE and MALDI-TOF MS 
provides the possibility of accurate, fast and multiplexed detection [167-169]. The single 
chamber design eliminates the use of on-chip valves, resulting in greatly simplified fluid 
handling, and integration of PCR with SBE on-chip has the potential to improve assay 
efficiency. Miniaturization reduces sample and reagent consumption, and when 
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implemented in array format, this integrated SNP detection approach can potentially allow 
parallelized and high-throughput analysis of patient samples. We demonstrate this bead-
based SNP genotyping approach by detecting the SNP on exon 1 of HBB gene located in 
chromosome 11, which alters the sixth amino acid in the beta hemoglobin to cause sickle 
cell anemia, a life-threatening disorder [170]. 
2.2. Principle and Design 
2.2.1. Principle of Bead-Based SNP Genotyping 
Our bead-based SNP genotyping method performs PCR, SBE, and desalting reactions 
on microbeads in a single microchamber. The chamber is first packed with polymer 
microbeads that are functionalized with reverse primers via a biotin-streptavidin link and 
mixed with the target template DNA and PCR reagents, followed by thermal cycling to 
generate double-stranded DNA (dsDNA) (Figure 2.1A&B), which is then purified by a 
buffer wash (Figure 2.1C). By introducing NaOH solution, template single-strand DNA 
(ssDNA) is chemically eluted, leaving ssDNA complementary to the template on the 
microbeads (Figure 2.1D) to be analyzed in the following steps. Subsequently, SBE 
reactants are introduced, and allele-specific primers anneal to the complementary strand 
immediately adjacent to the polymorphic site. These primers then undergo SBE, by 
thermally cycling the reaction mixture in the presence of dideoxyribonucleotide 
triphosphates (ddNTPs) and enzyme, to generate primers extended by only one base 
(Figure 2.1E) [169]. Washing with deionized water (DI water) then removes free primers, 
salts and any other impurities for purification of the bead-bound extended and unextended 
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allele-specific primers (Figure 2.1F). The additional nucleotide is then identified 
according to the difference in mass between the extended and unextended primers. 
 
Figure 2.1: Principle of bead-based SNP detection. (A) The first cycle of PCR on bead-
immobilized reverse primers generates dsDNA. (B) Additional PCR cycles generate 
dsDNA. (C) A buffer wash purifies bead-bound dsDNA. (D) Template ssDNA is 
chemically eluted from beads. (E) SBE is performed on bead-bound ssDNA 
complementary to the template. (F) The SBE product is purified and then desalted for 
subsequent MALDI-TOF MS detection. 
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2.2.2. Design and Fabrication 
The microfluidic device used to demonstrate the bead-based SNP genotyping approach 
consists of a polydimethylsiloxane (PDMS) microchamber situated on a temperature 
control chip integrated with a micro heater and temperature sensor (Figure 2.2A&B). The 
tapered microchamber (Figure 2.2A&B, 150 µm in height) with an approximately 5 µL 
volume contains dam-like structures (Figure 2.2A&B, 15 µm in height), called weirs, to 
retain microbeads (50 - 80 µm in diameter) during wash steps. The surfaces of 
microchamber are coated with Parylene C to prevent evaporative loss of reactants [171]. 
On the temperature control chip, a resistive sensor (16.5 mm L × 50 µm W) is located 
beneath the center of the chamber, and a resistive serpentine-shaped heater (296 mm L × 
500 µm W) surrounds the temperature sensor. Thus, the chamber is heated with its 
temperature near the center measured by the sensor to complete a closed-loop temperature 
control setup. 
The temperature control chip was first fabricated using standard microfabrication 
techniques. Briefly, a glass slide (Fisher HealthCare, Houston, TX) was cleaned by piranha. 
Chrome (10 nm) and gold (100 nm) thin films were deposited by thermal evaporation and 
patterned by wet etching. Then, a passivation layer of 1 µm of silicon dioxide was deposited 
using plasma-enhanced chemical vapor deposition (PECVD). Finally, the on-chip 
temperature sensor and heater were equipped with contact pads (2.5 mm  2.5 mm, also 
fabricated from gold), which were opened by etching the oxide layer using hydrofluoric 
acid and connected to measurement instruments via wire bonding (Figure 2.2C). 
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In parallel, the microfluidic chamber was fabricated from PDMS (Sylgard 184, Dow 
Corning Inc. Midland, MI) using soft lithography techniques. SU-8 photoresist 
(MicroChem Corp., Newton, MA) was spin-coated and patterned on a silicon wafer to form 
mold-defining microfluidic features. Next, a PDMS prepolymer solution (base and curing 
agent mixed in a 10:1 ratio) was cast onto the mold and cured on a hotplate at 72 °C for 1 
hour (Figure 2.2D).  
 
Figure 2.2: (A) Schematic of the bead-based SNP genotyping device. (B) Cross-sectional 
view along line a-a illustrating the layered structure of the device. (C) - (G) Fabrication 
process for the device: (C) Deposition, patterning and passivation of gold sensor and 
heater; (D) Fabrication of SU-8 mold; (E) Demolding of PDMS microchamber, and 
bonding between microchamber and temperature control chip; (F) Deposition of Parylene 
C; (G) Packing of streptavidin beads. 
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Subsequently, the inlet and outlet were punched on the resulting sheet bearing the 
microfluidic features, which was then bonded to the temperature control chip after 
treatment of the bonding interfaces with oxygen plasma for 15 seconds (Figure 2.2E).  
Finally, the surface of the microchamber was coated with a thin layer of Parylene C 
via chemical vapor deposition (Figure 2.2F), prior to packing streptavidin beads (Figure 
2.2G). An image of a fabricated device is shown in Figure 2.3.  
 
Figure 2.3: Photograph of a fabricated device. 
2.3. Experimental 
2.3.1. Materials 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
indicated. Streptavidin beads (Pierce Streptavidin Plus UltraLink Resin) were obtained 
from Thermo Fisher Scientific Inc. (Rockford, IL). ddNTPs were purchased from Jena 
Bioscience GmbH (Jena, Germany). Deoxyribonucleotide triphosphates (dNTPs) and 
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GoTaq Flexi DNA Polymerase were obtained from Promega Corp. (Madison, WI). Thermo 
Sequenase was purchased from GE Healthcare (Piscataway, NJ). Template DNA, 
including a mutated type (5’-CCT CAC CAC CAA CTT CAT CCA CGT TCA CCT TGC 
CCC ACA GGG CAG TAA CGG CAG ACT TCT CCA CAG GAG TCA GAT GCA CCA 
TGG TGT CTG TTT GAG GTT GCT AGT GAA CAC AGT TGT GTC AGA AGC AAA 
TGT AAG CAA TAG ATG GCT CTG CCC TGA CT-3’, the SNP site is underlined and 
SBE primer annealing site is italic) and an unmutated type (5’-CCT CAC CAC CAA CTT 
CAT CCA CGT TCA CCT TGC CCC ACA GGG CAG TAA CGG CAG ACT TCT CCT 
CAG GAG TCA GAT GCA CCA TGG TGT CTG TTT GAG GTT GCT AGT GAA CAC 
AGT TGT GTC AGA AGC AAA TGT AAG CAA TAG ATG GCT CTG CCC TGA CT-
3’, the SNP site is underlined and SBE primer annealing site is italic) of the HBB gene, 
double biotin modified reverse primer (5’-double biotin-AGT CAG GGC AGA GCC ATC 
TA-3’), fluorescein amidite (FAM) modified forward primer (5’-FAM-CCT CAC CAC 
CAA CTT CAT CC-3’, M.W. = 6651), and SBE primer (5’-ACG GCA GAC TTC TCC-
3’, M.W = 4513) were synthesized and purified by Integrated DNA Technologies 
(Coralville, IA). 
2.3.2. Experimental Setup 
Closed-loop temperature control of the microchamber was achieved using the 
integrated temperature sensor, heater, and the fan under the temperature control chip with 
a proportional-integral-derivative (PID) algorithm implemented in a LabVIEW (National 
Instruments Corp., TX) program on a personal computer. The resistance of the sensor was 
measured by a digital multimeter (34420A, Agilent Technologies Inc., CA), and the heater 
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and fan were connected to two DC power supplies (E3631, Agilent Technologies Inc., CA) 
respectively. The inlet was connected to a syringe that contained reaction buffer or washing 
buffer driven by a syringe pump (KD210P, KD Scientific Inc., MA). The outlet was 
connected to a microcentrifuge tube for collection of genotyping product to MALDI-TOF 
MS or experimental waste. All fluorescent images of beads were taken using an inverted 
epifluorescence microscope (Diaphot 300, Nikon Instruments Inc., NY) with a CCD 
camera (Model 190CU, Micrometrics, NH), after removing the device from the fan (Figure 
2.4). 
 
Figure 2.4: Experimental setup for bead-based SNP genotyping. 
2.3.3. Experimental Procedure 
Just prior to experimentation, the streptavidin beads in the microchamber were rinsed 
with binding and washing (B&W) buffer (5 mM Tris-HCl, 0.5 mM EDTA, 1 M NaCl, and 
0.01% Tween 20, pH=7.5). The reverse primer (50 pmol) in B&W buffer was introduced 
and incubated with the beads for 30 min, followed by washing with B&W buffer at 10 
L/min for 10 min.  
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Bead-based PCR was performed for 30 thermal cycles as follows: 95 °C for 15 s, 56 °C 
for 30 s, and 72 °C for 30 s. A 5 L sample of PCR reactants was introduced twice, prior 
to cycling and between 15th and 16th cycle, and each sample consisted of 0.08 pmol of 
template, 8.33 pmol of forward primer, 1× GoTaq Flexi Buffer, 0.83 units of GoTaq Flexi 
DNA Polymerase, 1.67 nmol of dNTP and 6.25 nmol of MgCl2 (1.25 mM). The microbeads 
were then rinsed with 0.15 mM NaOH in B&W buffer at 5 L/min for 10 min to elute 
template ssDNA, followed by a rinse of pure B&W buffer at 10 L/min for 10 min, leaving 
complementary strand on the beads. 
To perform SBE, the SBE primer targeting the SNP on the complementary sequence 
of exon 1 of the HBB gene was extended by a single base in the microchamber using 
ddNTPs. A 5 L sample of SBE reactants was introduced to the microchamber twice, prior 
to SBE and between 5th and 6th thermal cycle, and underwent 10 thermal cycles as follows: 
90 °C for 15 s, 40 °C for 30 s, and 70 °C for 30 s. Each SBE reactant consisted of 6.67 
pmol of primer, 16.67 pmol of ddNTP, 1× Thermo Sequenase reaction buffer and 2.67 
units of Thermo Sequenase. 
The microchamber was then rinsed using B&W buffer at 5 L/min for 10 min, 
followed by desalting with DI water at 5 L/min for 20 min. Finally, the microchamber 
was incubated at 95 °C for 1 min, followed by a rinse with DI water at 20 L/min and 





2.4. Results and Discussion 
This section presents and analyzes experimental results from the fabricated bead-based 
SNP genotyping device. We first characterize the temperature control chip. Then, bead-
based PCR, chemical elution, in-situ desalting and thermal elution are performed using 
exon1 of the HBB gene to characterize each functional unit. Finally, the integrated 
procedure is executed on-chip to demonstrate successful SNP genotyping. 
2.4.1. Temperature Control Characterization 
The temperature-resistance relationship of the thin-film gold temperature sensor was 
calibrated following fabrication. The experimental data showed that the measured 
resistance (R) of the sensor exhibited a highly linear relationship with temperature (T), 
which can be fitted to R = R0 [1 +  (T - T0)], where R0 is the sensor resistance at reference 
temperature T0, and  is the temperature coefficient of resistance (TCR) of the sensor. The 
TCR was determined to be 3.06×10-3 °C-1 for a typical chip, which had a reference 
resistance of 83.44 Ω at a reference temperature of 21.9 °C. Time-resolved tracking of on-
chip thermal cycling showed that the chamber temperatures attained specified setpoints via 
control of the on-chip heater and off-chip fan quickly and precisely (Figure 2.5). The 
thermal time constant of a typical temperature control chip was 126 s based on an 
exponential fit. The time constants of closed loop temperature control (based on an 
exponential fit) were 1.4s for heating from 56°C to 72°C, 1.9 s for heating from 72 °C to 
95 °C and 8.7 s for cooling from 95 °C to 56 °C, which represented a significant 
improvement over typical time responses of conventional PCR thermal cyclers (e.g., 6s for 
heating from 56°C to 72°C, 8 s for heating from 72 °C to 95 °C, and 16 s for cooling from 
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95 °C to 56 °C for the Eppendorf Mastercycler® Personal used in our related experiments 
below).  
 
Figure 2.5: Time-resolved tracking of the chamber temperature. 
2.4.2. Characterization of Bead-Based PCR and Chemical Elution 
To characterize bead-based PCR, reactants were thermally cycled on-chip and 
fluorescent bead intensity was then measured and compared to control tests. To obtain 
consistent results under controlled experimental conditions, template DNA was used as the 
target sequence for the characterization. After B&W buffer washing, the fluorescent 
intensity of beads was significantly higher than those without thermal cycling, enzyme or 
templates, which were only 5%, 7% and 16% of the original test (Figure 2.6A). This 
indicates that the bead-based PCR process did amplify template DNA and that the 





Figure 2.6: (A) Characterization of bead-based PCR: fluorescent intensity of beads with 
different PCR parameters, measured in arbitrary units (a.u.). (B) Verification of removal 
of template ssDNA by NaOH: fluorescent intensity of beads before and after rinsing with 
NaOH, and after introduction of FAM-modified forward primers. Error bars represent 
standard deviations based on four independent measurements of fluorescent microbeads. 
Prior to SBE, template ssDNA generated during PCR must be removed from the bead-
bound complementary strand. To test the efficiency of the chemical elution method, the 
template ssDNA was first amplified using fluorescently labeled forward primers and 
double biotinylated reverse primers in a conventional thermal cycler, and the amplification 
product was immobilized onto the streptavidin beads, which were packed in the 
microchamber afterwards. The fluorescent intensity of the beads was then measured before 
and after rinsing with buffer containing 0.15 mM NaOH. The fluorescent intensity of rinsed 
beads was 87% lower than that of pre-elution beads (Figure 2.6B), indicating that most 
template ssDNA had been removed from the bead surface. To further demonstrate that the 
template ssDNA had been removed from the beads, rather than the dsDNA, 5 L of 5 M 
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FAM-modified forward primers in 1× PCR buffer was introduced into the microchamber. 
After incubating at 56 °C for 1 min, followed by washing with B&W buffer, the fluorescent 
intensity of the beads was similar to that before introduction of the NaOH elution (Figure 
2.6B), which suggested that complementary strand remained bound to the beads following 
the elution of template ssDNA. These results indicate a sufficiently high on-chip chemical 
elution efficiency using NaOH. 
2.4.3. Verification of Thermal Elution and In-Situ Desalting 
To generate a DNA solution prior to detection with MALDI-TOF MS, hybridized 
primers must be desalted and then thermally eluted into DI water. The effect of desalting 
and the efficiency of the thermal elution method were tested to ensure that DNA loss during 
this step would not compromise detection by MS. The fluorescently labeled forward primer 
in B&W buffer was first hybridized to the ssDNA on the beads and desalted with DI water. 
The fluorescent intensity of the beads was then measured before and after rinsing at 95 °C, 
and the elution product was manually pipetted to a MALDI plate and tested using MALDI-
TOF MS. During desalting, the microchamber was rinsed with DI water, and the 
fluorescent intensity remained at 95.5% of pre-desalting intensity (Figure 2.7A). The 
chamber temperature was then elevated to elute hybridized primers. After elution, the 
fluorescent intensity of the beads was only 26% of pre-desalting intensity and 28% of pre-
elution intensity (Figure 2.7A). To control for effects of temperature on fluorescent 
intensity, fluorescently labeled microbeads were heated in the thermal cycler for different 
durations. As shown in Figure 2.7B, it was obvious that heating for 4 min did not generate 
a noticeable change in fluorescent intensity, which showed that the intensity of the 
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fluorescent label was stable in response to elevated temperatures, and that elution of 
primers was indeed the reason for the decrease in fluorescent intensity. Furthermore, 
following MALDI-TOF MS, a distinct mass spectral peak at 6651 m/z (Figure 2.7C) 
indicated effective desalting efficiency, showing the promise of using this method to desalt 
and elute genotyping products. The repeated experiments have shown similar results, from 
all of which the mass spectral peaks can be recognized consistently. These results 
demonstrate effective in-situ desalting and efficient thermal primer elution. 
 
Figure 2.7: Verification of thermal elution and in-situ desalting. (A) Fluorescent intensity 
of beads before desalting, after desalting and after denaturation procedure. (B) Fluorescent 
intensity of FAM-labeled microbeads following heating. (C) A MALDI-TOF mass 
spectrum of thermally eluted FAM-modified forward primers. Error bars represent 
standard deviations based on four independent measurements of fluorescent microbeads. 
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2.4.4. Integrated SNP Detection 
Having tested the individual procedures necessary for SNP detection, the procedures 
were integrated and the SBE products were analyzed using MALDI-TOF MS. 
Theoretically, the mass of extended primer can be calculated according to the equation mp 
= mr + mn – mb, where mp is the mass of extended primer, mr is the mass of unextended 
primer, mn is the mass of corresponding ddNTP and mb is the mass of bond formation (175 
m/z). We detected SNPs on both mutated HBB gene and unmutated HBB gene. As the 
target nucleotides of the mutated and unmutated template DNA are adenosine and 
thymidine, a single dideoxyadenosine triphosphate (ddATP, M.W. = 472) and 
dideoxythymidine triphosphate (ddTTP, M.W. = 463) were incorporated into each primer, 
respectively. Thus the mass of the product for mutated and unmutated HBB gene were 
respectively expected to be 4810 Daltons (4513+472-175), as shown by the distinct peak 
at 4810 m/z in Figure 2.8A, and 4801 Daltons (4513+463-175), as shown by the peak at 
4801 m/z in Figure 2.8B. The peak located at 4513 m/z in both Figure 2.8A and Figure 
2.8B was induced by unextended primers, which would not compromise the identification 
of the nucleotide at a SNP site. Repeated experiments on genotyping of both mutated and 





Figure 2.8: MALDI-TOF mass spectrum of SNP detection product with all operations 
integrated. (A) Mass spectrum of genotyping mutated HBB gene. (B) Mass spectrum of 
genotyping unmutated HBB gene. (*: extended SBE primer) 
2.5. Conclusion 
We have developed a bead-based genotyping approach by incorporating PCR, SBE 
and desalting using solid-phase-based reactions in a single microfluidic chamber, and 
coupling this method to MALDI-TOF MS. The device consists of a microchamber that is 
situated on a temperature control chip integrated with a temperature sensor and heater, and 
is equipped with weirs to retain microbeads during wash steps. The microchamber surfaces 
are coated with Parylene C to prevent sample loss. The integrated temperature sensor and 
heater allow closed-loop temperature control for thermal cycling and thermally induced 
primer elution. By employing such solid-phase-based reactions, our approach can 
significantly simplify fluid handling by avoid utilizing any on-chip valves, and hence 
potentially be applicable for high-throughput assays. 
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Our experiments have shown efficient on-chip thermal cycling using the device 
design, which enables effective bead-based PCR, SBE and thermal elution. In addition, 
successful chemical elution using NaOH has been achieved. Subsequently, the capability 
of the device to perform in-situ desalting using solid-phase-based reactions was 
demonstrated. Finally, genotyping of SNPs on both a mutated and an unmutated HBB gene 
using the presented device was performed, coupled with MALDI-TOF MS. The 
nucleotides at SNP sites have been successfully recognized, although a 100% nucleotide 
incorporation was not achieved and could be addressed by running a larger number of 
cycles and introducing more effective mixing during thermal cycling. 
In addition to successfully detecting an individual SNP, these results also indicate the 
compatibility of our approach with multiplexed genotyping. For example, if multiple 
primers are used to perform an extension simultaneously, each primer can detect a different 
SNP. Because the maximum molecular weight of ddNTPs is 488 Daltons 
(dideoxyguanosine triphosphate, ddGTP), by ensuring that the primers are designed with a 
mass difference of at least 500 Daltons, the mass spectrum of each different primer and 
extended products will not overlap. As a result, different mass spectral peaks can be 
recognized in the same spectrum to detect multiple SNPs. 
Further study will involve the development of device that employs a more efficient 





Chapter 3. Microfluidic Multiplex Genotyping of Single-
Nucleotide Polymorphisms: a Multi-Step Solution-Based 
Approach 
The bead-based single-nucleotide polymorphism (SNP) genotyping approach 
described in Chapter 2 demonstrated the feasibility of integrating polymerase chain 
reaction (PCR), allele specific single-base extension (SBE), and desalting into a single 
microchamber for SNP genotyping. However, due the insufficient purification method, that 
approach is not able to eliminate all impurities in the product and is not suitable for 
multiplexing.  
In this chapter, a multi-step SNP genotyping microfluidic device, which performs 
single-base extension of SNP specific primers and solid-phase purification (SPP) of the 
extension products on a temperature-controlled chip, is presented. The products generated 
by the device are ready for immediate detection by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), providing 
identification of the alleles at the target loci. The integrated device enables efficient and 
automated operation, while maintaining the high accuracy and sensitivity provided by MS. 
The multiplex genotyping capability was validated by performing rapid, accurate and 
simultaneous detection of 4 loci on a synthetic template. The work presented in this chapter 






The successful sequencing of the human genome has offered opportunities for the 
interrogation of subtle genetic variations to elucidate the genetic bases of biological 
functions and diseases. SNPs are the most abundant type of genetic variations, with more 
than 10 million SNPs in public databases, occurring approximately once every 100 to 300 
bases in the human genome [48]. SNPs provide the genetic fingerprint of an individual, 
which is essential for genome-wide association studies and genetic biomarker discovery. 
Moreover, some SNPs are often associated with a phenotypic change or may directly 
contribute to disease development.  For example, a somatic point mutation at codon 600 of 
the v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene results in an amino 
acid change from valine to glutamate. This mutation activates the BRAF kinase and has 
been associated with a variety of tumor types, particularly melanomas [175, 176]. In 
addition, it provides a cancer therapy target and has been used in patient screening to 
identify responsive groups to BRAF kinase inhibitors, such as vemurafenib [177]. Thus, 
the accurate detection of SNPs is of great importance for disease prevention, diagnosis, 
prognosis, and prediction of drug responsiveness, and has become an indispensable tool in 
personalized medicine. With the increasing demand for SNP detection, there are more and 
more samples needed to be handled in a cost- and time-effective manner. While it is 
challenging, the capability to accurately process multiple different samples in parallel is 
becoming essential in biological applications.    
A variety of biological methods have been developed for SNP genotyping, including 
the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) 
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[51], DNA hybridization [55], TaqMan [178], allele-specific ligation [57] and allele-
specific SBE [179], using detection schemes such as fluorescence detection and mass 
spectrometry (MS). The introduction of micro- and nanotechnology has revolutionized 
biological analysis, as the miniaturization of assays facilitates integration, improves speed, 
efficiency and accuracy, reduces labor, and provides the potential for high-throughput and 
point-of-care applications. Furthermore, the use of smaller sample volumes lowers reagent 
consumption and energy requirements, and shortens reaction cycles [180, 181]. Integrated 
with micro- and nanotechnology, a variety of genotyping microdevices have been explored. 
For example, the allele-specific hybridization and ligation protocols with fluorescent 
detection have been incorporated into a microchip for the determination of influenza virus 
subtypes [182], and for the discrimination of single-nucleotide mismatches [183, 184]. The 
RFLP-based microchip combined with a capillary electrophoresis separation device has 
also been developed to identify SNPs in the thiopurine S-methyltransferase gene [185]. In 
addition, the TaqMan genotyping assay has been integrated into nanofluidic circuits and 
commercialized by Fluidigm Corporation with significant advantages over the 
conventional thermal cycling process [186, 187]. Nevertheless, optical detection has its 
intrinsic limitations, as optical signals for the use of detecting ultra-low abundance 
nucleotide variations tend to generate false-positive results, causing insufficient accuracy 
and sensitivity. Mass spectrometric detection is advantageous over optical detection in 
terms of sensitivity and accuracy, which are especially critical for detecting low frequency 
mutations, such as somatic mutations in tumors and mitochondrial mutations [188, 189]. 
However, the only commercially available mass spectrometric genotyping platform, the 
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Sequenom MassARRAY®, is not integrated into an automatic system, which requires 
substantial manual labor prior to mass spectrometric analysis, including traditional 
thermocycling, manual resin purification, and etc. The manual handling of each step would 
not only contribute to errors, but also limit the throughput. Moreover, its multiplexing 
capability is also limited, as unextended primers remain in the final sample and potentially 
overlap with extended primers targeting different polymorphic sites [190]. This limitation 
can be overcome by introducing SPP, in which only extended primers are captured for 
mass spectrometric analysis, eliminating interference from the excess primers [168]. 
Therefore, it is highly desirable to integrate SBE and SPP required for multiplex SNP 
genotyping in a single microfluidic device, so that samples can be processed automatically 
while maintaining the high accuracy and sensitivity of MS.  
To achieve this goal, this chapter presents the development and testing of a multi-step 
SNP genotyping microfluidic device that additionally includes a two-step SPP scheme for 
solution-based SBE product, making multiplexing practically attainable. All required steps 
of the SNP genotyping reactions are integrated in the device, which is coupled to external 
instrumentation for MALDI-TOF MS. Experiments with uniplex and 4-plex SNP detection 
have demonstrated that the device is capable of accurate, rapid and automated analysis with 
reduced consumption of samples and reagents, and can potentially be used in high-






3.2. Principle, Device Design and Fabrication 
This section describes the principle, design and fabrication of our microfluidic device. 
We first describe the microfluidic SBE-SPP based SNP genotyping approach, and then 
present the device design and fabrication. 
3.2.1. Principle of Microfluidic SNP Genotyping  
The principle of our microfluidic SNP genotyping assay is as follows. In the SBE 
reaction, a locus specific primer hybridizes to the template DNA strand with its 3’ end 
immediately adjacent to the polymorphic site. Then, it is extended with a single 
dideoxyribonucleotide, bearing a biotin moiety attached via a chemically cleavable linker, 
complementary to the polymorphic site (Figure 3.1A). Next, the extended primer is 
extracted by streptavidin beads packed in a microchamber (Figure 3.1B). The captured 
primer extension product is then released from the solid phase via chemical cleavage using 
tris(2-carboxyethyl)phosphine (TCEP) (Figure 3.1C). Finally, the released product is 
desalted using octadecyl carbon chain (C18) bonded silica beads in a microchannel (Figure 
3.1D) and detected by MALDI-TOF MS (Figure 3.1E). The nucleotide at the SNP site is 
identified according to the mass difference between the resulting product and the original 




Figure 3.1: Principle of SNP genotyping by SBE-SPP. (A) SNP specific primer is extended 
by a single base using ddNTPs-N3-biotin. (B) SNP specific extended primer is extracted 
by streptavidin coated microbeads. (C) Captured extended primer is chemically cleaved 
from the microbead surface. (D) The released extended primer is desalted using C18 bonded 
silica beads. (E) The desalted SNP specific primer is identified by MALDI-TOF MS. 
3.2.2. Device Design and Fabrication 
The SNP genotyping microfluidic device consists of two microchambers situated on a 
temperature controlled chip for SBE and SPP respectively, a microchannel for desalting, 
and four pressure-driven microvalves for fluidic control (Figure 3.2). The inner surfaces 
of the SBE microchamber (400 µm in height with an approximate 10 µL volume) are 
66 
 
coated with Parylene C to prevent evaporative loss of reactants [171]. The SPP 
microchamber (200 µm in height with an approximate 4 µL volume) contains dam-like 
structures called weirs (20 µm in height) at both ends to retain streptavidin coated 
microbeads (50 - 80 µm in diameter). The desalting microchannel (1 mm in width, 24 mm 
in length, and 200 µm in height with an approximate 5 µL volume) also contains weirs (20 
µm in height) to retain C18 bonded silica beads (45 - 60 µm in diameter). The microchamber 
and microchannel are fully packed with streptavidin beads and C18 bonded silica 
microspheres, respectively. The weirs have a semi-circular profile and can be completely 
sealed by underlying elastomeric microvalves actuated by the oil-filled channels 
underneath (20 µm in height), driven by nitrogen gas. Two groups of temperature control 
units are integrated on the chip, each containing a serpentine-shaped thin-film temperature 
sensor (linewidth: 25 m) and a heater (linewidth: 300 m) beneath the center of the SBE 
or SPP microchambers. Therefore, the chamber temperatures can be precisely controlled 
in separate closed loops using the corresponding integrated temperature sensors and 
heaters. 
 
Figure 3.2: Planar schematic of the microfluidic SBE-SPP device for SNP genotyping. 
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The microfluidic genotyping device is fabricated using standard MEMS technology. 
The temperature control chip was fabricated using standard microfabrication techniques. 
Briefly, gold (150 nm) and chrome (5 nm) thin films were thermally evaporated onto the 
glass substrate, and patterned by photolithography and wet etching, resulting in resistive 
temperature sensors and resistive heaters (Figure 3.3A). Then, 1 m of silicon dioxide was 
deposited using plasma-enhanced chemical vapor deposition (PECVD) to passivate the 
sensors and heaters (Figure 3.3B). The contact regions for electrical connections were 
opened by etching the oxide layer away with hydrofluoric acid. 
The polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corning Inc., Midland, MI) 
sheet bearing microfluidic features was fabricated using soft lithography techniques. A 
layer of AZ-4620 positive photoresist (20 µm, Clariant Corp., Somerville, NJ) was spin-
coated on a silicon wafer (Silicon Quest International, Inc., San Jose, CA), exposed to 
ultraviolet light through a photomask, developed, and baked to form the weirs as well as 
the flow channels which have a semi-circular cross section that can be sealed completely 
(Figure 3.3C). Then, layers of SU-8 photoresist (MicroChem Corp., Newton, MA) were 
patterned to finalize the mold with microfluidic features. Next, a PDMS prepolymer 
solution (base and curing agent mixed in a 10:1 ratio) was cast onto the mold and cured on 
a hotplate at 72 °C for 1 h (Figure 3.3D). The resulting PDMS sheet was peeled off from 




Figure 3.3: (A) Deposition and patterning of gold sensors and heaters. (B) Passivation 
of gold sensors and heaters. (C) Fabrication of fluidic channel mold for on-chip valves 
using positive photoresist AZ-4620. (D) Finalization of mold for microfluidic chambers 
and channels using SU-8. (E) Demolding of PDMS microfluidic channels. (F) Fabrication 
of SU-8 mold for oil-filled channels. (G) PDMS spin-coating. (H) Bonding of PDMS 
microfluidic channel to PDMS-coated mold for oil-filled channels.  (I) Peeling off of 
PDMS sheet containing fluidic channels and oil-filled valve actuation channels. (J) 
Bonding of PDMS sheet to temperature control chip. (K) Deposition of Parylene C. (L) 




In parallel, a layer of SU-8 photoresist was patterned on another silicon wafer to 
establish oil-filled channels for microvalve actuation (Figure 3.3F). Next, a thin PDMS 
membrane was spin-coated onto the silicon wafer (Figure 3.3G) to which the PDMS sheet 
with the microchannels was then bonded after treating the bonding interfaces with oxygen 
plasma for 20 seconds (Figure 3.3H). Afterward, the PDMS sheet together with the thin 
PDMS membrane was peeled off (Figure 3.3I), punched to form inlets and then bonded 
irreversibly onto the temperature-controlled chip after another oxygen plasma treatment 
(Figure 3.3J). 
Finally, the surfaces of the SBE microchamber were coated with a thin layer of 
Parylene C via chemical vapor deposition (Figure 3.3K), and streptavidin beads and C18 
bonded silica microspheres were packed in the SPP chamber and desalting channel (Figure 
3.3L). 
An image of a fabricated device is shown in Figure 3.4. 
 
Figure 3.4: Photograph of a fabricated device. Multiple microchambers and microfluidic 
channels are colored in orange, and oil-filled channels that impinge upon elastomeric 






All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
indicated. Streptavidin beads (Pierce Streptavidin Plus UltraLink Resin) were obtained 
from Thermo Fisher Scientific (Rockford, IL). Deionized (DI) water was purchased from 
Life Technologies (Grand Island, NY). Dideoxyribonucleotide triphosphates (ddNTPs) 
were purchased from Jena Bioscience (Jena, Germany). Primers were synthesized by 
Integrated DNA Technologies (Coralville, IA). The chemically cleavable biotinylated 
dideoxyribonucleotide set, ddNTPs-N3-biotins (ddATP-N3-biotin, ddGTP-N3-biotin, 
ddCTP-N3-biotin and ddUTP-N3-biotin), was synthesized in-house as described previously 
[191], and their molecular weights and chemical structures are shown in Supplementary 
Information (Table 3-1 and Figure 3.5). Thermo Sequenase™ was purchased from GE 
Healthcare (Piscataway, NJ). C18 modified reversed-phase silica microspheres were 
obtained from Sorbent Technologies (Norcross, GA). 
Table 3-1: Mass of ddNTPs-N3-biotins (Da) 
ddATP-N3-biotin ddGTP-N3-biotin ddCTP-N3-biotin ddUTP-N3-biotin 





Figure 3.5: Chemical structure of chemically cleavable biotinylated 
dideoxyribonucleotide set, ddNTPs-N3-biotins (ddATP-N3-biotin, ddGTP-N3-biotin, 
ddCTP-N3-biotin and ddUTP-N3-biotin). 
3.3.2. Experimental Setup and Procedure 
Closed-loop temperature control of both SBE and SPP microchambers is achieved 
using two separate temperature control units with a proportional-integral-derivative (PID) 
algorithm implemented in LabVIEW (National Instruments, TX) and a fan positioned 
under the temperature control chip. Each temperature control unit contains a serpentine-
shaped, gold resistive temperature sensor and heater. The resistance of the two temperature 
sensors is measured by a digital multimeter (34410A, Agilent Technologies, CA) and a 
digital micro-ohmmeter (34420A, Agilent Technologies, CA), respectively. The two 
heaters and the fan are connected to DC power supplies (E3631, Agilent Technologies, 
CA) respectively (Figure 3.6).  
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Fluid control is achieved using microfabricated pressure-driven valves [192]. Four oil-
filled channels, each controlled by an air control valve (6464K16, McMaster-Carr, NJ), are 
connected to a nitrogen gas tank (Tech Air, NY) via a pressure regulator (CONCOA North 
America, VA). The microfluidic device inlets are connected to a set of five syringes that 
contain 50% acetonitrile (ACN), 0.1 M triethylammonium acetate buffer (TEAA), binding 
and washing (B&W) buffer (5 mM Tris-HCl, 0.5 mM EDTA, 1 M NaCl, and 0.01% Tween 
20, pH 7.5), 100 mM TCEP (pH 9.0, adjusted with ammonium hydroxide) and deionized 
water (DI water) respectively; and the fluidic flow is regulated by syringe pumps (KD210P, 
KD Scientific, MA, and NE-1000, New Era Pump System, NY). The outlet is connected 
to a microcentrifuge tube to collect the final genotyping product for MALDI-TOF MS 
analysis (Figure 3.6). 
 
Figure 3.6: Experimental setup for microfluidic SNP genotyping by SBE-SPP. 
To conduct the microfluidic SNP genotyping, the C18 silica microspheres suspended 
in methanol were first packed in the desalting channel and dried overnight at 60 °C. Then, 
the fluidic channels were filled with DI water, and the streptavidin beads were packed in 
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the SPP chamber (Figure 3.7A, Figure 3.8A). Pressure-driven microvalves (V1 - V4) were 
closed by default with 200 kPa pressure.  
During an experiment, the C18 silica beads were rinsed with 50% ACN (Figure 3.7B, 
Figure 3.8B, 20 µL/min for 1 min) followed by 0.1M TEAA (Figure 3.7C, Figure 3.8C, 
20 µL/min for 2 min) for wetting and equilibration. Meanwhile, by opening valve V3, 
B&W buffer was introduced to rinse the streptavidin beads (Figure 3.7D, Figure 3.8D, 10 
µL/min for 5 min) to provide the optimal binding condition for biotin and streptavidin.  
Then, by opening valve V1, a 10 µL reagent composed of 2 µL target template, 75 
pmoles of ddATP-N3-biotin, 50 pmoles of ddUTP-N3-biotin, 50 pmoles of ddCTP-N3-
biotin, 75 pmoles of ddGTP-N3-biotin, 40 pmoles of each locus specific primer, 1 × 
Reaction Buffer and 8 unit Thermo Sequenase™ was introduced into the SBE chamber 
(Figure 3.7E, Figure 3.8E) and went through 30 thermal cycles of 94 °C for 15 s, 40 °C 
for 60 s and 69 °C for 30 s (Figure 3.7F).  
Next, by opening valves V2 and V3, the SBE product was transferred into the SPP 
chamber and extracted under continuous flow conditions by the streptavidin beads at a flow 
rate of 5 µL/min for 2 minutes (Figure 3.7G, Figure 3.8F), followed by rinsing with 50 
µL of B&W buffer at a flow rate of 10 µL/min (Figure 3.7H, Figure 3.8G). Subsequently, 
by opening valve V3, 10 µL of 100 mM TCEP (pH 9.0) was introduced into the SPP 
chamber (Figure 3.7I, Figure 3.8H), and incubated at 65 °C for 10 minutes to cleave the 




Figure 3.7: (A) Filling of the microfluidic channels with DI water. (B) Rinsing of C18 
bonded beads with 50% ACN. (C) Rinsing of C18 bonded beads with 0.1M TEAA. (D) 
Rinsing of streptavidin beads with B&W buffer. (E) Introduction of SBE reaction solution. 
(F) Thermal cycling. (G) Extraction of SBE product by streptavidin beads in SPP chamber. 
(H) Rinsing of streptavidin beads with B&W buffer to wash off the unextended primer and 
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other impurities. (I) Introduction of TCEP. (J) Incubation at 65 °C to release the SBE 
product. (K) Transfer of cleaved SBE fragments to desalting channel. (L) Rinsing of C18 
bonded beads with 0.1M TEAA. (M) Rinsing of C18 bonded beads with DI water. (N) 
Elution of desalted SBE fragments with 50% ACN. Colored ink is used to represent the 
actual reagents. Purple: DI water; Dark Orange: TEAA; Light Blue: ACN; Green: B&W 
buffer; Blue: SBE sample; Dark Blue: TCEP.   
 
Figure 3.8: (A) Filling of the microfluidic channels with DI water. (B) Rinsing of C18 
bonded beads with 50% ACN. (C) Rinsing of C18 bonded beads with 0.1M TEAA. (D) 
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Rinsing of streptavidin beads with B&W buffer. (E) Introduction of SBE reaction solution 
and thermal cycling. (F) Extraction of SBE product by streptavidin beads in SPP chamber. 
(G) Rinsing of streptavidin beads with B&W buffer to wash off the unextended primer and 
other impurities. (H) Introduction of TCEP and incubation at 65 °C to release the SBE 
product. (I) Transfer of cleaved SBE fragments to desalting channel. (J) Rinsing of C18 
bonded beads with 0.1M TEAA. (K) Rinsing of C18 bonded beads with DI water. (L) 
Elution of desalted SBE fragments with 50% ACN. Colored ink is used to represent the 
actual reagents. Orange: DI water; Pink: TEAA; Black: ACN; Purple: B&W buffer; Green: 
SBE sample; Blue: TCEP.   
Finally, by opening valve V4, the cleaved SBE products were transferred to the 
desalting channel at a flow rate of 1 µL/min for 5 min (Figure 3.7K, Figure 3.8I), followed 
by rinsing with 100 µL of 0.1 M TEAA (Figure 3.7L, Figure 3.8J) and 50 µL of DI water 
(Figure 3.7M, Figure 3.8K) at a flow rate of 20 µL/min to eliminate any impurities and 
salts. The desalted product was then eluted with 2 µL of 50% ACN (Figure 3.7N, Figure 
3.8L) and characterized with a Voyager DETM MALDI-TOF mass spectrometer (Applied 
Biosystems, Life Technologies, Grand Island, NY). 
3.4. Results and Discussion 
This section presents and analyzes experimental results from the microfluidic SNP 
genotyping device. We first characterize the temperature-controlled chip and evaluate the 
localized heating and temporal accuracy of the temperature field in the chambers. Then, 
characterization of SBE, and optimization of SPP, chemical cleavage and desalting are 
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performed to investigate factors that influence the assay efficiency. Finally, the integrated 
uniplex and multiplex “SNP” genotyping is carried out to demonstrate the feasibility of the 
microfluidic device. 
3.4.1. Characterization of Temperature Control 
The temperature-resistance relationships of the resistive temperature sensors for both 
the SBE and SPP chambers were calibrated following fabrication to provide accurate 
temperature control. The resistance of the thin film gold resistor is linearly dependent on 
temperature, as given by R = R0 [1 + α (T - T0)], where R is the sensor resistance at 
temperature T, R0 is the sensor resistance at reference temperature T0, and α is the sensor’s 
temperature coefficient of resistance (TCR). Measurements of SBE sensor resistance at 
varying temperatures displayed highly linear temperature dependence and the TCR was 
calculated to be 2.74 × 10-3 °C-1. The temperature-resistance relationship of the SPP sensor 
also exhibited linear behavior with a TCR value of 2.76 × 10-3 °C-1. 
We then characterized the temperature control of the buffer-filled SBE chamber to 
simulate thermal cycling in the SBE process. The SBE chamber temperature was controlled 
by an integrated heater and a fan beneath the chip via a closed-feedback loop. In accordance 
with the experimental fits (Figure 3.9A, 10 cycles are shown), the control algorithm was 
able to ramp rapidly to the specified temperature with approximate closed-loop time 
constants of 2.13 s from 40 °C to 69 °C, 2.25 s from 69 °C to 94 °C and 10.51 s from 94 
°C to 40 °C, respectively. During the thermal cycling for the SBE chamber, the highest 
temperature reached in the SPP chamber was 33.27 °C (Figure 3.9A), which would not 
affect the streptavidin affinity [193]. Figure 3.9B shows a temperature profile in the buffer-
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filled SPP chamber during heating, using the closed-loop temperature control.  The channel 
temperature increased from room temperature (25 °C) to 65 °C rapidly in about 13.7 s (with 
an insignificant overshoot of ~ 0.25 °C) where it remained for approximately 10 min, which 
was sufficient for the chemical cleavage reaction to release the captured SBE products. 
 
Figure 3.9: Time-resolved tracking of (A) the temperatures inside the buffer-filled SBE 
chamber and SPP chamber during thermal cycling, and (B) the temperature inside the 
buffer-filled SPP chamber during the chemical cleavage procedure. 
3.4.2. Characterization of Single-Base Extension 
To characterize the feasibility and efficiency of on-chip SBE reaction, a synthetic 
template (5’-GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTTGTGC 
GTGGAGTTCGACAAGGCAGGGTCATCTAATGGTGATGAGTCCTATCCTTTTCTC
TTCGTTCTCCGT-3’) was prepared. A primer (5’-GATAGGACTCATCACCA-3’, 5163 
Da) targeting the template (annealing site underlined and italicized) was extended by a 
single base (ddUTP-N3-biotin) in the SBE chamber. The SBE reaction solution contained 
10 pmoles (334 ng) of synthetic DNA template, 40 pmoles of primer, 60 pmoles of ddUTP-
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N3-biotin (1192 Da), 1 × Thermo Sequenase™ reaction buffer and 4 units of Thermo 
Sequenase™ in a total volume of 10 µL. After introduction to the SBE chamber, the 
solution was subjected to 5 thermal cycles of 94°C for 15 s, 40°C for 60 s and 69°C for 30 
s. Theoretically, the mass of extended primer can be calculated according to the equation 
me = mr + mn - mb, where me is the mass of extended primer, mr is the mass of unextended 
primer, mn is the mass of corresponding ddNTP-N3-biotin, and mb is the mass loss upon 
phosphodiester bond formation (175 Da). Thus, the expected mass of the primer extension 
product after the SBE extension was calculated to be 6180 Da (5163 + 1192 − 175). As 
shown in Figure 3.10, the appearance of the ddUTP-N3-biotin extension product peak at 
6180 m/z and the disappearance of the primer peak at 5163 m/z indicated an efficient 
enzyme incorporation reaction. The use of on-chip thermal cycling also reduces the 
operation time. For example, 30 on-chip thermal cycles require only 60 min, as compared 
to 85 min for a traditional thermal cycler (Eppendorf Mastercycler® Personal). With further 
optimization of the microfluidic device, the number of cycles and the time for each step 
(denaturation, annealing and extension) can be additionally dramatically reduced. With 
optimal surface-to-volume ratio design, one can achieve more efficient temperature 




Figure 3.10: MALDI-TOF mass spectrum of SBE product (the peak marked with an 
asterisk is presumably due to the impurities in the commercial synthetic primer). 
3.4.3. Optimization of Solid-Phase Purification and Chemical Cleavage 
To optimize the SPP process, various concentrations of biotinylated ssDNA 
(5163_biotin: 5’-biotin-GATAGGACTCATCACCA-3’) in 5 µL of 1 × Thermo 
Sequenase™ reaction buffer were introduced into a streptavidin bead packed SPP 
microchamber at different flow rates. After capture, the beads with the biotinylated DNA 
were washed with DI water at a flow rate of 10 µL/min for 5 min. Waste was collected, 
vacuum dried and then dissolved in 5 µL of DI water. For both input and output ssDNA 
solutions, the UV absorbance at 260 nm were measured on a NanoDrop 2000c instrument 
(Thermo Fisher Scientific, Rockford, IL) using 1 × Thermo Sequenase™ reaction buffer 
as the reference and the concentration was calculated according to the Beer-Lambert law. 
Approximately 30 pmoles, 65 pmoles and 170 pmoles of ssDNA 5163_biotin in 5 µL 1 × 
Thermo Sequenase™ reaction buffer were introduced into the SPP microchamber with 
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streptavidin beads at 1 µL/min, which were then washed with DI water. After SPP, the total 
amounts of biotinylated ssDNA not captured by the beads were all below 2 pmoles (Figure 
3.11A). These results indicate that the binding capacity of the streptavidin beads packed in 
the SPP microchamber is at least 160 pmoles under a constant flow rate of 1 µL/min.  
In another optimization experiment, we evaluated the effect of flow rate on SPP 
efficiency. Approximately 170 pmoles biotinylated ssDNA in 5 µL 1 × Thermo 
Sequenase™ reaction buffer was introduced into the SPP microchambers at varying flow 
rates of 0.2 µL/min, 1 µL/min, 5 µL/min, and 20 µL/min respectively, followed by DI 
water wash. After SPP, the total amounts of biotinylated ssDNA not captured by the beads 
for both flow rates of 0.2 µL/min and 1 µL/min were below 2 pmoles (Figure 3.11B). 
However, at flow rates of 5 µL/min and 20 µL/min, the amounts of uncaptured biotinylated 
ssDNA fragments increased to about 5 pmoles and 13 pmoles (Figure 3.11B), respectively. 
These results imply the binding capacity of streptavidin beads packed in the SPP 
microchamber decreases as the flow rate increases, since the reaction time between biotin 
and streptavidin is reduced. Nevertheless, taking into account the operation time, 5 µL/min 
with 5 pmoles loss in a total of 170 pmoles is still considered an efficient binding condition.   
Finally, in order to evaluate the binding specificity of streptavidin to the biotinylated 
DNA products, approximately 140 pmoles of unbiotinylated ssDNA (5163: 5’-
GATAGGACTCATCACCA-3’) in 5 µL 1 × Thermo Sequenase™ reaction buffer was 
flowed into the SPP microchamber packed with streptavidin beads at 1 µL/min, followed 
by the same DI water wash (Figure 3.11C). The amount of ssDNA collected was about 
126 pmoles, which indicated a negligible non-specific binding of unbiotinylated ssDNA to 
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the streptavidin beads. At faster flow rates, the non-specific binding would be even less. 
Given these results, we conclude that performing SPP at 5 µL/min is both binding- and 
time-efficient. At this rate, the extraction of 10-µL reaction solution could be simply 
achieved within 2 min, as compared to in-tube reaction, which requires constant mixing 
and longer reaction time [194]. The microfluidic SPP device also improves sample 
recovery, as the physical entrapment of the beads allows extensive washing and provides 
a more efficient SPP process. 
To characterize DNA recovery from the solid phase, the same SBE reactions were 
performed as described in Section 4.2 using a commercial thermal cycler (Eppendorf 
Mastercycler® Personal). Similarly to our previous experiments, the SBE extension 
products (6180 Da) were purified by streptavidin microbeads packed in the SPP 
microchamber. Then, 10 µL of 100 mM TCEP solution (pH 9.0) was introduced and 
incubated at 65°C for 10 min. Incubation of the extension products in TCEP solution 
resulted in the cleavage of the linker tethering the biotin to the dideoxyribonucleotides. 
Theoretically, the mass of cleaved product can be calculated by the equation mp = me – mc, 
where mp is the mass of cleaved product, me is the mass of extended primer and mc is the 
mass change upon cleavage (476 Da). As shown in Figure 3.11D, the mass peak for the 
extension product completely disappeared, whereas the single peak corresponding to the 




Figure 3.11: (A) Total amounts (pmol) of biotinylated ssDNA (5163_biotin) inflow and 
outflow from the SPP chamber at a flow rate of 1 µL/min. (B) Total amount (pmol) of 
biotinylated ssDNA (5163_biotin) introduced into and obtained from the SPP chamber at 
different flow rates. (C) Total amount (pmol) of ssDNA (5163) inflow and outflow from 
the SPP channel at a flow rate of 1 µL/min. (D) MALDI-TOF mass spectrum of released 
extension products from solid phase after TCEP cleavage. The average values were 
calculated from at least three repeated experiments, with error bars representing the 
standard deviation. 
3.4.4. Optimization of Desalting 
It is necessary to remove salts from the cleavage solution while concentrating and 
purifying enough samples for mass spectrometric analysis [195]. Traditionally, for small 
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sample amounts, C18 bonded resin packed pipette tips are used, and it requires extensive 
manual pipetting. In contrast, a C18 bonded microspheres packed microfluidic desalting 
channel essentially eliminates the manual procedures and provides great potential to 
expand this microfluidic method for high-throughput applications using multi-channels.  
To optimize the desalting process, various concentrations of ssDNA (4207: 5’- 
CTCTCTGGCCGCGT-3’) in 5 µL of 100 mM TCEP (pH 9.0) were introduced into the 
desalting channel at different flow rates, followed by a DI water wash at a flow rate of 20 
µL/min for 10 min. Waste was collected, vacuum dried and dissolved in 5 µL of DI water. 
The concentrations of both input and output ssDNA solutions were measured with a 
NanoDrop instrument based on UV absorption using 100 mM TCEP (pH 9.0) as the 
reference. Approximately 20 pmoles, 45 pmoles and 100 pmoles of ssDNA were 
introduced into the desalting channel at 1 µL/min, which was then washed with DI water. 
After desalting, the total amounts of ssDNA not adsorbed by the C18 resin were about 1 
pmole, 5 pmoles and 40 pmoles (Figure 3.12A). These results indicate that the binding 
capacity of the C18 microspheres packed in the desalting channel is approximately 55 
pmoles under a constant flow rate of 1 µL/min. This amount of DNA is far higher than the 
detection limit of MS [196]. Theoretically, the binding capacity and recovery efficiency 
increases with a larger binding interface at a constant flow rate, which could be achieved 
by a larger number of C18 particles in the fixed stationary phase [197]. However, this would 
build up back pressure due to the requirement for a longer microfluidic channel [198]. On 
the other hand, the size of C18 microspheres is inversely proportional to the binding 
capacity and recovery efficiency [195]. The use of larger particles would result in a lower 
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surface-to-volume ratio due to the geometrical restriction of the microchannel. But, smaller 
particles also significantly contribute to the accumulation of back pressure [198]. 
Therefore, the trade-off between channel length/particle size and binding capacity/recovery 
efficiency is an important design consideration.  
In addition, we evaluated the effect of flow rate on desalting efficiency. Approximately 
45 pmoles of ssDNA in 5 µL of 100 mM TCEP (pH 9.0) was flowed into the desalting 
channel at 0.2 µL/min, 1 µL/min, or 5 µL/min, followed by DI water wash. After desalting, 
the total amounts of ssDNA not adsorbed by the C18 beads were 1 pmole, 5 pmoles and 14 
pmoles (Figure 3.12B) respectively. These results imply that the binding capacity and 
recovery efficiency of the C18 microspheres packed in the desalting channel decreases as 
the flow rate increases, since the interaction time between the analyte and stationary phase 
(microspheres) is reduced [197]. However, lower flow rates result in longer operation time, 
significantly decreasing the assay efficiency. Therefore, the optimal selection of flow rate 
is another essential design consideration. 
 
Figure 3.12: (A) Total amount (pmol) of ssDNA (4207) introduced into and obtained from 
the desalting channel at flow rate of 1 µL/min, followed by DI water wash. (B) Total 
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amount (pmol) of ssDNA (4207) inflow and outflow from the desalting channel at different 
flow rates, followed by DI water wash. The average values were calculated from at least 
three repeated experiments, with error bars representing the standard deviation. 
3.4.5. Uniplex and Multiplex Assays 
Having demonstrated each functional unit of the microfluidic device, we performed 
the entire “genotyping” microfluidic operation (SBE, SPP, TCEP cleavage and desalting) 
within the fully integrated device using the same primer and template as described in 
Section 3.4.2. The mass of final product can be calculated according to the equation  
 mp = mr + mn - mb - mc       (1) 
where mp is the mass of product, mr is the mass of unextended primer, mn is the mass of 
corresponding ddNTP-N3-biotin, mb is the mass loss upon phosphodiester bond formation 
(175 Da), and mc is the mass change upon cleavage (476 Da). The nucleotide at the query 
“SNP” position was identified correctly as the molecular weight of the primer is 5163 Da 
and therefore the peak at 5704 m/z (5163 + 1192 − 175 − 476) corresponds to an extension 
product with ddUTP-N3-biotin after cleavage (Figure 3.13A). This result demonstrates that 
the device is able to perform a fully integrated SNP detection as designed. 
To validate the multiplex genotyping capability, we used a synthetic template with 4 
known positions as the query loci to mimic multiplex SNP genotyping.  The SBE reaction 
contained 40 pmoles each of the 4 SBE primers in a total volume of 10 µL. The final 
product masses can be calculated according to equation (1). The primer sequences, 
molecular weights of primer and their potential final genotyping products are listed in 
Table 3-2, while their annealing sites are shown in Figure 3.13C. As shown in Figure 
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3.13B, nucleotides at these four sites were unambiguously identified. These results 
demonstrate the feasibility of using this microfluidic device for integrated and miniaturized 
SNP multiplex genotyping with high accuracy and sensitivity, with the potential for high-
throughput and fully automated nucleotide variant detection. In addition, compared with 
SBE based genotyping on conventional platforms, the device employs on-chip temperature 
control, which allows for efficient temperature equilibration in the microchamber, 
significantly shortening thermal cycling times during amplification. This capability, as well 
as the ability to accommodate DNA fragments of multiple sizes, also provides the promise 
for microfluidic mini-MS sequencing, in which the fragments generated from Sanger 
dideoxyribonucleotide reactions are identified via MS at single nucleotide resolution, 
rather than by traditional gel electrophoresis and fluorescence detection [191]. With the 
accuracy and sensitivity of MS, the device has great potential for accurate sequencing of 
small but highly polymorphic regions [191, 194]. 

















a TCTCTGGCCGCGTGTCT 5144 5594 5723 5571 5685 
b CTCTCTGGCCGCGT 4207 4657 4786 4634 4748 
c TAGATGACCCTGCCTTGTC 6084 6534 6663 6511 6625 
d GATAGGACTCATCACCA 5163 5613 5742 5590 5704 
Note: The masses of genotyping products shown in red bold type refer to the expected 




Figure 3.13: MS results for uniplex and multiplex assays: (A) MALDI-TOF mass 
spectrum of uniplex “SNP” genotyping product with all operations integrated. (B) MALDI-
TOF mass spectrum of 4-plex “SNP” genotyping products using the microfluidic device. 
(C) SBE primer annealing sites and query positions. The letters highlighted in bold and 
yellow indicate the query positions, mimicking SNPs in a SNP genotyping assay; and the 
red arrow indicates the direction of primer extension. The template sequence is displayed 
on three lines. 
3.5. Conclusion 
The ability to accurately detect SNPs is critical for disease prevention, diagnosis and 
prognosis, and for prediction of drug response and clinical outcomes of patients. To 
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demonstrate a critical step towards a potentially high-throughput microfluidic genotyping 
array, this chapter presents a microfluidic device that automatically performs all the 
required biochemical steps for multiplex SNP genotyping based on the combined SBE-
SPP approach.  
The device consists of two microchambers situated on a temperature control chip for 
respectively carrying out SBE and SPP reactions, as well as a microchannel for desalting. 
These functional components are connected in series by microchannels with a semi-circular 
cross section and can be controlled by microfabricated elastomeric valves actuated by the 
underlying oil-filled channels driven by pressure. Moreover, integrated temperature 
sensors and heaters beneath the SBE and SPP microchambers allow independent, closed-
loop control of chamber temperatures. The surfaces of the SBE microchamber are coated 
with Parylene C to prevent sample loss during thermal cycling. Streptavidin coated 
microbeads and C18 bonded silica microspheres are fully packed in the SPP chamber and 
desalting channel respectively to extract SBE products and remove salt in preparation for 
MS. Due to the serial design, array-based high throughput integration can be simply 
achieved by parallel control of the above described individual functional units using 
microvalves. Hence, each of the units can carry out multiplex SNP genotyping of a single 
sample, and multiple samples can be processed in parallel using the array-based 
configuration.  
The temperature control units were characterized experimentally to ensure localized 
and efficient heating, as well as temporal accuracy of the temperature field. We 
demonstrated 100% extension of primer with cleavable mass-tagged ddNTPs and efficient 
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chemical release of purified SBE products, with shortened temperature cycling time due to 
higher heat transfer efficiency of on-chip temperature control, leading to improved single-
base resolution and ease of product extraction. The device’s capability of SPP and desalting 
was tested at different flow rates. The efficiency of both SPP and desalting were shown to 
be flow rate dependent. Although lower flow rate leads to higher capture efficiency, it also 
dramatically increases the total operation time for the microfluidic genotyping. Therefore, 
the tradeoff between the efficiency of SPP/desalting and that of the full assay is an essential 
design consideration. Finally, uniplex and 4-plex assays on a mock synthetic template, 
which mimic the SNP detection process, were carried out within the fully integrated device. 
The accurate detection of these “SNPs” demonstrates the feasibility of using the 
microfluidic device for rapid, automated, integrated and miniaturized multiplex SNP 
genotyping with high accuracy and sensitivity.  
Further study will involve high-throughput and fully automated nucleotide variant 
detection and accurate indel mini-sequencing. Due to the serial design, arrays of this 
microfluidic device can be simply achieved on single chips by concerted control of the 
individual functional units arrayed in parallel to allow analysis of samples from many 
different patients. Such array-based devices can be created essentially by the same process 




Chapter 4. Specific Capture and Temperature-Mediated 
Release of Cells: Demonstration of an Aptameric Microchip 
In this chapter, a proof-of-concept microfluidic device for specific capture and 
temperature-mediated release of cells using nucleic acid aptamers is presented. The device 
consists of a microchamber situated on a temperature control chip that includes an 
integrated temperature sensor and heaters. The chamber surface is functionalized with 
aptamers to capture target cells with high specificity. We demonstrate the device by 
capturing CCRF-CEM cells, a human acute lymphoblastic leukemia (ALL) T cell line, with 
a highly selective DNA aptamer sgc8c. Controlled release of CCRF-CEM cells from the 
aptamer surface is then conducted at an elevated temperature using on-chip temperature 
control unit. This allows the nondestructive retrieval of target cells, which eliminates the 
use of potentially harsh chemicals, and enables efficient regeneration of the aptamer 
surface. The work presented in this chapter has resulted in two peer-reviewed conference 
proceedings [199, 200] and a journal publication [201]. 
4.1. Introduction 
Isolation of cells from biological samples involves the separation and retrieval of cell 
subpopulations from a heterogeneous mixture in blood or other body fluids, and is widely 
used in both fundamental cell biology research and clinical diagnostics. For example, the 
ability to detect and characterize cancer cells from blood or other body fluids is essential 
for detecting cancer in early stages and understanding cancer development and progression 
mechanisms, such as metastasis, would significantly improve survival rates [110]. In 
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addition, studies of phenotypically pure subpopulations of human lymphocytes can provide 
valuable information concerning immune responses to injury and disease [202]. To enable 
these applications, target cells must be selectively captured, and in some instances, such as 
tissue engineering [203] and cell-based therapeutics [204], retrieved nondestructively 
without any mechanical or biochemical damage.  
Isolation of cells can be based on the size or volume, density, electrical properties, or 
surface characteristics, using methods such as filtration, centrifugation, dielectrophoresis, 
or affinity binding [74, 205, 206]. Among these methods, affinity binding, which 
recognizes cells by binding of ligands to biomarkers on cell membranes, is highly attractive 
due to its high specificity to target cells. The most commonly employed ligands for affinity 
cell isolation are antibodies, which are generated in vivo against target antigens found on 
cell membranes. Antibody-based cell isolation techniques have been implemented using 
methods such as magnetic activated cell sorting (MACS) and fluorescence-activated cell 
sorting (FACS) [206, 207]. MACS uses a magnetic field to manipulate antibody-coated 
microbeads specifically bound to the cells and is amenable to high-throughput operation 
[208]. Relying on a single physical parameter (i.e., the presence or absence of magnetic 
force) to distinguish between different cell types, MACS is in general a single-parameter 
cell isolation method. In comparison, FACS usually uses multiple species of fluorescently 
labeled antibodies and allows sorting of multiple cell types simultaneously [207]. Thus, 
FACS is a multi-parameter method, although it is relatively low-yield and typically 
requires more complex and expensive experimental instrumentation.  
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Microfluidic technology can potentially enable low-cost, automated and portable cell 
isolation systems with improved sensitivity, resolution and efficiency as well as minimized 
sample and reagent consumption [209]. Microfluidic cell isolation devices have 
implemented aforementioned separation principles, for instance exploiting differences in 
the size [210], acoustic response [91], dielectrophoretic characteristics [211], and the 
affinity of cells to ligands [110]. In particular, microfluidic affinity assays using ligands 
with high specificity to cell membrane proteins have shown great promise for cell isolation 
[110, 212]. For example, by using anti-epithelial cell adhesion molecule (anti-EpCAM) 
antibodies immobilized on microposts, the isolation of rare circulating tumor cells (CTCs) 
from samples of whole blood has been demonstrated [110]. Unfortunately, antibodies 
generally have limited stability, are expensive and time-consuming to develop, and 
antibody-coated surfaces are susceptible to biofouling due to non-specific interactions 
between antibodies and other proteins [111]. Moreover, rapid and nondestructive release 
of antibody-bound cells is generally difficult [213], as the antibody-antigen binding is 
practically irreversible under normal physiological conditions [214].  
Aptamers are oligonucleotides or peptides that bind specifically to target molecules. 
Isolated from a randomized oligonucleotide or peptide library using a synthetic selection 
process called systematic evolution of ligands by exponential enrichment (SELEX) [125], 
aptamers can recognize a large variety of target biomolecules, such as small molecules 
[112], peptides [114], and proteins [215], via unique three-dimensional conformations 
formed through interactions with the targets. Recently, aptamers have also been developed 
for cellular targets, such as ALL precursor T cells [216], liver cancer cells [217], and even 
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stem cells [218]. Since aptamers are produced using synthetic processes and are stable and 
amenable to chemical modifications [123], they offer an attractive alternative to antibodies 
as affinity ligands for isolation of rare cells. Although most aptamers use cell lines as their 
targets, they are often capable of targeting the more general population of diseased cells 
from real patient samples. For example, the aptamer sgc8c generated for a type of human 
ALL T cell line, CCRF-CEM cells, is capable of specifically targeting ALL T cells in 
patient blood [216, 219, 220]. Thanks to ongoing research efforts to develop improved 
SELEX methods and instruments, it is expected that aptamers will become readily 
available to recognize an increasingly broad collection of biological targets [221]. 
Aptamers have been explored in microfluidic systems as affinity ligands for cell 
isolation [222-225]. For example, surface-immobilized aptamers targeting prostate-
specific membrane antigen (PSMA) and aptamers targeting protein tyrosine kinase 7 
(PTK7) have been used to separate LNCaP cells and CCRF-CEM cells, respectively, from 
heterogeneous cell mixtures [217, 222, 223, 225]. However, there has been very limited 
work on releasing the captured cells from aptamer-functionalized surfaces. Attempts to 
rapidly and nondestructively release cells using methods such as tryptic digestion of target 
proteins [225], exonuclease degradation of aptamers [226], and hydrodynamic shear by 
infused air bubbles [223] have been hindered by several issues. Trypsin is able to digest 
only a small portion of biomarkers involved in affinity cell capture [227] and may 
negatively affect cell viability and phenotypic properties [228, 229], while the use of 
exonucleases is limited by inefficient diffusive transport of the enzymes, slow enzymatic 
reaction rates, and the destruction of the cell recognition surfaces. Similarly, air bubbles, 
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which release cells from aptamer surfaces by shear force, may cause physical damage to 
cells, while also generating dead volumes in microfluidic devices that lead to low cell 
release efficiency. There is hence a strong need for methods that allow specific capture and 
efficient, nondestructive release of subpopulations of cells in microfluidic devices. 
Aptamer-target interactions are significantly influenced by environmental conditions; 
in particular, the affinity binding between aptamers and biomolecules can be strongly 
temperature dependent [198, 230, 231]. Cell-specific aptamers also target biomolecules, in 
this case proteins expressed on the cell membrane [217]. Therefore, it is reasonable to 
expect that interactions between aptamers and cells are also highly temperature sensitive. 
In this chapter, we investigated the specific capture and subsequent temperature-mediated 
release of cells in an aptamer-functionalized microfluidic device. Target cells can be 
captured with high specificity by a surface-immobilized aptamer, enriched by repeated 
introduction of multiple samples, and purified by washing with buffer. This is followed by 
a moderate temperature change of the surface, produced on-chip, to reversibly disrupt the 
cell-aptamer interaction, allowing release and elution of viable target cells for downstream 
analysis and regeneration of the aptamer-functionalized surface for device reuse. The 
device is applied to CCRF-CEM cells to demonstrate its potential utility for specific 







4.2. Principle and Design 
This section describes the principle and design of our microfluidic device. We first 
describe the specific cell capture and thermally controlled cell release approach, and then 
present the device design. 
4.2.1. Cell Capture and Release Principle 
The principle of aptamer-based specific capture and temperature-mediated release of 
cells is as follows. Aptamer molecules specific to target cells are immobilized on solid 
surfaces within a microfluidic device. A cell suspension containing target and non-target 
cells is introduced into the device and incubated for an appropriate period of time. The 
target cells are specifically captured by the surface-immobilized aptamer molecules via 
affinity binding (Figure 4.1A), while the non-target cells are removed by washing (Figure 
4.1B). Next, exploiting the strong temperature-dependence of affinity binding of aptamers 
and cells, the device temperature is increased to disrupt the binding and release the captured 
target cells from the surface-immobilized aptamer molecules (Figure 4.1C). This 
temperature-mediated cell release can be accomplished with a temperature increase such 




Figure 4.1: Principle of specific cell capture and temperature-mediated release. (A) Cell 
capture at room temperature. (B) D-PBS wash after capture. (C) Cell release at a 
moderately higher temperature. 
The principle of aptamer-based specific capture and temperature-mediated release of 
cellular targets will be demonstrated using CCRF-CEM cells, a human ALL cell line. ALL 
is the most common cancer for children from 0 to 14 years old, representing one third of 
all malignancies in that age group [232, 233]. CCRF-CEM cells are recognized by the DNA 
aptamer sgc8c (Figure 4.2) [220, 222, 223], which binds to the extracellular portion of 
PTK7 [234]. Toledo cells, a human diffuse large-cell lymphoma cell line not recognized 




Figure 4.2: Structural formula of sgc8c aptamer [220]. 
4.2.2. Design 
 The microfluidic device used for cell capture and temperature-mediated cell release 
consists of a microchamber situated on a temperature control chip (Figure 4.3). The 
tapered chamber (2 mm in length, 1mm in width and 20 m in height), whose surfaces are 
functionalized with aptamers specific to a target cell type, is connected to two inlets (3.5 
mm in length, 0.7 mm in width and 600 m in height) respectively for introduction of 
sample and washing buffer, and one outlet for collection of released cells or waste fluids. 
The microfluidic channels connecting these fluidic ports and the chamber are 0.5 mm in 
width and 20 m in height. Integrated on the temperature control chip are a serpentine-
shaped temperature sensor (linewidth: 25 m) beneath the center of the chamber, and two 
serpentine-shaped heaters (linewidth: 300 m) on each side of the temperature sensor. The 
chamber temperature can be controlled in closed loop using these integrated temperature 




Figure 4.3: Schematic of the microfluidic device for the specific capture and temperature-
mediated release of CCRF-CEM cells. Dimensions are given in micrometers. 
4.3. Experimental 
4.3.1. Materials 
 Chlorotrimethylsilane, (3-mercaptopropyl) trimethoxysilane (3-MPTS), 4-
maleimidobutyric acid N-hydroxysuccinimide ester (GMBS), streptavidin and bovine 
serum albumin (BSA) were obtained from Sigma-Aldrich (St. Louis, MO). 5,5',6,6'-
tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), propidium 
iodide (PI), RPMI-1640 media, fetal bovine serum (FBS), penicillin-streptomycin (P/S, 
penicillin 10,000 unit/mL, streptomycin 10,000 µg/mL), Dulbecco's phosphate-buffered 
saline (D-PBS) and the Vybrant® multicolor cell-labeling kit (DiI, DiO and DiD) were 
purchased from Invitrogen (Carlsbad, CA). CCRF-CEM and Toledo cell lines were 
obtained from the American Type Culture Collection (ATCC, Manassas, VA). The 
biotinylated sgc8c aptamer with a polyT(9) spacer at the 5’ end of the sequence (biotin-5'-
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TT TTT TTT TAT CTA ACT GCT GCG CCG CCG GGA AAA TAC TGT ACG GTT 
AGA-3', Kd = 0.78 nM) was synthesized and purified with high-performance liquid 
chromatography (HPLC) by Integrated DNA Technologies (Coralville, IA). 
4.3.2. Microfluidic Device Fabrication 
The temperature control chip was fabricated using standard microfabrication 
techniques. A glass slide (Fisher HealthCare, Houston, TX) was cleaned by piranha. 
Chrome (10 nm) and gold (100 nm) thin films were deposited by thermal evaporation and 
patterned by wet etching to generate the temperature sensor and heaters which were then 
passivated by 1 µm of silicon dioxide that was deposited using plasma-enhanced chemical 
vapor deposition (PECVD). Finally, contact regions for electrical connections to the sensor 
and heaters were opened by etching the oxide layer using hydrofluoric acid (Figure 4.4A). 
In parallel, the microchamber was fabricated from polydimethylsiloxane (PDMS) 
(Sylgard 184, Dow Corning Inc. Midland, MI) using soft lithography techniques. Layers 
of SU-8 photoresist (MicroChem Corp., Newton, MA) were spin-coated on a silicon wafer 
(Silicon Quest International, Inc., San Jose, CA), exposed to ultraviolet light through 
photomasks, baked, and developed to form a mold defining the microfluidic features. Next, 
a PDMS prepolymer solution (base and curing agent mixed in a 10:1 ratio) was cast onto 
the mold and cured on a hotplate at 72 °C for 1 hour (Figure 4.4B). The resulting sheet 




Figure 4.4: Device fabrication: (A) Deposition, patterning and passivation of gold sensor 
and heaters. (B) Fabrication of SU-8 mold. (C) Demolding of PDMS microchamber. (D) 
Treatment with chlorotrimethylsilane and PDMS spin-coating. (E) Bonding of PDMS 
microchamber to PDMS-coated temperature control chip. (F) Insertion of inlet and outlet 
capillary tubes. (G) Photograph of a fabricated device. (H) Micrograph of the temperature 
sensor and heaters in the device. Dimensions are given in micrometers. 
Subsequently, the surface of the temperature control chip was treated with 
chlorotrimethylsilane, and a PDMS layer (approximately 100 m) was spin-coated onto 
the chip (Figure 4.4D). Then, the PDMS sheet was bonded to the PDMS membrane on the 
chip after treatment of the bonding interfaces with oxygen plasma for 15 seconds (Figure 
4.4E). Finally, capillary tubes (O.D. = 813 µm and I.D. = 495 µm) were inserted into the 
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inlet and outlet ports (Figure 4.4F), resulting in a packaged device. Following each 
experiment, the PDMS film and chamber were easily removed from the temperature 
control chip, allowing the chip to be reused for the next experiment. A fabricated and 
packaged device is shown in Figure 4.4 G and H. 
4.3.3. Surface Modification 
The biotinylated sgc8c aptamer was functionalized in a freshly fabricated device using 
an established protocol with slight modifications [110]. The microchamber was first treated 
with 4% (v/v) 3-MTPS in ethanol for 30 min at room temperature, followed by an ethanol 
wash. Then, 2 mM GMBS in ethanol was introduced and incubated for 20 min at room 
temperature, followed by an ethanol wash and drying by nitrogen. Next, the chamber was 
incubated overnight with 100 µg/mL streptavidin in D-PBS at 4 °C, followed by a D-PBS 
wash. Finally, 10 µM of biotinylated sgc8c aptamer in D-PBS was introduced into the 
chamber and incubated at room temperature for 20 min. A D-PBS wash was used to remove 
free aptamer molecules, leaving immobilized aptamer molecules on the surface. Just prior 
to cell introduction, the chamber was incubated with 1 mg/mL BSA solution in D-PBS at 
room temperature for at least 30 min to minimize nonspecific adsorption of cells. 
4.3.4. Cell Culture and Preparation 
Both CCRF-CEM and Toledo cells were incubated with RPMI-1640 media 
supplemented with 10% FBS and 1% P/S, and were kept at 37 °C in a humidified incubator 
containing 5% CO2. Before microfluidic experiments, each cell type was collected through 
centrifugation, resuspended at 1 × 108 cells/mL in D-PBS supplemented with 1 mg/mL 
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BSA, and then kept on ice. Cells were mixed or diluted to different concentrations prior to 
introduction into the microfluidic device. 
4.3.5. Experimental Setup 
 Closed-loop temperature control of the chamber was achieved using the integrated 
temperature sensor and heaters with a proportional-integral-derivative (PID) algorithm 
implemented in a LabVIEW (National Instruments Corp., TX) program on a personal 
computer. The resistance of the sensor was measured by a digital multimeter (34420A, 
Agilent Technologies Inc., CA), and the two heaters were connected to a DC power supply 
(E3631, Agilent Technologies Inc., CA). The microfluidic device’s two inlets were 
connected to syringes that respectively contained cell mixture and D-PBS, and was each 
driven by a syringe pump (KD210P, KD Scientific Inc., MA). The outlet was connected to 
a microcentrifuge tube for collection of released cells or experimental waste. Unless 
indicated otherwise, all phase contrast images and fluorescent images of the chamber were 
taken using an inverted epifluorescence microscope (Diaphot 300, Nikon Instruments Inc., 




Figure 4.5: Experimental setup for specific capture and temperature-mediated release of 
cells. 
4.3.6. Testing Procedure 
During cell capture experiments, a batch of CCRF-CEM cells was introduced into the 
chamber and incubated without any fluid flow for 1 min. This process was repeated several 
times, followed by a wash with D-PBS at 5 μL/min for approximately 1 min. An image of 
the cell-laden chamber was taken and used to manually count the number of captured cells, 
which was used to compute the captured cell density on the surface. To test the specificity 
of cell capture, CCRF-CEM and Toledo cells were labeled with the fluorescent dyes DiO 
and DiI, respectively, and fluorescent images were taken after the first introduction of the 
cell mixture as well as after D-PBS washing.  
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In temperature-mediated cell release experiments, the chamber was heated using the 
integrated heaters via closed loop temperature control to a desired temperature for 2 min, 
and flows of D-PBS at various rates were used to rinse the chamber. Images of the chamber 
were taken every 2 seconds, and used to manually count the cells that remained on the 
aptamer-immobilized surface. 
To test cell viability, the retrieved cells were kept in D-PBS with 10% FBS containing 
PI (2 μM) and JC-1 (10 μg/mL) at 37 °C for 1 hour, and then phase contrast and fluorescent 
images were taken with an inverted microscope (DMI6000B, Leica Microsystems Inc., IL) 
equipped with a digital camera (Retiga 2000R, Qimaging, Canada) and commercial image 
acquisition software (InVitro, Media Cybernetics Inc., MD). Moreover, a batch of cells 
was treated in a water bath at 48 °C for 2 minutes and then cultured for 4 days. The 
concentration of cultured cells was determined each day using a hemacytometer (Chang 
Bioscience Inc., CA). 
4.4. Results and Discussion 
This section presents and analyzes experimental results from the aptamer-based 
microfluidic device. We first characterize the temperature control chip and evaluate the 
uniformity of the temperature field in the chamber. Then, specific capture and temperature-
mediated release of cells are performed using CCRF-CEM and Toledo cell lines to 
investigate factors that influence the efficiency of cell capture and release. Finally, the 





4.4.1. Temperature Sensor Characterization 
The temperature sensor was first calibrated using an environmental test chamber 
(9023, Delta Design Inc., CA) maintained at a series of temperatures which are measured 
with high accuracy temperature reference probes (5628, Fluke Calibration, UT). The 
measured resistance (R) of the thin-film gold temperature sensor was observed to vary 
linearly with temperature (T). The dependence could be represented by the relationship R 
= R0 [1 + α (T - T0)], where R0 is the sensor resistance at a reference temperature T0, and  
is the temperature coefficient of resistance (TCR) of the sensor. Fitting this relationship to 
the measurement data allowed determination of the parameter values, which were used to 
determine the chamber temperature from the measured sensor resistance during cell capture 
and release experiments. The temperature sensor typically had a measured resistance of 
209.60 Ω at a reference temperature of 21.9 °C with a TCR of 2.58×10-3 1/°C, as shown in 
Figure 4.6A. We then characterized the temperature control of the chamber through which 
D-PBS buffer was continuously infused to simulate the cell capture or release process. The 
chamber temperature, controlled in closed loop by the integrated heaters via feedback from 
the temperature sensor, was seen to increase from room temperature (~24 °C) to 48 °C 
rapidly (with an approximate closed loop time constant of 2.7 s based on an exponential 
fit) while exhibiting a minimal overshoot (~ 0.2 °C) (Figure 4.6B). The temperature 
remained within approximately 0.1 °C of the desired temperature setpoint for the duration 




Figure 4.6: (A) Resistance of temperature sensor (R) showing highly linear dependence 
on temperature (T). The solid line represents a linear fit to the experimental data with a 
regression equation: R = 209.6 [1 + 2.58×10-3 (T-21.9)] (coefficient of determination 
R2=0.999). (B) Time-resolved tracking of the temperature inside the D-PBS filled chamber, 
with the inset showing noise that was present during temperature measurements. 
4.4.2. Simulation of Temperature Distribution 
To evaluate the uniformity of the temperature distribution in the chamber, we present 
results from numerical simulation using a three-dimensional steady-state heat transfer 
model [235]. The model considers heat conduction in the solid materials as well as forced 
convection due to the buffer flow (flow rate: 5 L/min), with natural convection neglected. 
Properties at room temperature are used for the solid materials, and the property of the 
aqueous buffer is evaluated at the average temperature (36 °C) over the range (24 °C to 48 
°C) used in the experiments. The model includes the Pyrex glass substrate (thermal 
conductivity: 1.3 W/m·K), gold heaters (thermal conductivity: 317 W/m·K), a PDMS 
membrane (thermal conductivity: 0.16 W/m·K) above the SiO2 electrical passivation layer, 
liquid buffer in the chamber (thermal conductivity 0.62 W/m·K), and PDMS sheet (thermal 
conductivity: 0.16 W/m·K), with the SiO2 passivation layer neglected due to its small 
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thickness (< 1 μm). The model is solved using the COMSOL Multiphysics software 
package (COMSOL, Inc., CA). 
The temperature distribution in the chamber at a flow rate of 5 µL/min is shown in 
Figure 4.7. It can be seen that the temperature throughout the chamber was quite uniform, 
thanks to the heater design, which has a relatively large size with respect to that of the 
chamber. The temperature variation is less than 0.03 C on the lower chamber surface, to 
which aptamer molecules are immobilized (Figure 4.7A), as well as xz-plane of symmetry 
inside the chamber (Figure 4.7B). There is approximately a 0.2 °C difference between the 
temperatures on the lower chamber surface and on the substrate surface where the 
temperature sensor is located. This temperature difference is insignificant compared to the 
magnitude of temperature changes used in thermally activated cell release, and if desired, 
could be used as a correction value because of the more uniform in-plane temperature 
distributions. Based on this numerical analysis, it is concluded that the temperature 
distribution generated by the on-chip heaters is sufficiently uniform in the chamber for the 
cell capture and release experiments. 
 
Figure 4.7: Numerically determined temperature distribution in the chamber within (A) 
xy-plane on the lower surface of the chamber and (B) xz-plane of symmetry.  
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4.4.3. Specific Cell Capture 
To verify specific cell capture at room temperature, a mixture of CCRF-CEM cells 
(target cell type, 3.5×106 cells/mL) and Toledo cells (non-target cell type, 5.0×106 
cells/mL) was introduced into the sgc8c aptamer-modified microchamber and incubated 
for 1 min. The total number of CCRF-CEM cells observed on the surface, 51 in total, was 
less than that of Toledo cells, 78 in total (Figure 4.8A). However after washing, all non-
specifically adsorbed Toledo cells were removed, leaving only specifically captured 
CCRF-CEM cells on the surface. Moreover, after 10 cell samples were introduced (each 
followed by rinsing with D-PBS), the target cells dominated the chamber surface, with only 
8 non-target Toledo cells visible amongst a few hundred CCRF-CEM cells (Figure 4.8B). 
This demonstrates the specific and effective capture of CCRF-CEM cells using the surface-
immobilized aptamers, and the capability of the device to enrich target cells from a 
heterogeneous mixture. 
To test the transient behavior of the cell capture process, CCRF-CEM cell suspensions 
with concentrations of 5.0×106 cells/mL were introduced into the aptamer-functionalized 
chamber and allowed to incubate for varying lengths of time. After incubation, D-PBS was 
used to remove unbound cells. The percentage of captured cells in each introduction was 
calculated by η ≈ Na / Nb, where Na is the number of captured cells, i.e., cells that remained 
on the microfluidic aptamer-functionalized surface after washing, and Nb is the maximum 
number of cells that can be captured due to geometric limitations. Because of the height of 
the chamber (20 µm) and the low cell density of the introduced cell suspension, we 
assumed that only a single monolayer of cells could be arranged on the lower surface of 
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the chamber. Therefore, Nb is also equal to the number of cells observed in the chamber 
before washing. As shown in Figure 4.8C, increasing incubation time resulted in an 
increase in cell surface density.  
 
Figure 4.8: (A) Image of the chamber after the introduction of a cell sample. (B) Image of 
the chamber after the introduction of 10 cell samples and D-PBS washing. (C) Time 
response of cell capture: percentage of cells captured (η) versus incubation duration (t). 
The solid line represents an exponential fit to the experimental data with a regression 
equation: 
/241 te    (R
2=0.982, n=3). (D) Concentration response of cell capture: 
density of captured cells (ρcapture) as a function of the cell suspension concentration (ccell). 
The solid line represents a linear fit to the experimental data with a regression equation: 





We consider a monovalent model for the equilibrium affinity binding between surface 
immobilized aptamer sgc8c (of initial surface density γ0 at t = 0) and cell membrane protein 
PTK7 (approximated as a sheet of protein of initial surface density σ0 at t = 0) to form a 






 where kon and koff are respectively the association and 
dissociation rate constants for the binding between sgc8c and PTK7. The binding kinetics 
is governed by: on 0 0 off( )( ) .
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 where Kd = koff / kon is the equilibrium dissociation constant 
(with the unit of surface density). According to the initial condition that y = 0 at t = 0, this 













 As cell capture 
happens only when there are sufficient aptamer-protein complexes, the percentage of cells 
















This exponential relationship is consistent with our experimental observation (Figure 
4.8C), and a least square fit suggests that cell capture time constant τ is approximately 
equal to 24 s (coefficient of determination R2 = 0.982). Cell loss during washing could be 
almost completely eliminated via incubation by setting incubation time (t) to a value such 
that percentage of cells captured (η) approximates to 1. The time constant (τ) indicates the 
rate at which the surface concentration of captured cells approaches its maximum value, 
and can be used to calculate the time needed to isolate a number of target cells from the 
heterogeneous cell suspension. It was estimated that approximately 92% of introduced cells 
exposed to the aptamer-functionalized surface were captured after incubating for 1 min. 
These results, which were similarly obtained at other cell concentrations ranging from 
0.5×106 to 10×106 cells/mL, could be further improved by optimizing the channel design 
[110], surface topography [226], and operation conditions such as flow rates [237]. 
We next investigated the effects of the cell suspension concentration on the surface 
density of captured cells. Cell capture experiments were conducted using samples with 
varying cell concentrations (0.5 to 10×106 cells/mL). In each experiment, 5 aliquots of cells 
were introduced into the chamber, each followed by a 1-min incubation. Each test was 
performed in triplicate simultaneously on identical devices (n = 3). All of the devices were 
fabricated at the same time to guarantee chamber surfaces were generated with nominally 
identical aptamer densities to ensure consistent experimental data. Experiments with the 
most dilute cell suspension (0.5×106 cells/mL) yielded captured cells with a surface density 
of 17±4 cells/mm2 (n = 3), while those with the most concentrated cell suspension (10×106 
cells/mL) resulted in a captured cell density of approximately 399±160 cells/mm2 (n = 3), 
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as shown in Figure 4.8D. It can be seen that in this range of cell concentrations, the 
captured cell density was approximately proportional to the cell concentration ρcapture = A 
ccell, where ccell is the cell suspension concentration (cells/mL), and A is a proportionality 
constant that depends on device characteristics such as the surface density of immobilized 
aptamer molecules and equilibrium cell-aptamer affinity association, and testing 
parameters such as the number of samples introduced to the chamber. The linear equation 
fitted the experimental data well (R2 > 0.99), resulting in a value of A equal to 0.3874 
mL/mm2. These results indicate that there is a large dynamic range of cell suspension 
concentrations over which the device can capture a predictable surface concentration of 
cells for downstream analysis. 
4.4.4. Temperature-Mediated Cell Release 
We next tested the thermally induced release of captured cells from the aptamer-
functionalized chamber surfaces. Prior to the experiment, CCRF-CEM cells were captured 
by the surface-immobilized sgc8c aptamer, and unspecific bound cells were removed by 
D-PBS washing. Then, the cell-laden chamber was rinsed at either room temperature or 48 
°C (Figure 4.9A). It was seen that approximately 80% of cells were released from the 
surfaces after rinsing with D-PBS at 5 µL/min and 48 °C for 2 min, whereas negligible cell 
release was observed when rinsing at room temperature with an identical buffer solution 
and flow rate. These results suggest that the release of CCRF-CEM cells may have been 




Figure 4.9:  (A) Percentage of captured cells remaining on the substrate as a function of 
time while rinsing at constant temperature (48 °C and room temperature) and flow rate (5 
µL/min). (B) Captured cell density versus the number of cell suspension samples 
introduced while the temperature was maintained at either 48 °C or room temperature. (C) 
Effect of temperature on cell release efficiency while rinsing at 5 µL/min. (D) Effect of 
flow rate on cell release efficiency while the chamber temperature was maintained at 48°C. 
We then tested this hypothesis of cell release due to heat-induced conformational 
changes to aptamer structure, seeking to exclude denaturation of cell membrane proteins 
as the cause of cell release. To do so, we conducted additional tests in which cells were 
heated prior to capture in the device, and compared the results to those from heating the 
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device itself during cell capture. The cell suspension, diluted to 5×106 cells/mL, was heated 
at 48 °C for 2 min, followed by introduction to the chamber at room temperature. In 
parallel, an unheated cell solution of 5×106 cells/mL was introduced into a chamber with 
the chamber temperature set to 48 °C. In both tests, 10 aliquots of cells were introduced 
into the chamber, followed by 1 min of incubation after each cell introduction. Heat treated 
cells were captured at room temperature up to a concentration of 288 ± 10 cells/mm2 (n = 
3), as shown in Figure 4.9B. Unheated cells in a 48°C chamber achieved a surface density 
of only 43 ± 3 cells/mm2 (n = 3), and the presence of these remaining surface-bound cells 
was attributed to non-specific adsorption. These results suggest that the conformational 
changes in the aptamer structure, rather than the denaturation of the target cell membrane 
protein PTK7 [217] at the increased temperature, caused the release of the specifically 
captured cells. 
Having eliminated denaturation of the cell surface protein as the cause of cell release, 
we then investigated the relative impact on cell release of the chamber temperature 
compared to the hydrodynamic shear stress applied by the buffer flow. Cell detachment 
from aptamer-functionalized substrates is governed by the balance between the 
hydrodynamic shear stress applied on cell surfaces and the temperature-dependent binding 
strength of aptamers and their target cells. Therefore, changes in either the chamber 
temperature or the buffer flow rate would result in different cell release efficiencies. We 
first tested the effects of temperature on cell release by varying the chamber temperature 
from 30°C to 48°C while rinsing with D-PBS (Figure 4.9C). It was clearly seen that with 
the elevated temperature, an increasing number of cells were detached from the substrate. 
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Moreover, as the local temperature increased from 30 to 48°C, the viscosity of the aqueous 
washing buffer would decrease by approximately 35% [238], which would lead to a 35% 
lower shear stress at the cell membranes. This indicates that at higher temperatures there is 
a greater loss of binding between the aptamers and the cells, most likely due to temperature-
dependent changes in conformational structure of aptamers. Next, we further evaluated the 
effect of shear stress on cell release, by performing identical experiments while varying the 
flow rate through the chamber. As shown in Figure 4.9D, a higher flow rate caused more 
cells to detach from the substrate, as a result of increased shear stress disrupting the cell-
aptamer binding. As either a higher temperature or a larger shear stress poses a greater risk 
of cell damage, the tradeoff between them is an important design consideration. 
As conformational changes in aptamer structures are reversible, this indicates that we 
can create a regenerable cell-capture surface, which would reduce the average cost of 
assays using the microfluidic device. To verify the reusability of the aptamer-
functionalized surface, three experimental cycles were performed in the same device, with 
each cycle consisting of first introducing a dilute cell solution to the microchamber at room 
temperature, then releasing cells at 48 °C and 5 µL/min for 2 min, and finally regenerating 
the aptamer-functionalized surface (releasing all remaining cells) via washing with D-PBS 
at 60 °C and 50 µL/min for 2 min, and then at room temperature and 50 µL/min for 2 min.  
Following the first cycle, similar densities of captured cells were observed for succeeding 
cycles, with a maximum difference of captured cell density of only 8% between the first 
and the second capture (Figure 4.10). Given these results, we conclude that the 
regeneration of cell capture function of the microfluidic device can be both effective and 
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consistent. Although some residual cells remained on the surfaces after each regeneration, 
this could be addressed by using a higher temperature and flow rate. 
 
Figure 4.10: Cell capture and re-capture on the regenerated aptamer-functionalized 
surface: the normalized percentage of remaining cells after the first, second and third 
capture and regeneration cycle. 
4.4.5. Cell Viability Assay 
Cell viability is important for downstream applications such as tissue engineering and 
cell-based therapeutics [203, 204]. To evaluate cell viability, released cells were collected 
after rinsing at 5 µL/min and 48 °C for 2 min, at which point PI [239] and JC-1 [240, 241] 
were used to stain cells. PI is a red-fluorescent nuclear stain that is not permeant to live 
cells. JC-1 accumulates in healthy mitochondria as indicated by red fluorescence, the 
intensity of which decreases along with mitochondrial depolarization occurring in the early 
stage of apoptosis. Our experimental results showed that the PI stained cells did not emit 
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any red fluorescence (Figure 4.11A), and the JC-1 stained cells exhibited bright red 
fluorescence (Figure 4.11B), indicating that the collected cells were viable.  
 
Figure 4.11: Image of PI stained cells (A) and JC-1 stained cells (B) following cell capture 
and release experiment, generated by a combination of phase contrast and fluorescent 
micrographs. (C) Concentrations of normal cells and heat-treated cells as a function of 
culture duration. 
To obtain further confirmation of cell viability, we performed cell culture testing. 
Because of practical difficulties [242] in conducting cell culture using cells directly 
retrieved from the microfluidic device without an on-chip cell culture component, we 
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performed off-chip cell proliferation assays, in which cells from a well-mixed suspension 
were treated in water bath at 48 °C for 2 min and then cultured for several days. Meanwhile, 
cells from the same suspension were also cultured without any treatment for the same 
period to serve as a control. The growth curves of normal and heat-treated cells are shown 
in Figure 4.11C, in which heat-treated cells are seen to have a similar proliferation rate as 
normal cells. This indicates that the brief period of modestly elevated temperature used in 
the cell release experiment would not induce detectable cell damage, allowing the 
thermally released cells to remain viable. 
4.5. Conclusion 
The ability to isolate and retrieve live cells from biological samples is critical in both 
basic cell biology studies and clinical diagnostics. In this chapter, we have developed an 
aptamer-based microfluidic device for specific capture and temperature-mediated release 
of cells. The device consists of a microchamber situated on a temperature control chip that 
includes an integrated temperature sensor and heaters. The chamber surface is 
functionalized with aptamers to capture target cells with high specificity. The integrated 
temperature sensor and heaters allow closed-loop control of the chamber temperature, 
enabling thermally induced release of the captured cells without causing any physical or 
chemical damage.  
The temperature control chip was first characterized experimentally and numerically 
to ensure temporal and spatial accuracy of the temperature field, respectively. Further 
experiments demonstrated highly specific capture and enrichment of CCRF-CEM cells 
using the sgc8c aptamer, followed by measurements of the sensitivity of cell capture to the 
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concentration of cell suspension and to the incubation time within the chamber. 
Subsequently, efficient temperature-mediated release of cells was achieved, and the effects 
of the chamber temperature and shear stress on the aptamer-cell interaction were 
investigated. It is found that both higher temperatures and higher shear stresses facilitate 
cell release, and the tradeoff between these two factors is an important design 
consideration, due to the greater risk of cell damage when using either a higher temperature 
or a larger shear stress. Finally, the released cells were shown to be viable, and the aptamer-
functionalized surfaces were successfully regenerated and shown to be reuseable. These 
results demonstrate that our approach can potentially be used in basic biological research 
and clinical diagnostics for the isolation of viable pure cell subpopulations.  
Further studies will involve more stringent cell viability testing, such as using 
quantitative flow cytometry and gene expression analysis to confirm that thermal release 
processes induce no variations in cells at both cellular and genetic levels. If necessary, 
appropriate measures, such as the use of aptamers with lower affinity or stronger 
temperature dependence to allow cell release at lower temperatures, can be used to 
minimize such cellular or genetic variations.  
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Chapter 5. Specific Capture and Temperature-Mediated 
Release of Cells: Spatial Selectivity via Patterned Aptamer 
Surfaces  
The microfluidic device described in Chapter 4 demonstrated the feasibility of aptamer 
functionalized surface for highly specific cell isolation. Moreover, it explored, for the first 
time, the temperature response of binding affinity between aptamers and cells, and 
therefore allowed thermally activated release and retrieval of captured cells. Although 
novel, the cell release in Chapter 4 was not spatially selective in that all captured cells were 
released from the entire microfluidic surfaces. 
In this chapter, a proof-of-concept microfluidic device for spatially selective specific 
capture and temperature-mediated release of cells using nucleic acid aptamers is presented. 
The device consists of a microchamber situated on a microchip with four groups of micro 
heaters and temperature sensors. Aptamers are patterned on design-specified regions of the 
chip surface, and the heat generated by the micro heaters is restricted to each aptamer-
functionalized area. We demonstrate the device by performing specific capture of CCRF-
CEM cells, a human acute lymphoblastic leukemia (ALL) cell line, with surface patterned 
DNA aptamer sgc8c. Spatially selective release of CCRF-CEM cells is achieved by 
utilizing a group of microheater and temperature sensor that restricts temperature changes, 
and therefore the disruption of cell-aptamer interactions, to a design-specified region. The 
work presented in this chapter has resulted in a peer-reviewed conference proceeding [243] 




Specific cell isolation is important in basic biological research and clinical diagnostics.  
Antibodies that are specific to cell membrane proteins are most often employed to achieve 
this goal. For example, magnetic-activated cell sorting (MACS) and fluorescence-activated 
cell sorting (FACS) are highly attractive due to their high specificity to target cells [206, 
207]. The MACS method relies on the presence or absence of magnetic forces to recognize 
different cell types. Although it is amenable to high-throughput operations, there is 
generally no difference between the magnetic forces generated by microbeads with 
different surface-modified antibodies specific to different target cells [208]. Hence, MACS 
is a single-parameter cell isolation method, and lacks the capability to distinguish and sort 
multiple types of cells. On the other hand, FACS uses different species of antibodies with 
different fluorescent labels to recognize target cells. Multiple characteristics of cells can be 
monitored, and thus different cell types can be separated and collected simultaneously 
[207]. However, the application of FACS is restricted by its relatively low yield and 
complex and expensive experimental instrumentation. 
Microfluidic technologies have been developing to enable more efficient and effective 
cell isolation with improved sensitivity and resolution, minimized sample and reagent 
consumption, lower cost, and the capability of automation and point-of-care (POC) [209]. 
To achieve specific cell isolation, antibodies have always been employed [110, 212]. For 
example, the isolation of rare circulating tumor cells (CTCs) from whole blood samples 
has been achieved in a microfluidic device with micropillars that are functionalized with 
anti-epithelial cell adhesion molecule (anti-EpCAM) antibodies [110]. Unfortunately, 
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antibodies are not always stable, and are expensive and time-consuming to develop [111]. 
In addition, in order to achieve molecular and functional analysis [245] or cell based 
therapeutics [204], cells must be released with minimal contamination and negligible 
disruption to their viability. However, the interaction between antibodies and antigens are 
not reversible under normal physiological conditions [213, 214]. Cells are hence typically 
released from antibody-functionalized surfaces using trypsin to digest antibody-specific 
cell membrane proteins [246], or varying the substrate hydrophobicity to detach 
hydrophobically anchored antibodies [247]. Tryptic digestion is not efficient, only 
applicable to a small portion of biomarkers involved in affinity cell capture [227], and may 
influence cell viability and phenotypic properties [228, 229]. Meanwhile, temperature 
dependent substrate property alteration cannot cause the dissociation of antibodies from 
the antigens, leaving the antibodies attached to cell membranes [247]. Therefore, there is a 
strong need for methods that allow rapid and non-destructive release of cells from affinity 
surfaces. 
Aptamers, which are oligonucleotides that bind specifically to target molecules, have 
the potential to resolve these problems. Aptamers can be selected from a randomized 
oligonucleotide library using a synthetic process [125]. Compared with antibodies, 
aptamers are stable, designable and amenable to chemical modifications [123]. Meanwhile, 
the binding between aptamers and target molecules is reversible due to conformational 
changes caused by temperature variations [198, 201]. In addition, recent advances in 
synthetic aptamer development have resulted in aptamers for multiple cellular targets, such 
as ALL precursor T cells [216], liver cancer cells [217] and stem cells [218]. These 
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aptamers bind to cell membrane proteins by hydrogen bonds, hydrophobic interactions, 
van der Waals interactions, aromatic stacking, or their combinations. Such affinity binding 
allows the aptamers to capture target cells specifically [248, 249]. Therefore, aptamers are 
attractive alternatives to antibodies as affinity ligands for cell isolation. For example, 
aptamers targeting prostate-specific membrane antigen (PSMA) have been used in a 
microfluidic system to separate LNCaP cells from a heterogeneous cell mixture [225]. 
Release of aptamer-captured cells has been accomplished by methods such as exonuclease 
degradation of aptamers [226], air bubble dislodging [223], and temperature stimulation 
[201]. Unfortunately, the use of exonuclease is inefficient due to the slow diffusive 
transport of enzymes and the low enzymatic reaction rate, while the use of air bubbles may 
damage cells and generate dead volumes leading to low cell release efficiency.  
In the previous chapter, we demonstrated that these issues could be addressed by 
temperature-mediated cell release, although the release was not spatially selective in that 
all captured cells were released from the entire microfluidic surfaces. This chapter presents 
a microfluidic device with a surface selectively functionalized with cell-specific aptamers 
and integrated micro heaters with temperature sensors to achieve specific cell capture and 
temperature-mediated release of selected groups of cells. Aptamers are patterned on 
design-specified regions of the chip surface, and the heat generated by the micro heaters is 
restricted to each aptamer-functionalized chip area. Target cells can be captured by the 
surface-patterned aptamers with high specificity. A moderate temperature change is then 
produced using a group of micro heater and temperature sensor to reversibly break the cell-
aptamer binding in the selected chip area, allowing the release and retrieval of viable target 
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cells from this region for downstream applications. After the temperature change is 
reversed, the aptamer-functionalized surface recovers its binding affinity to target cells. 
The device has been applied to CCRF-CEM cells, a human ALL T cell line, and sgc8c, an 
aptamer specific to these cells [220], to demonstrate its capability for specific capture and 
non-destructive, spatially selective temperature-mediated release of target cells.  
5.2. Experimental  
5.2.1. Principle  
The principle of aptamer-based specific cell capture and spatially selective 
temperature-mediated cell release is as follows. Cell specific aptamers are first patterned 
on design-specified regions of the surface of a temperature-control chip. A cell suspension 
containing target cells is introduced into the device. Target cells located on the aptamer 
modified regions are captured specifically by the patterned aptamers (Figure 5.1A), while 
those situated outside the aptamer-functionalized surface are not captured and removed by 
a Dulbecco’s phosphate-buffered saline (D-PBS) wash (Figure 5.1B). Next, the 
temperature of a specific region is increased to change the conformational structure of 
aptamers, by activating the microheater. Thus, the binding strength between target cells 
and aptamers is decreased. Cells within this region can then be easily washed away and 
collected, while cells in other regions are not affected (Figure 5.1C). After the temperature 
is reversed, aptamers recover their ability to capture cells. In addition, this moderate 
temperature change does not affect the cell viability [201]. For demonstration, the 
microfluidic device is functionalized with the aptamer sgc8c for specific capture and 




Figure 5.1: Principle of specific cell capture and spatially selective temperature-mediated 
cell release. (A) Cell capture at room temperature. (B) D-PBS wash to remove non-target 
cells. (C) Temperature-mediated release of a selected group of cells. 
5.2.2. Design and Fabrication 
The microfluidic device used for specific cell capture and spatially selective 
temperature-mediated cell release consisted of a tapered microchamber (2.7 mm in length, 
2.2 mm in width, and 20 μm in height) situated on a microchip with four groups of 
serpentine-shaped heaters (linewidth: 50 μm) and serpentine-shaped temperature sensors 
(linewidth: 20 μm) (Figure 5.2). 
 
Figure 5.2: Schematic of the microfluidic device for specific cell capture and temperature-
mediated selective cell release. 
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The microchip was fabricated using standard microfabricatation techniques. Briefly, a 
chrome (~10 nm) / gold (~200 nm) / chrome (~10 nm) thin film was first deposited and 
patterned to form micro resistive heaters, which were then passivated by approximately 1 
μm silicon dioxide using plasma-enhanced chemical vapor deposition (PECVD) (Figure 
5.3A). The micro heaters generated joule heat when subjected to a DC voltage. Next, an 
additional chrome (~10 nm) / gold (~200 nm) / chrome (~10 nm) thin film was deposited 
and patterned to form the temperature sensors, which were also passivated by 
approximately 1 μm silicon dioxide (Figure 5.3B). Subsequently, the microchip was 
incubated with 4% (v/v) 3-mercaptopropyl trimethoxysilane (3-MPTS) in ethanol for 30 
min at room temperature, followed by an ethanol wash. The microchip was then treated 
with 2 mM 4-maleimidobutyric acid N-hydroxysuccinimide ester (GMBS) in ethanol for 
20 min at room temperature, followed by another ethanol wash and drying by nitrogen. 
Afterward, the microchip was incubated with 100 μg/mL streptavidin in D-PBS at 4 °C 
overnight, and a polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corning Inc. Midland, 
MI) membrane with through openings (diameter: 400 μm) was manually attached onto the 
microchip surface, to which the biotinylated sgc8c aptamers were immobilized through 
biotin-streptavidin interaction (Figure 5.3C). After peeling off the PDMS membrane, only 
aptamers immobilized on the microchip remained, and those modified on the membrane 
were removed (Figure 5.3D). Finally, the microchamber was fabricated from PDMS using 
standard soft lithography methods (Figure 5.3E&F), and then attached onto the microchip 




Figure 5.3: Microchip fabrication and aptamer immobilization: (A) Deposition, patterning 
and passivation of gold heaters. (B) Deposition, patterning and passivation of gold 
temperature sensors. (C) Attachment of a PDMS membrane with through holes onto the 
microchip, and functionalization of biotinylated aptamers. (D) Removal of the PDMS 
membrane. (E) Fabrication of SU-8 mold. (F) Casting of PDMS microchamber. (G) 
Bonding of the PDMS microchamber onto the microchip. (H) Photograph of a fabricated 





3-MPTS, GMBS, streptavidin and bovine serum albumin (BSA) were obtained from 
Sigma-Aldrich (St. Louis, MO). 5,5’,6,6’-Tetrachloro-1,1’,3,3’-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1), RPMI-1640 media, fetal bovine 
serum (FBS), penicillin-streptomycin (P/S, penicillin 10000 units/mL, streptomycin 10000 
mg/mL) and D-PBS were purchased from Invitrogen (Carlsbad, CA). CCRF-CEM was 
obtained from the American Type Culture Collection (ATCC, Manassas, VA). The 
biotinylated sgc8c aptamer (biotin-5’- (triethylene glycol)9 -AT CTA ACT GCT GCG 
CCG CCG GGA AAA TAC TGT ACG GTT AGA-3’, Kd = 0.78 nM) was synthesized and 
purified with high-performance liquid chromatography (HPLC) by Integrated DNA 
Technologies (Coralville, IA). 
5.2.4. Experimental Setup 
Closed-loop temperature control of each aptamer-modified region was achieved by 
using the corresponding integrated temperature sensor and heater with a proportional-
integral-derivative (PID) algorithm implemented in a LabVIEW (National Instruments 
Corp., TX) program on a personal computer. The sensor resistances were measured by a 
digital multimeter (34420A, Agilent Technologies Inc., CA) through a 4-way mechanical 
switch. The micro heaters were connected to a DC power supply (E3631, Agilent 
Technologies Inc., CA) through another 4-way mechanical switch. The microfluidic 
device’s inlet was connected to a syringe driven by a syringe pump (KD210P, KD 
Scientific Inc., MA). The outlet was connected to a microcentrifuge tube in order to collect 
released cells. Unless indicated otherwise, all phase contrast images of cells captured on 
130 
 
the microchip surface were taken using an inverted epifluorescence microscope (Diaphot 
300, Nikon Instruments Inc., NY) with a CCD camera (Model 190CU, Micrometrics, NH) 
(Figure 5.4). 
 
Figure 5.4: Experimental setup for specific cell capture and spatially selective 
temperature-mediated cell release. 
5.2.5. Experimental Procedure 
CCRF-CEM cells were incubated with complete culture media that consisted of 
RPMI-1640 media supplemented with 10% FBS and 1% P/S, and were kept at 37 °C in a 
humidified incubator containing 5% CO2. Cells were collected through centrifugation, 




During the cell capture experiments, the microfluidic device was first treated with 1 
mg/mL BSA in D-PBS for at least half an hour. Then, a suspension of CCRF-CEM cells 
was introduced into the microchamber at 1μL/min for 2 min, followed by a D-PBS wash 
at 5μL/min. An image of the microchip surface was then taken and used to show the 
specific capture of cells onto the aptamer-modified surface.  
In the spatially selective temperature-mediated cell release experiments, the 
microchamber was rinsed with complete culture media with 10 μg/mL JC-1 at 5 μL/min, 
and a selected region on the microchip was heated using the integrated heater via closed 
loop temperature control for 20 s. An image was then taken and used to show the selective 
release. 
To test cell viability, the retrieved cells in complete culture media with 10 μg/mL JC-
1 were kept at 37 °C in an incubator with 5% CO2 for 1 h, and a fluorescent image was 
taken with an inverted microscope (IX81, Olympus Corp., PA) equipped with a digital 
camera (C8484, Hamamatsu Corp., NJ). 
5.3. Results and Discussion 
5.3.1. Temperature Control 
To evaluate spatially selective heating through on-chip temperature control, we 
present results from a numerical simulation using a three-dimensional steady-state heat 
transfer model in COMSOL Multiphysics® (COMSOL, Inc., Los Angeles, CA) [201]. The 
model considers heat conduction in the solid materials as well as forced convection due to 
the buffer flow (flow rate: 5 μL/min), while neglecting natural convection due to relatively 
small temperature changes and the small length scales of the chamber. The temperature 
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distribution on the lower surface of the microchamber is shown in Figure 5.5A. It can be 
seen that the temperature increase generated by each micro heater is restricted to the 
surrounding area as desired, indicating the feasibility of temperature-mediated release of a 
selected group of cells. 
 
Figure 5.5: On-chip temperature control: (A) Simulated temperature distribution on the 
lower surface of the microchamber, showing spatially selective heating. (B) Linear 
temperature dependence of the resistance of the temperature sensor. (C) Time-resolved 
tracking of the temperature of each heating region inside the buffer filled chamber. 
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Prior to performing the experiments, we first characterized the temperature sensors 
using an environmental test chamber (Model 9023, Delta Design Inc., CA) maintained at 
a series of temperatures which were measured with a high accuracy temperature reference 
probe (Model 5628, Fluke Calibration, UT) [19]. The resistance (R) of the temperature 
sensor varied linearly with temperature (T). The dependence was well represented by the 
relationship R = R0 [1 + α (T - T0)], where R0 is the sensor resistance at a reference 
temperature T0, and  is the temperature coefficient of resistance (TCR) of the sensor. 
Fitting this relationship to the measurement data allowed the determination of TCR, which 
was used to determine the temperature in the region directly above the sensor from the 
measured resistance during experiments. A typical micro temperature sensor in this design 
had a measured resistance of 22.66 Ω at a reference temperature of 25.3 °C with a TCR of 
2.16×10-3 1/°C (Figure 5.5B).  
Further verification of selective heating in the aptamer-patterned regions is provided 
by on-chip temperature control using the integrated thin-film heaters and temperature 
sensors. We experimentally monitored the temperature of all four heating regions with 
continuous D-PBS infusion (flow rate: 5 μL/min) to simulate the cell release process, when 
the temperature of heating region 1 was controlled in a closed-loop by the integrated heater 
via feedback from the temperature sensor. The temperature of region 1 increased from 
room temperature to 48 °C rapidly (approximately 10 seconds) and remained within 
approximately 0.2 °C of the desired temperature setpoint (48 °C) for the entire heating 
duration, while those of regions 2-4 all remained below 28 °C during the whole process 
(Figure 5.5C). This implies that the temperature change in one region does not 
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significantly affect the temperatures in other regions, and thus enables the spatially 
selective temperature-mediated cell release. 
5.3.2. Spatially Selective Specific Capture and Temperature-Mediated Release of 
Cells 
We first tested the patterning of aptamers onto the surface of a microchip. 
Fluorescently labeled biotinylated ssDNA was used to functionalize the microchip, which 
was then observed under a fluorescent microscope. As shown in Figure 5.6, only the area 
exposed to reagents, which was in the through opening region, showed bright green 
fluorescence, indicating the feasibility of immobilizing aptamers onto design-specified 
regions of a microchip. 
 
Figure 5.6: Immobilization of aptamers in design-specified regions of the chip surface. 
To demonstrate spatially selective cell capture, a CCRF-CEM cell suspension of 5 × 
106 cell/mL with 1 mg/mL BSA was introduced into the devices with immobilized 
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aptamers at 1 µL/min for 2 min, followed by a D-PBS wash at 5 µL/min for 1 min. CCRF-
CEM cells only became attached to the aptamer functionalized surfaces (Figure 5.7A), and 
not to the bare surface, confirming spatially selective cell capture. Because of the manually 
performed surface modification process, aptamers were not precisely immobilized onto the 
surface above the micro-heaters. Therefore, the shape of aptamer-captured CCRF-CEM 
cell patterns did not strictly follow the envelope of the micro-heaters. 
 
Figure 5.7: Specific cell capture and spatially selective temperature-mediated cell release: 
(A) CCRF-CEM cells were captured by the aptamer functionalised surface; (B) 
Temperature-mediated cell release in regions 2 and 3; (C) Temperature-mediated cell 
release in region 4; (D) Specific cell recapture on the same aptamer functionalised surface. 
Scale bars: 400 µm. 
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To test temperature-mediated release of a selected group of cells, the cell laden 
chamber was then rinsed with complete culture media with 10 μg/mL JC-1 at 5 µL/min, 
while the temperature in regions 2 and 3 increased to 48 °C in series, by using the integrated 
heaters. It can be seen that only the cells within regions 2 and 3 became detached from the 
aptamer-surface, which may have been caused by conformational changes of the aptamer 
structure [201], whereas negligible cell release was observed in other regions (Figure 
5.7B). Next, we further increased the temperature in region 4, and observed noticeable cell 
release in this region, and cells in region 1 were not affected (Figure 5.7C). These results 
indicate the success of temperature-mediated release of selected groups of cells. 
To verify the reusability of the aptameric surface, another CCRF-CEM cell suspension 
with the same concentration was introduced into the same device at 1 µL/min for 2 min. 
Following a D-PBS wash at 5 µL/min for 1 min, similar densities of captured cells were 
observed in all the regions (Figure 5.7A and D), implying that the microfluidic device with 
aptamers is reusable. 
5.3.3. Cell Viability Assay 
To enable downstream (e.g., tissue engineering and cell-based therapeutic) 
applications [203, 204], the released and retrieved cells must be viable. To evaluate cell 
viability, released cells in complete culture media with 10 μg/mL JC-1 from multiple 
devices were collected and incubated at 37 °C with 5% CO2 for 1 h, centrifuged and 
resuspended in 10 μL of complete culture media. JC-1 exists as a monomer in cytoplasma 
exhibiting green fluorescence and it accumulates in undepolarized healthy mitochondria 
showing red fluorescence, the intensity of which decreases along with mitochondrial 
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depolarization during apoptosis or death of cells [240, 241].  The released cells showed 
bright red fluorescence (Figure 5.8), indicating that they were still viable and the 
temperature-mediated cell release process did not affect the cell viability. In addition, to 
further decrease the potential cell damage, releasing cells at lower temperature is possible 
using appropriately selected aptamers [250]. 
 
Figure 5.8: Micrograph of JC-1 stained cells following cell capture and temperature-
mediated cell release performed on a microfluidic device. 
5.4. Conclusion 
Spatially selective capture, release and retrieval of cells on affinity surfaces are 
important in basic biological research and clinic diagnostics. In this chapter, we have 
developed a microfluidic device for specific cell capture and selective temperature-
mediated cell release using cell-specific aptamers and integrated micro heaters and 
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temperature sensors. The device consists of a microchamber situated on a microchip with 
four groups of micro heaters and temperature sensors. Aptamers are patterned on design-
specified regions of the chip surface, and the heat generated by the micro heaters is 
restricted to each aptamer-functionalized chip area. A moderate temperature change using 
a group of micro heater and temperature sensor breaks the cell-aptamer binding in the 
selected chip area, allowing the release and retrieval of target cells from this region without 
detectable cell damage. The microchip is first characterized experimentally and 
numerically to ensure spatially selective temperature control. Further experiments show 
specific capture of CCRF-CEM cells using the aptamer sgc8c, followed by efficient and 
spatially selective temperature-mediated release. In addition, the aptamer functionalized 
surface is shown to be reusable and the retrieved cells are viable. The results demonstrate 
that our approach can potentially be used for cell purification from biological samples and 
selective cell retrieval for downstream analysis.  
Further studies will involve systems that employ a more controllable surface 
modification method to precisely control the size of patterned aptamers and use a more 




Chapter 6. Mechanically Tunable Microfluidic Trapping of 
Cells 
The microfluidic devices described in Chapter 4 and Chapter 5 demonstrated the 
feasibility of using solid surface with patterned aptamer for highly specific cell capture and 
spatially selective temperature-mediated cell release. However, they lacked flexibility in 
controlling the number of cells in each spot. 
In this chapter, we exploited the large compliance of elastomers to create an array of 
cell-trapping microstructures, whose dimensions can be mechanically modulated by 
inducing uniformly distributed strain via application of external force on the chip. The 
device consists of two elastomer polydimethylsiloxane (PDMS) sheets, one of which bears 
dam-like, cup-shaped geometries to physically capture cells. The mechanical modulation 
is used to tune the characteristics of cell trapping to capture a predetermined number of 
cells, from single cells to multiple cells. Thus, enhanced utility and flexibility for practical 
applications can be attained, as demonstrated by tunable trapping of MCF-7 cells, a human 
breast cancer cell line. The work presented in this chapter has resulted in two peer-reviewed 
conference proceedings [243, 251] and a journal publication [252]. 
6.1. Introduction 
Cell manipulation, such as separation, isolation, positioning, trapping and sorting of 
cells, has important applications in basic biological research and clinical diagnostics. For 
example, in order to study the effect of anticancer drugs, cell groups with multiple cells are 
needed for testing multicellular resistance [253]. However, the analysis of a large 
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population of cells obscures the heterogeneous information within cell groups, such as the 
large genetic variation between individual cells [254, 255]. Therefore, in addition to 
multicellular analysis, investigations on single cell or a small number of cells are necessary. 
For instance, in order to study the phenotypic heterogeneity driven by cell cycle, cell aging, 
and epigenetic regulation, single cells must be isolated and identified [256]. Furthermore, 
in the study of cell-cell contact, such as the communication through junctional proteins 
[257] and membrane-receptor to membrane-ligand interactions [258], or cell fusion that 
enables the study of nuclear reprogramming [83], pairing of two cells, either the same type 
or different types, is required. As a result, target cells have to be trapped in particular 
positions without any mechanical or biochemical damage, and the number of cells trapped 
should be able to be adjusted according to the application. 
Microfluidic technologies have been developing to allow more effective and efficient 
cell trapping and cell positioning, offering numerous advantages not possible with 
conventional platforms [259, 260]. Microfluidic cell trapping that employs either physical 
barriers, such as microwells [80, 261], microcups [82, 83] and cell-based valves [262, 263], 
or molecular interactions, such as micropatterning surfaces with polymers [264] or ligands 
[265], is easy to handle, does not require complicated fabrication procedures, and can 
realize high-throughput operation. With different dimensions of microwells [80] or 
microcups [82], or variant diameters of patterned ligand spots [266], cell trapping with 
different numbers of cells can be achieved. For example, by utilizing weir-like capture cups 
with different depths, cell trapping with different numbers of cells in each trap have been 
reported [82]. However, once the design and fabrication of the device have been completed, 
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it is no longer possible to alter the characteristics of the cell traps. Thus, these methods lack 
flexibility in precisely controlling the number of trapped cells, while cell arrays of single, 
two and multiple cells are all needed in cell biology applications [83, 267, 268]. On the 
other hand, cell trapping methods that use optical [269], acoustic [91], dielectrophoretic 
[211], hydrodynamic [270], or their combinations [271], employ different kinds of external 
force during the experiment to separate and restrict cells in particular locations, and thus 
allow dynamic and precise control over the number of cells trapped. However, the 
application of these methods is also limited by either sophisticated operation systems or 
complicated microfabriation processes. 
These limitations can potentially be addressed by utilizing physical barrier based cell 
trapping techniques and employing elastomeric polymers, whose large deformability could 
provide flexibility and controllability in cell manipulation. In relevant work, large 
compliance of polymers has been used in micro- and nanofluidic applications. For 
example, deformable elastomeric microdevices have been used in the gating and regulation 
of fluids in microflow control, in which a thin compliant flap was used to alter the flow 
resistance by varying the applied pressure [272]. A nanofluidic system has also been 
designed and fabricated using oxidized PDMS, in which transport characteristics were 
dynamically manipulated by the modulation of channel dimensions [273]. In addition, a 
pneumatically controlled elastomeric microstructure has been reported for patterning and 
manipulation of a large number of cells at the macro scale [274]. These demonstrate the 




This chapter presents a tunable cell trapping microchip that utilizes the large 
deformability of elastomeric polymers to precisely control the number of cells captured at 
the single and individual cell level. The device consists of two thin sheets of the elastomer 
PDMS, one of which bears microstructures to physically capture cells. The microstructures 
each feature a dam-like, cup-shaped geometry (called a capture cup) with supporting pillars 
on both sides. We for the first time exploit the large compliance of elastomers to create an 
array of cell-trapping microstructures, whose dimensions can be mechanically modulated 
by inducing uniformly distributed strain via the application of an external force on the chip. 
The mechanical modulation is used to tune the characteristics of cell trapping to capture a 
predetermined number of cells, from single cells to multiple cells. The microchip is applied 
to MCF-7 cells to verify the significant influence of microstructure deformation on the 
number of cells trapped, and thus demonstrate the effectiveness of using physical 
modulation to enable nondestructive and flexible cell manipulation, which can potentially 
be used in cell biology research and clinical diagnostics. 
6.2. Experimental 
6.2.1. Design and Fabrication 
The tunable cell trapping microchip consists of two thin sheets of elastomer PDMS, 
one of which bears microstructures to physically capture cells. The microstructures each 
have a dam-like, cup-shaped geometry (approximately 40 µm in height, henceforth called 
a capture cup) with supporting pillars (approximately 7 µm in height) on both sides (Figure 
6.1). When a cell approaches a microstructure, the carrier fluid passes over the dam, while 
the cell is trapped in the capture cup. If one or more cells are trapped in the microstructure, 
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the flow field upstream will immediately change, attaining a higher velocity component in 
the transverse direction. Therefore, cells moving into this region will gain more significant 
transverse kinetic energy and may be more likely to flow around the microstructure, rather 
than being trapped in the capture cup.  
 
Figure 6.1: The cell trapping principle. (A) Plan view and cross-sectional views along lines 
(B) a-a and (C) b-b of cell trapping approach. Dimensions are given in micrometers. 
The cell trapping characteristics can be tuned through mechanical modulation of 
microstructures via the application of strain to the chip (Figure 6.2). The microchip is 
stretched by mounting it onto a motherboard. This induces uniform uniaxial tensile strain 
in the cell trapping region, which is situated in a slender bar-shaped portion of the 
microchip. Using different microchip mounting pin locations, the strain in the cell trapping 
region can be varied. This mechanical modulation changes the geometry of the 
microstructures, and also alters the flow field, thereby allowing the number of cells trapped 




Figure 6.2: Principle of tunable cell trapping via modulation of microstructure dimensions. 
(A) Single cells are trapped in the microstructures before application of strain. (B) Multiple 
cells are trapped in the microstructures after application of strain. Inset: detail of 
microstructure geometries before and after the application of strain. 
The tunable cell trapping microchip was fabricated using standard soft lithography 
techniques. Briefly, the SU-8 (MicroChem Corp., Newton, MA) mold that defines 
microfluidic features was first fabricated (Figure 6.3A). Then two PDMS (Sylgard 184, 
Dow Corning Inc.,) sheets, one bearing the microfluidic structures and the other used as 
the substrate, were cast (Figure 6.3B) and punched with the inlet and outlet (Figure 6.3C). 
Subsequently, the two PDMS sheets were bonded to each other after oxygen plasma 
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treatment (Figure 6.3D).  Finally, an acrylic motherboard, onto which the fabricated 
microchip was mounted, was fabricated with a laser cutter. The assembled device is shown 
in Figure 6.4A, and the details of cell trapping microstructures are shown in Figure 6.4 B 
and C. 
 
Figure 6.3: The microchip fabrication process. (A) Fabrication of the SU-8 mold. (B) 
Casting of the PDMS microfluidic sheet and the PDMS substrate. (C) Demolding of PDMS 




Figure 6.4: (A) A fabricated and assembled tunable cell trapping microchip. (B) Scanning 
electron micrograph image of the cell-trapping region, showing densely packed cup-shaped 
microstructures (scale bar: 100 µm). (C) Detail of the trap microstructure, including a dam-
like capture cup with supporting pillars on both sides (scale bar: 10 µm). 
6.2.2. Materials 
Chlorotrimethylsilane, and bovine serum albumin (BSA) were obtained from Sigma-
Aldrich (St. Louis, MO). 5,5',6,6'-tetrachloro-1,1',3,3'-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1), Minimum Essential Medium (MEM), 
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fetal bovine serum (FBS), penicillin-streptomycin (P/S, penicillin 10,000 unit/mL, 
streptomycin 10,000 µg/mL), 0.25% Trypsin-EDTA, Dulbecco's phosphate-buffered 
saline (D-PBS) and Vybrant® multicolor cell-labeling kit (DiI, DiO and DiD) were 
purchased from Life Technologies (Grand Island, NY). MCF-7 cell line was obtained from 
the American Type Culture Collection (ATCC, Manassas, VA). 
6.2.3. Experimental Procedure 
MCF-7 cells were incubated with the complete culture media, including MEM 
supplemented with 10% FBS and 1% P/S, and were kept at 37 °C in a humidified incubator 
containing 5% CO2. Before microfluidic experiments, cells were labeled by incubating 
them with 0.5% (v/v) DiO in the complete culture media for 20 min and then treated in the 
3mL of trypsin-EDTA for at least 15 min to be detached from substrate and to prevent the 
nonspecific adsorption. Next, a triple volume of the complete culture media was added to 
stop trypsinization. Cells were then collected through centrifugation, resuspended at 1 × 
108 cells/mL in complete culture media supplemented with 5 mg/mL BSA, and kept on ice.  
Prior to experimentation, the microfluidic channel was incubated with 5 mg/mL BSA 
in D-PBS for at least half an hour to prevent the unspecific adsorption. Then, the cell 
suspension was diluted to 1 × 106 cells/mL in D-PBS supplemented with 5 mg/mL BSA, 
and introduced into the microchip with or without extension at 10 µL/min for 1 min. 
Afterward, D-PBS was used to rinse the channel at 10 µL/min for 1 min. Finally, a 
fluorescent image of cell-laden chamber was taken and used to manually count the number 




6.3. Results and Discussion 
6.3.1. Microstructure Deformation 
The mechanical modulation of microstructures is realized by mounting the microchip 
onto different locations of a motherboard, initially free of extension (Figure 6.5A) to a 
tensile strain of approximately 79% (Figure 6.5B). According to the extension experiments, 
along with the increased strains, the trapping cup width decreased from 28.8 ± 0.8 µm to 
18.0 ± 0.6 µm and the cup depth increased from 25.0 ± 0.4 µm to 36.3 ± 0.7 µm (Figure 
6.5C). This deformation will significantly alter the number of cells able to be trapped [82]. 
 
Figure 6.5: Modulation of microstructures for cell trapping: Phase contrast micrographs 
of cell trapping microstructure before (A) and after (B) after applying 79% relative 
extension along x direction (scale bars: 50 µm). (C) The depth and width variations of 
microstructures as the normal strains increased from 0 to 0.8. 
To evaluate the uniformity of microstructure deformation, we first tested the strain 
distribution and present results from a COMSOL Multiphysics® (COMSOL, Inc., Los 
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Angeles, CA) numerical simulation using a three-dimensional structural model, consisting 
of the trapping region. The nonlinear elasticity of the structural material (PDMS) and the 
large strain involved in the microstructure deformation is considered. PDMS is modeled as 
an isotropic, incompressible hyperelastic material [272], and the Mooney-Rivlin 
constitutive law is applied [275, 276]. A Young’s modulus of 387 kPa is used for PDMS, 
as determined by the 100:7 base-to-curing agent ratio of the prepolymer solution [277]. 
Our results show a highly uniform strain distribution in the xy-plane throughout the 
trapping region (Figure 6.6), indicating a uniform deformation of the microstructure array.  
 
Figure 6.6: Numerically determined distributions of the normal strain components on the 
lower surface of the microchannel (xy-plane) within cell trapping region: (A) x-component; 
(B) y-component; and (C) z-component. 
A further numerical analysis shows when the gap between each row of microstructures 
was elongated from 98 µm (Figure 6.7A) to 175 µm (Figure 6.7B), leading to a 79% 
relative extension along x direction in the trapping region, the cup depth increased from 25 
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µm (Figure 6.7A&C) to 37 µm (Figure 6.7B&D), and the cup width decreased from 28 
µm (Figure 6.7A&C) to 19 µm (Figure 6.7B&D). These dimension changes are consistent 
with the results from the experimental analysis. 
 
Figure 6.7: Numerically determined microstructure deformation (A) before and (B) after 
applying 79% relative extension along x direction. 3D models of the microstructure (C) 
before and (D) after applying 79% extension. Scale bars: (A)(B) 100 µm, (C)(D) 25 µm. 
6.3.2. Tunable Cell Trapping 
To demonstrate tunable cell trapping, a cell suspension of 1×106 cells/mL in D-PBS 
with 5 mg/mL BSA was introduced into the chip (pretreated with 5 mg/mL BSA in D-PBS) 
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at 10 µL/min for 1 min, after which D-PBS was used to rinse the channel. The 7 µm height 
gap between two pillars allows a fraction of fluid carrying cells to enter the capture cup. 
Based on the dimensions of the cell trapping microstructure, once one cell or multiple cells 
occupy the capture cup, the fraction of fluid passing through the gap significantly reduces, 
leading to increased transverse velocity and decreased longitudinal velocity. Thus, more of 
a cell’s longitudinal component of kinetic energy will be converted to the transverse 
component, increasing the tendency for additional cells to flow around the microstructure 
and therefore preventing them from being trapped. As shown in Figure 6.8A, without 
extension, single cell trapping was dominant, whereas multiple cells were captured as a 
result of an approximately 72% strain applied to the chip (Figure 6.8B).  
Moreover, the results indicate the number of cells trapped strongly depends on the 
geometrical characteristics of the microstructures (Figure 6.8C). Without the application 
of strain, 41% of microstructure trapped single cells and 31% of them captured two cells. 
However, when the chip was extended by approximately 72%, the fractions of single-cell 
trap and two-cell trap decreased to 4% and 24%, respectively, and 39% of microstructures 
trapped three cells. These results show that the distribution of cell capture per cup shifted 
up from a mode of 1 without extension to a mode of 3 with the application of 72% uniaxial 
tensile strain. 
To evaluate cell viability after trapping, trapped cells were stained by JC-1 (10 μg/mL) 
at 37 °C for 30 min, and fluorescent images were taken with an inverted epifluorescence 
microscope (Diaphot 300, Nikon Instruments Inc., NY) with a CCD camera (Model 190CU, 
Micrometrics, NH). The intensity of red fluorescence caused by the accumulation of JC-1 
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in healthy mitochondria will decrease during depolarization occurring in the early stage of 
apoptosis [240, 241]. The trapped cells from both the unextended and extended (72%) 
device did not exhibit any degradation of red fluorescence (Figure 6.8D&E), indicating 
the trapped cells were viable. 
 
Figure 6.8: Fluorescent micrographs of cell trapping (A) before and (B) after application 
of strain. (C) The distribution of trapped cells before and after microstructure modulation. 
Images of JC-1 stained trapped cells (D) before and (E) after application of strain. Scale 
bars: 100 µm. 
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These results demonstrate that our approach can potentially allow the formation of a 
cell array with a predetermined cell number in each cell trap, from single cells to multiple 
cells. 
To explain the observed tunable cell trapping, the flow field before and after extension 
was analyzed by three-dimensional computational fluidic dynamics (CFD) analysis to 
explore the characteristic parameters that affect the number of cells trapped using ANSYS 
Fluent® (ANYSIS, Inc., Canonsburg, PA). 3-D models for the trapping regions were 
developed considering the cell as a rigid body. Fluid velocity along a reference line, which 
is denoted a-b (Figure 6.9A) and lies slightly above the capture cup centerline, was 
measured. As a crude approximation, it is assumed the cell travels with same velocity as 
the carrier flow. The transverse-to-longitudinal kinetic energy ratio can be represented by 
a dimensionless parameter R = Vy
2/Vx
2. As an example, the kinetic energy ratio R for the 
case without mechanical chip extension and without cells trapped along the line a-b is 
shown in Figure 6.9A, in which a maximum value is denoted by Rmax. When the cell’s 
transverse kinetic energy is significant compared to its longitudinal kinetic energy, cells 
are more likely to move around the microstructure instead of becoming trapped in the cup. 
Therefore, this maximum kinetic energy ratio can be used as an indicator of the 
microstructure array behavior. That is, a larger value of Rmax indicates a lower probability 
of cells to become trapped.  
The values of Rmax were calculated for a microstructure that has captured a varying 
number of cells when the device is unstretched or extended by 72% (Figure 6.9B). The 
relatively small values of Rmax when no cell is trapped in a cup on the unstretched device 
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(0.0114), and when zero (0.0032), one (0.0084) or two (0.0151) cells are trapped in the 
stretched device, suggest that an additional cell could relatively easily access the cup and 
become trapped. On the other hand, the relatively large values of Rmax when a single cell is 
trapped in a cup on the unstretched device (0.0218) and when three cells are trapped in a 
cup on the extended device (0.0207) suggest that it is difficult for additional cells to move 
into the cup. These results are consistent with experimental data. 
 
Figure 6.9: (A) Numerically determined transverse-to-longitudinal kinetic energy ratio (R) 
along the reference line a-b on the middle surface of the microfluidic channel. (B) 
Dimensionless parameter Rmax when a varying number of cells are trapped in a cup on an 
unstretched (B1 and B2) and stretched device (B3-B6). 
6.4. Conclusion 
Biological research and clinical diagnostics rely on controlled cell manipulation, such 
as isolation, positioning and trapping. We have developed an elastomeric polymeric 
microchip for mechanically tunable cell trapping. The device consists of two thin PDMS 
sheets, one of which bears microstructures to physically capture cells. Each microstructure 
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consists of a dam-like, cup-shaped geometry with supporting pillars on both sides. The 
employment of PDMS, which has large deformability, enables the mechanical modulation 
by inducing uniformly distributed strain via application of external force on the chip. 
Numerical analysis shows uniform strain distribution in the cell trapping region and 
effective modulation of cell trapping microstructures. Further analysis of the flow field 
suggests that the transverse-to-longitudinal kinetic ratio (Ey/Ex) of a cell can be used to 
reflect the possibility of trapping this cell. The experimental results also demonstrate the 
application of strain can significantly deform the cell trapping microstructure, thereby 
allowing for the cell array capable of trapping predetermined quantities of cells.  In 
addition, the trapped cells are shown to be viable. These results demonstrate that our 
approach can potentially enable effective, efficient and flexible formation of an array of 
cells on a microchip. 
Further studies will involve the system that has a larger dynamic range of the trapped 





Chapter 7. Isolation of Specific Cell-Binding Aptamers: a 
Hydrodynamically Based Approach and Early Results 
In Chapter 4 and Chapter 5, we presented microfluidic devices that utilize surface 
immobilized aptamers for specific cell capture and temperature mediated cell release. 
However, the limited availability of currently available cell-specific aptamer hinders its 
applications. 
In this chapter, preliminary results of a proof-of-concept microfluidic device for 
synthetically isolating cell-targeting aptamers from a randomized single-strand DNA 
(ssDNA) library is demonstrated. The device consists of two microchambers for selection 
and amplification respectively, and integrates cell culturing with affinity selection of cell-
binding ssDNA, which is then amplified by bead-based polymerase chain reaction (PCR). 
Coupling of the selection and amplification using pressure-driven flow controlled by 
microfabricated elastomeric valve realizes multi-round aptamer isolation on a single chip. 
The work presented in this chapter has resulted in a peer-reviewed conference proceeding 
[278], and a journal publication is under preparation. 
7.1. Introduction 
Aptamers are oligonucleotides (typically 12-80 nucleotide long) that recognize 
biological targets by specific affinity binding [125-127]. Isolated from a randomized 
oligonucleotide library using an in vitro synthetic selection process called systematic 
evolution of ligands by exponential enrichment (SELEX), aptamers can recognize a large 
variety of target molecules, such as metal ions [279, 280], small molecules [112, 113], 
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peptides [114], amino acids [115, 116], proteins [215], cells [117, 118], viruses [119, 120], 
and bacteria [44, 122], via unique three-dimensional conformations formed through 
interactions with target, and shows comparable affinity and selectivity as antibodies [123, 
281]. Compared with antibodies, aptamers, which are synthetically produced, can be more 
stable and more amenable to chemical modifications, have minimal batch-to-batch 
variability, and exhibit low immunogenicity for in vivo applications [123, 282]. Therefore, 
aptamers have the potential to be widely used in both fundamental biological researches 
[283] and clinical diagnostics and therapeutics [284, 285] . 
Recognition of cancer cells or cell surface biomarkers from a heterogeneous mixture 
in blood or other body fluids is critically important in cancer diagnostics [286, 287]. 
However, the lack of effective molecular ligands targeting cancer biomarkers hinders early 
cancer detection, and thus the effectiveness of the therapy [216, 288, 289]. Aptamers have 
been developed for cellular targets, such as acute lymphoblastic leukemia (ALL) precursor 
T cells [216], liver cancer cells [217] and even stem cells [218], and have been employed 
to isolate cancer cells from cell mixtures [201, 223] and to identify particular cancer 
subtypes [122, 216, 290]. However, conventional platforms for developing cell-targeting 
aptamers are labor-, time- and resource-intensive [124]; it generally takes months or even 
a year to reliably generate an aptamer [291]. 
Microfluidic technology has been employed to improve the SELEX efficiency via 
process integration, but early attempts were limited to molecular targets [139, 142, 143]. 
More recently, researchers reported several microfluidic systems used for the generation 
of aptamers targeting cells. For example, Lee and coworkers immobilized cells onto 
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magnetic bead surfaces for selection, and employed suction-based flow manipulation to 
transfer samples and reagents [292]. However, chemical modification of cells required by 
bead-based immobilization may negatively influence their viability, and the generation of 
single strand DNA (ssDNA) from double strand DNA (dsDNA) in solution by pure heating 
is inefficient, and could negatively affect the selection efficiency in the next round. In an 
alternative approach demonstrated in our lab, cells were hydrodynamically trapped in the 
microchamber, and ssDNA were electrokinetically transferred through an agarose gel filled 
channel between selection and amplification chambers [293]. However, physical trapping 
induces stress on cell, potentially compromising the expression of cell membrane proteins 
[294], to which cell-specific aptamers usually bind. In addition, cells exposed to high 
electrical fields during the electrophoresis could be irreversibly damaged [295]. 
To address these issues, this chapter presents a microfluidic device for cell-targeting 
aptamer development. The device consists of two microchambers, one for selection and 
one for amplification, with microfabricated resistive heaters and temperature sensors 
beneath for environmental control and thermal cycling. Cells are cultured on the bottom 
surface of selection chamber, which not only provides an immobilized layer of cells for 
cell-binding oligomer selection, but also minimizes changes to cell membrane proteins 
potentially caused by other immobilization approaches. Meanwhile, primer-coated 
magnetic beads, retained in the amplification chamber by an external magnet, provide solid 
support for the oligomer capture and amplification. In addition, the device employs 
pressure-driven flow controlled by pneumatically actuated microvalves to realize multi-
round isolation of cell-targeting aptamers on a single chip. Using MCF-7 cells as a target, 
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we have demonstrated the capability of our approach to efficiently generate cell-binding 
oligomers from a random ssDNA library. 
7.2. Principle, Device Design and Fabrication 
7.2.1. Principle of Microfluidic Cell-Targeting Aptamer Development 
Our microfluidic cell-targeting aptamer development approach integrates cell culture, 
affinity selection of cell-binding ssDNA, and bead-based polymerase chain reaction (PCR) 
into a single microfluidic device. Cells are first cultured in the selection chamber for a 
sufficiently long time to ensure cell attachment and surface biomarker regeneration. 
Selection of ssDNA is then performed by infusing a random ssDNA library into the 
chamber (Figure 7.1A), followed by multiple washes to remove weakly bound ssDNA 
(Figure 7.1B). Next, primer-functionalized magnetic beads are introduced and held in the 
amplification chamber. The remaining strongly bound ssDNA are thermally eluted (Figure 
7.1C), hydrodynamically transferred to the amplification chamber (Figure 7.1D), captured 
by the surface immobilized primers (Figure 7.1E), and amplified via bead-based PCR 
(Figure 7.1F). Afterward, the ssDNA are released from the bead surfaces (Figure 7.1G) 





Figure 7.1: Principle of microfluidic aptamer development: (A) ssDNA with random 
sequence binds to cells in the selection chamber; (B) weak binders are removed by 
washing; (C) strong binders are eluted and (D) transferred to the amplification chamber; 
(E) the strands are captured by magnetic beads with surface-immobilized reverse primers 
and (F) amplified through PCR; (G) the amplified single strands are released from bead 
surfaces and (H) transported back to the selection chamber for the next round. 
7.2.2. Device Design and Fabrication 
The microfluidic device consists of two microchambers situated on a temperature 
control chip for selection and amplification (Figure 7.2A). The surfaces of both 
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microchambers (30 µm in height) with an approximately 1.5 µL volume are coated with 
Parylene C to prevent evaporative loss of reactants [171]. A permanent magnet is place 
beneath the amplification chamber to retain the streptavidin-coated magnetic beads (2.8 
µm in diameter). The two channels that connect the microchambers are shaped with semi-
circular profiles (20 µm in height) that can be completely sealed by elastomeric 
microvalves actuated by pressure-driven, oil-filled channels (30 µm in height) above 
(Figure 7.2B). Integrated on the temperature control chip are two groups of temperature 
control units, each containing a serpentine-sharped resistive temperature sensor (linewidth: 
25 m) and serpentine-sharped heater (linewidth: 300 m) beneath the center of selection 
or amplification microchamber. The chamber temperatures can be hence controlled in 
closed loop separately using corresponding integrated temperature sensor and heater. 
 
Figure 7.2: (A) Top view and (B) cross-sectional view along line a-a of the aptamer 
development microfluidic device. 
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The temperature control chip was fabricated using standard microfabrication 
techniques. Briefly, gold (100 nm) and chrome (5 nm) thin films were thermally evaporated 
onto the glass substrate, and patterned by photolithography and wet etching, which resulted 
in resistive temperature sensors and resistive heaters. Then, 1 m of silicon dioxide was 
deposited using plasma-enhanced chemical vapor deposition (PECVD) to passivate 
sensors and heaters, the contact regions for electrical connections to which were opened by 
etching the oxide layer using hydrofluoric acid (Figure 7.3A). 
Subsequently, the microfluidic slab bearing microfluidic and pneumatic features was 
fabricated from PDMS using soft lithography techniques. A layer of AZ-4620 positive 
photoresist (20 µm, Clariant Corp. Somerville, NJ) was spin-coated on a silicon wafer 
(Silicon Quest International, Inc., San Jose, CA), exposed to ultraviolet light through 
photomasks, developed, and baked to form a round-shaped flow channels that can be sealed 
completely. Then, a layer of SU-8 photoresist was patterned to finalize the mold defining 
microfluidic features (Figure 7.3B). Next, a PDMS prepolymer solution (base and curing 
agent mixed in a 10:1 ratio) was spin-coated onto the silicon wafer, and cured on a hotplate 
at 72 °C for 15 min (Figure 7.3C). In parallel, a layer of SU-8 photoresist was patterned 
on another silicon wafer to establish pneumatic controlled oil-filled valve actuation 
channels (Figure 7.3D). Another PDMS prepolymer solution was cast onto the mold and 
cured on a hotplate at 72 °C for 1 hour (Figure 7.3E). The resulting PDMS slab was peeled 
off from the mold, punched to form pneumatic inlet, and bonded to the PDMS membrane 
on the silicon mold bearing the microfluidic features (Figure 7.3F). Afterward, the PDMS 
slab together with the thin PDMS membrane was peeled off, punched to establish fluidic 
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inlets and outlets, and then bonded onto the temperature control chip irreversibly after 
another oxygen plasma treatment (Figure 7.3G). 
Finally, the surface of SBE microchanmber was coated with a thin layer of Parylene 
C via chemical vapor deposition (Figure 7.3H). A fabricated device is shown in Figure 
7.4. 
 
Figure 7.3: (A) Deposition, patterning and passivation of gold sensors and heaters. (B) 
Fabrication of fluidic channel mold including on-chip valves and microfluidic chambers 
and channels using positive photoresist AZ-4620 and SU-8. (C) PDMS spin-coating (D) 
Fabrication of SU-8 mold for pneumatic controlled oil-filled valve actuation channels. (E) 
Casting of PDMS microfluidic channels. (F) Bonding of PDMS slab for pneumatic 
controlled oil-filled valve actuation channels to PDMS-coated mold for microfluidic 
channels. (G) Peeling off and bonding of PDMS sheet containing fluidic channels and 
pneumatic controlled oil-filled valve actuation channels to temperature control chip. (H) 




Figure 7.4: Image of a fabricated device. 
7.3. Testing Methods 
7.3.1. Materials 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise 
indicated. ssDNA random library (5’ – GCC TGT TGT GAG CCT CCT GTC GAA – 40N 
– TTG AGC GTT TAT TCT TGT CTC CC – 3’) and primers (Forward Primer: 5' – FAM 
– GCC TGT TGT GAG CCT CCT GTC GAA -3', and Reverse Primer: 5' – dual biotin – 
GG GAG ACA AGA ATA AAC GCT CAA – 3') were synthesized and purified by 
Integrated DNA Technologies (Coralville, IA). Deoxynucleotide triphosphates (dNTPs) 
and GoTaq Flexi DNA polymerase were obtained from Promega Corp. (Madison, WI). 
Minimum Essential Medium (MEM), fetal bovine serum (FBS), penicillin-streptomycin 
(P/S, penicillin 10,000 unit/mL, streptomycin 10,000 g/mL), Dulbecco’s phosphate-
buffered saline (D-PBS), 0.25% Trypsin-EDTA and streptavidin coupled magnetic beads 
(Dynabeads® M-270 Streptavidin) were purchased from Invitrogen (Carlsbad, CA). MCF-
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7 cell line was obtained from the American Type Culture Collection (ATCC, Manassas, 
VA). 
7.3.2. Testing Setup 
Closed-loop temperature control of both selection microchamber and amplification 
microchamber was achieved using two groups of temperature control units with a 
proportional-integral-derivative (PID) algorithm implemented in a LabVIEW (National 
Instruments Corp., TX) program on a personal computer. Each temperature control unit 
contained a serpentine-shaped resistive temperature sensor and a resistive heater. The 
resistance of two temperature sensors was measured by a digit multimeter (34410A, 
Agilent Technologies Inc., CA) and a digit micro-ohm meter (34420A, Agilent 
Technologies Inc., CA), respectively. Each resistive heater was connected to an 
independent, dedicated DC power supply (E3631, Agilent Technologies Inc., CA) (Figure 
7.5A).  
Fluid control was achieved using microfabricated pressure-driven valves [192]. Two 
oil-filled channels, each actuated by an air control valve (6464K16, McMaster-Carr, NJ), 
are connected to a nitrogen gas tank (Tech Air, NY) via a pressure regulator (CONCOA 
North America, VA). The microfluidic device inlets are connected to a set of syringes that 
contain samples, buffers and reagents driven by syringe pumps (KD210P, KD Scientific, 
MA). 
7.3.3. Testing Procedure 
Development of aptamers in the microfluidic device starts from culturing MCF-7 cells 
in the selection chamber for a sufficiently long time (>4 hours) to ensure cell attachment 
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and surface biomarker regeneration (Figure 7.5B). Next, streptavidin magnetic beads with 
surface immobilized primers (approximately 5 pmol) are introduced and held in the 
amplification chamber with a magnet (Figure 7.5C). Selection of ssDNA is then performed 
by washing the cells with D-PBS (10 µL/min Figure 7.5D), infusing a random ssDNA 
library (100 pmol) in 20 µL binding buffer (900 mL of D-PBS + 4.5 g of glucose + 5 mL 
of 1 M MgCl2 + 1 g of bovine serum albumin + 100 mL of FBS) through the chamber (1 
µL/min, 37°C), followed by nine washes using washing buffer (900 mL of D-PBS + 4.5 g 
of glucose + 5 mL of 1 M MgCl2 + 100 mL of FBS) (10 µL/min, 37°C) for 3 min each to 
remove weakly bound ssDNA (Figure 7.5E). Afterward, the remaining strongly bound 
ssDNA are thermally eluted (60 °C), hydrodynamically transferred to the amplification 
chamber (1 µL/min, 10 min), and captured by the surface immobilized primers (Figure 
7.5F). Subsequently, 2 μL of PCR reagent, consisting of 7 pmol of forward primer, 1× 
GoTaq Flexi buffer, 0.5 U of GoTaq Flexi DNA polymerase, 1 nmol of dNTP and 4 nmol 
of MgCl2, is introduced and subjected to 30 thermal cycles of 95 °C for 15 s, 59 °C for 30 
s, and 72 °C for 45 s (Figure 7.5G). Cells in the selection chamber are then detached using 
0.25 % trypsin-EDTA, followed by a D-PBS wash (Figure 7.5H). Target cells are next 
cultured (Figure 7.5I) and washed (Figure 7.5J) again. Afterward, ssDNA are released 
from the bead surfaces at 95 °C and are transported back to the selection chamber at 37 °C 
(1 µL/min) for 10 min, followed by nine washes using washing buffer (10 µL/min, 37°C) 
for 3 min each to remove weakly bound ssDNA (Figure 7.5K). Subsequently, streptavidin 
magnetic beads are removed and the amplification chamber is rinsed using D-PBS (Figure 
7.5L). Then, the new streptavidin magnetic beads with surface immobilized primers 
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(approximately 5 pmol) are introduced again (Figure 7.5M), and the process can be 
repeated (Figure 7.5F). 
 
Figure 7.5: (A) Experimental setup for microfluidic cell-targeting aptamer development. 
(B) Cell culture on chip. (C) Introduction of streptavidin magnetic beads with surface 
168 
 
immobilized reversed primers. (D) Washing of cells using D-PBS. (E) Infusion of random 
ssDNA library for selection and remove of weakly bound ssDNA by multiple washes. (F) 
Thermal elution, hydrodynamically transfer and capture of strongly bound ssDNA. (G) 
Introduction of PCR reagent and thermal cycling. (H) Removal of cells and rinsing of 
selection chamber. (I) Cell culturing on chip. (J) Washing cells using D-PBS. (K) Thermal 
release of amplified ssDNA from bead surface, and transfer back to the selection chamber 
for isolation of strongly bound ssDNA. (L) Removal of used streptavidin beads.  (M) 
Introduction of new streptavidin magnetic beads with surface immobilized reversed 
primers, and repetition of the entire process (F)-(M).  
7.4. Results and Discussion 
This section presents and analyzes experimental results from the microfluidic device 
for cell-targeting aptamer development. We first characterized the temperature-controlled 
chip and evaluated the temporal accuracy of the temperature field in the amplification 
chamber. Then, characterization of cell-binding ssDNA selection and cell-binding ssDNA 
amplification and elution were performed to demonstrate the feasibility of each functional 
unit. Finally, an integrated and closed-loop three round SELEX process was carried out, 
with the monitoring of the ssDNA enrichment progress.  
7.4.1. Characterization of Temperature Control 
The temperature sensor was first calibrated using an environmental test chamber 
(9023, Delta Design Inc., CA) maintained at a series of temperatures which are measured 
with high accuracy temperature reference probes (5628, Fluke Calibration, UT). The 
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measured resistance (R) of the thin-film gold temperature sensor was observed to vary 
linearly with temperature (T), represented by the relationship R=R0[1+α(T-T0)], where R0 
is the sensor resistance at a reference temperature T0, and  is the temperature coefficient 
of resistance (TCR) of the sensor.  
Fitting this relationship to the measurement data allowed determination of the 
parameter values, which were used to determine the chamber temperature from the 
measured sensor resistance during the selection, elution and amplification process. The 
temperature sensor under the amplification chamber had a measured resistance of 136.42 
Ω at a reference temperature of 25.0 °C with a TCR of 3.10×10-3 1/°C. We then 
characterized the temperature control of the chamber during thermal cycling. Time-
resolved tracking of on-chip thermal cycling showed that the amplification chamber 
temperatures attained specified setpoints via control of the on-chip heater and off-chip fan 
quickly and precisely (Figure 7.6). 
 
Figure 7.6: Time-resolved tracking of the temperatures inside the buffer-filled 
amplification during thermal cycling. 
170 
 
7.4.2. Characterization of Cell-Binding ssDNA Selection 
We then investigated the on-chip cell culture in the selection chamber. 2 µL of MCF-
7 cell suspension at 1 × 107 cells/mL in complete culture media was introduced into the 
selection chamber, which was then kept at 37 °C in a humidified incubator containing 5% 
CO2 for 5 hours. The selection chamber was next rinsed using D-PBS at 10 µL/min for 1 
min to remove unattached and dead cells, and a phase contract image was taken with an 
inverted microscope (IX81, Olympus Corp., PA) equipped with a digital camera (C8484, 
Hamamatsu Corp., NJ). Cells were attached well on the bottom surface (Figure 7.7A), 
indicating the success of using this method to restrain cells in the chamber and to regenerate 
cell membrane proteins. 
To characterize the isolation of cell-binding ssDNA from a random library, the 
temperature of selection chamber was kept at 37 °C for the whole procedure by using the 
temperature control unit located beneath. 100 pmol of ssDNA library in 20 µL binding 
buffer was infused into the chamber at 1 µL/min for 20 min. Then, cells were washed with 
9 aliquots of washing buffer at 10 µL/min, each for 3 min, to remove undesired ssDNA. 
Waste from each buffer wash were collected, amplified using PCR, and analyzed using 
polyacrylamide gel electrophoresis (PAGE), as shown in Figure 7.7B. As the cells 
continue to be rinsed, the amount of weakly bound ssDNA in each washing waste 
(identically amplified) decreases, indicated by the decreased band intensities of lanes W1 
to W9 (Figure 7.7C). In addition, the comparable band intensity of W9 to negative control 
(NC, no template in the PCR reagent) suggests that ssDNA did not exist in the waste of 
final washing. The low intensity of the desired band in lane W1 is caused by an unspecific 
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amplification when using a high concentration of weakly bound ssDNA from the first wash 
as the template, indicated by the high fluorescence intensity above the desired band (Figure 
7.7B). This phenomenon can be potentially avoided by optimizing the PCR conditions 
when amplifying the ssDNA in the wash waste, which was not the emphasis of this work. 
The results indicate that the extensive washing step can efficiently remove most of the 
weakly bound ssDNA from cell surface.  
 
Figure 7.7: (A) A phase contract image of cells cultured in the selection chamber for 5h. 
(B) Polyacrylamide gel electropherogram of amplified eluents obtained during selection 
process. (C) Bar graph indicating band intensities for lanes W1-NC. Lane W1: wash 1; 
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Lane W3: wash 3; Lane W5: wash 5; Lane W7: wash 7; Lane W9: wash 9; Lane E1: 
thermal elution at 1 µL/min and 60 °C; Lane E2: thermal elution at 5 µL/min and 60 °C; 
Lane E3: thermal elution at 10 µL/min and 60 °C; Lane NC: negative control, no template.  
To demonstrate the thermal elution of strongly bound ssDNA after washing, the 
microchamber temperature was raised to 60 °C using the same temperature control unit. 
The cells were then rinsed with 3 aliquots of washing buffer (10 µL) at 1 µL/min, 5 µL/min 
and 10 µL/min, respectively. The high band intensity of lane E1 (1 µL/min), E2 (5 µL/min) 
and E3 (10 µL/min) indicates successful enrichment of cell-binding ssDNA (Figure 
7.7B&C). In addition, although not able to elute all the strongly bound ssDNA, rinsing 
cells at 1 µL/min for 10 min is sufficient to remove and collect a significant amount of cell-
binding ssDNA, as suggested by the highest fluorescence intensity of the desired band at 
lane E1 (Figure 7.7B&C). These results indicate successful enrichment and retrieval of 
cell-binding ssDNA. 
7.4.3. Characterization of Cell-Binding ssDNA Amplification and Elution 
To characterize the bead-based amplification of cell-binding ssDNA, 10 µL thermal 
eluent was driven to the amplification chamber with primer-coated magnetic beads at 1 
µL/min and room temperature for 10 min. The magnetic beads were gently stirred by the 
permanent magnet to achieve a better capture efficiency. Then, 2 µL of PCR reactants were 
introduced and thermally cycled. After washing, the fluorescent images of beads with and 
without cycling were taken (Figure 7.8A&B), and fluorescence intensities of beads were 
then measured and compared (Figure 7.8D). Following amplification, the fluorescent bead 
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intensity was 10-fold higher, indicating efficient ssDNA amplification through bead-based 
PCR. 
To collect the amplified cell-binding ssDNA, the magnetic beads were rinsed at 95 °C 
and 1 µL/min for 10 min. The rinsed beads (Figure 7.8C) showed an intensity that was 
10% of the pre-elution intensity, and was only 2.6% higher than that of pre-thermal cycling 
intensity (Figure 7.8D), indicating a highly efficient ssDNA dehybridization and 
separation from surface immobilized complementary strands. 
 
Figure 7.8: Verification of bead-based PCR and ssDNA elution. Fluorescent images of 
beads (A) before and (B) after 25 cycles of PCR, and (C) after thermally induced ssDNA 
elution; (D) bar graph depicting the fluorescent intensities of the beads. Scale bar 10 µm. 
7.4.4. Demonstration of Closed-Loop Cell-Targeting Aptamer Generation 
To demonstrate the feasibility of multiple-round, closed-loop cell specific aptamer 
generation, a three-round ssDNA selection, enrichment and amplification process was 
carried out. The weakly bound ssDNA of each wash in all three rounds, and the thermally 
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eluted strongly bound ssDNA in the third round were collected from the selection chamber 
(Figure 7.9A), amplified and analyzed with PAGE (Figure 7.9B). In the first round, there 
was still some ssDNA in the waste of the 9th wash. However, in the second and third round, 
there was nearly no ssDNA in the waste of the 9th wash. This indicates that the aptamer 
generation process was able to successfully increase the binding affinity of ssDNA pool to 
the target cells after each round. In addition, the high fluorescent intensity of the thermal 
elution lane in the gel image (Figure 7.9C) suggests that ssDNA specific to the target cells 
were successfully isolated, enriched and amplified. 
 
Figure 7.9: (A) Schematic of three-round, closed-loop cell-targeting ssDNA generation. 
(B) Polyacrylamide gel electropherogram of amplified eluents obtained during the three 
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selection processes; (B) bar graph indicating band intensities for lanes W11-NC. Lane 
W11: round 1, wash 1; Lane W19: round 1, wash 9; Lane W21: round 2, wash 1; Lane 
W29: round 2, wash 9; Lane W31: round 3, wash 1; Lane W39: round 3, wash 9; Lane E: 
thermal elution; Lane NC: negative control, no template.  
7.5. Conclusion 
Cell-targeting aptamers are of great importance in a wide variety of field, but their 
applications have been hindered by the limited choice of aptamers and labor-, time- and 
resource-intensive development process. We developed a microfluidic device for 
synthetically isolating and enriching cell-targeting aptamers from a randomized ssDNA 
library. The device integrates cell culturing with affinity selection of cell-binding ssDNA, 
which is then amplified by bead-based polymerase chain reaction (PCR). Coupling of the 
selection and amplification using pressure-driven flow realizes multi-round aptamer 
isolation on a single chip.  
Our experimental results show successful on-chip cell culture in the selection chamber 
and efficient cell-targeting ssDNA selection from a randomized library. The employment 
of bead-based PCR allows effective amplification of enriched cell-specific ssDNA, and 
separation of amplified ssDNA from complementary strands immobilized on the bead 
surfaces. In addition, the successful three-round cell-targeting ssDNA generation process 
indicates the feasibility of using this approach for aptamer development. These results 
demonstrate that our device can be further implemented to achieve fully automated aptamer 
generation, and thus has the potential to broaden current aptamer applications in 
fundamental biological researches and clinical diagnostics.   
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Future study will involve characterization of resulting aptamer candidates, such as 
cloning and sequencing of isolated cell-binding ssDNA, and dissociation constant (Kd) 
measurement. Currently cell immobilization approach (cell culture) can only be applied to 
adherent cells, a refined method may also be investigated to broaden the applicable scope 
of this device. Moreover, the function of counter selection need to be incorporated into 
current device, significantly increasing the specificity of isolated aptamer. In addition, 
besides DNA aptamers, RNA aptamers are another major type of aptamer. Therefore, on-
chip transcription and reverse transcription can also be explored, further expanding the 




Chapter 8. Conclusion and Future Work 
8.1. Conclusion 
Genetic analysis and cell manipulation play an import role in personalized medicine 
and can greatly benefit from microfluidic technology. In this thesis, several microfluidic 
devices have been developed for genetic analysis and cell manipulation. With on-chip 
temperature control, microfluidic handling, and physical modulation, such devices have 
been demonstrated to be capable of single nucleotide polymorphism (SNP) genotyping, 
specific cell capture and temperature mediated cell release, tunable cell trapping, and cell-
binding aptamer development on microfluidic surfaces.  
In Chapter 2, a bead-based SNP genotyping device is presented. This approach utilized 
solid phase to integrate all the reactions, including polymerase chain reaction (PCR), single 
base extension (SBE), and purification, into a single chamber. The device consisted of a 
microchamber situated on a temperature control chip, which was further coupled to matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) 
for product analysis. Closed-loop, accurate temperature control was achieved by a 
proportional-integral-derivative (PID) algorithm with time constants of 2 s for heating and 
9 s for cooling during the thermal cycling process, which was much more efficient than 
conventional thermal cyclers. The feasibility of our microfluidic device has been 
demonstrated by applying it to the genotyping of SNP on exon 1 of HBB gene, which 
causes sickle cell anemia. 
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As a significant improvement to bead-based SNP genotyping, a multi-step, multiplex 
SNP genotyping device is presented in Chapter 3. The device consisted of two 
microchambers situated on a temperature control chip for respectively carrying out SBE 
and solid-phase purification (SPP) reactions, as well as a microchannel for desalting. These 
functional components were connected in series by microchannels with a semi-circular 
cross section and could be controlled by microfabricated elastomeric valves situated 
beneath. 100% primer extension and efficient chemical release of SBE product have been 
demonstrated by using house-synthesized cleavable mass-tagged dideoxynucleotide 
triphosphate (ddNTPs) and on-chip temperature control units. Moreover, the tradeoff 
between the efficiency of SPP/desalting and that of the full assay has also been 
investigated. In addition, 4-plex assays on a mock synthetic template, which mimic the 
SNP detection process, were carried out within the fully integrated device to demonstrate 
the feasibility of using the microfluidic device for rapid, automated, integrated and 
miniaturized multiplex SNP genotyping with high accuracy and sensitivity. 
Chapter 4 presents the investigation of temperature dependent affinity between 
aptamers and cells using a microfluidic device integrating on-chip temperature sensing and 
temperature control. The device consisted of a microchamber, with surface functionalized 
aptamers to capture target cells with high specificity, situated on a temperature control 
chip. The specificity of cell isolation has been demonstrated by separating CCRF-CEM 
cells from a heterogeneous cell solution, followed by measurements of the sensitivity of 
cell capture to the concentration of cell suspension and to the incubation time within the 
chamber. To test the temperature-dependent binding between the target cells and surface 
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coated aptamers, the temperature of the chamber was maintained at different setpoints, 
while washing buffer was used to continuously rinse the chamber. It was found that both 
higher temperatures and higher shear stresses facilitated cell release, and the tradeoff 
between these two factors was an important design consideration, due to the greater risk of 
cell damage when using either a higher temperature or a larger shear stress. In addition, the 
released cells were shown to be viable, and the aptamer-functionalized surfaces were 
successfully regenerated and shown to be reusable. 
In Chapter 5, based on the principle demonstrated in Chapter 2, a microfluidic device 
for spatially selective specific capture and temperature-mediated release of cells is 
presented. The approach utilized a highly localized heating effect, enabled by a 
microfabricated resistive heater and temperature sensor, to change the affinity properties 
of aptamers in a specific region, without affecting those in other regions. The device 
consisted of a microchamber situated on a microchip with four groups of micro heaters and 
temperature sensors, and aptamers were patterned on design-specified regions of the chip 
surface. Both experimental and numerical results have demonstrated spatially selective 
temperature control. Further experiments showed efficient, spatially selective temperature-
mediated and nondestructive release of CCRF-CEM cells, and also indicated a reusable 
aptamer functionalized surface. 
Chapter 6 exploits the large compliance of elastomers (PDMS) to create an array of 
cell-trapping microstructures, whose dimensions can be mechanically modulated by 
inducing uniformly distributed strain via the application of external forces on the chip. Both 
numerical and experimental analysis showed effective deformation of microstructures, 
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whose width decreased from 28.8 µm to 18.0 µm and depth increased from 25.0 µm to 
36.3 µm when a 79% extension was applied. The dependence of the number of cells trapped 
per trap on the geometrical characteristics of the microstructures was investigated by 
capturing MCF-7 cells on the device with different applied extensions, and indicated that 
the mode of the distribution for cells per microstructure shifted from 1 to 3 when applying 
72% uniaxial tensile strain. In addition, the trapped cells were shown to be viable. 
In Chapter 7, preliminary studies on a microfluidic device for synthetically isolating 
and enriching cell-targeting aptamers from a randomized single-strand DNA (ssDNA) 
library are presented. The pure hydrodynamic approach integrated the functions of cell 
culture, affinity selection of cell-binding ssDNA, and bead-based PCR. The microfluidic 
device consisted of two microchambers, one for selection and the other for amplification, 
that were connected through elastomeric microvalves to realize closed-loop, multi-round 
aptamer development. The success of isolating MCF-7 cell-targeting ssDNA from a 
randomized library and the efficiency of bead-based ssDNA amplification have been 
investigated. In addition, the feasibility of using this approach for aptamer development 
has been demonstrated by a closed-loop, three-round cell specific ssDNA generation 
process. 
8.2. Future Work 
The main contributions of the MEMS-based devices detailed in this thesis are 
demonstrations of proof-of-principle critical functional building blocks that can potentially 
enable integrated microsystems for personalized cancer medicine, which is a healthcare 
paradigm that allows physicians to tailor cancer treatment strategies for individual patients, 
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based on the exclusive patient-specific characteristics of disease revealed by evidence such 
as genetic variation identification, and cellular and pathological response to pharmaceutical 
drug candidates. In addition to future work discussed at the end of each individual chapter, 
the following opportunities can also be pursued in extension of this thesis research. 
8.2.1. Integration of Specific Cell Purification and SNP Genotyping 
The completion of the human genome and recent advances in whole genome 
sequencing have contributed to a more detailed understanding of molecular bases of 
diseases and impacts of genetics to diseases. Analysis of SNPs will contribute to 
personalized cancer medicine by predicting the risk of genetically related diseases and drug 
responses. In the research presented in this thesis, we have realized cell isolation from 
heterogeneous solutions and SNP genotyping from a low concentrated target sequence. To 
achieve a fully integrated device for genetic variation identification, a functional unit for 
cell lysis and genome DNA (gDNA) digestion needs to be integrated with cell isolation 
and SNP genotyping. The strategy of cell lysis, gDNA digestion, and purification of DNA 
fragments containing target sequences can be investigated in a future study. In addition, 
the on-chip detection method, such as nanoelectromechanical–mass spectrometry system 
[296], can also be explored to further increase the integration level, eliminating the 
requirement for external detection instrumentation. 
8.2.2. Integration of Specific Cell Purification and Tunable Cell Array Establishment 
High level integration has been a major feature of MEMS device, with significant 
advantages including reduced consumption of labor and resources, improved efficiency 
and accuracy, minimized device footprint, and enhanced portability. We have presented 
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microfluidic devices for specific cell purification and tunable cell array establishment. 
These two devices can be further integrated to achieve an anti-cancer drug screening device, 
providing patient-specific information on cellular and/or pathological response to specific 
pharmaceutical drugs. To do so, circulating-tumor-cells (CTCs) would be separated and 
enriched from blood samples, followed by nondestructive retrieval, which can be 
accomplished by the device described in Chapter 2 and 3. The retrieved cells would be 
introduced into the device presented in Chapter 4 to establish the cell array. Obviously, to 
achieve the personalized anti-cancer drug screening device, the interface between the two 
functional units have to be properly defined. Therefore, the development of cell 
transportation module and the modification of cell trapping geometry that optimizes 
loading efficiency can be investigated in future studies. In addition, on-chip short-term cell 
culture with infusion of drugs can be incorporated into the existing device, utilizing a 
similar reported technique [268].  
8.2.3. Gene Expression Analysis for Identification of Substantial Variations among 
Cells 
Gene expression analysis at the single-cell level is critical to understanding the 
substantial variations among cells in a heterogeneous population [297]. Quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) allows effective single-cell 
gene expression analysis with high specificity and sensitivity, and large dynamic ranges. 
In this thesis, we have described the key techniques and proof-of-principle functional units 
that are required for a microfluidic qRT-PCR platform, including on-chip temperature 
control, solid-phase purification, specific cell purification or unspecific cell trapping, bead-
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based or solution-based DNA amplification, and on-chip elastomeric micro valves for 
fluidic regulation. Since conventional qRT-PCR platforms are labor-intensive, have high 
reagent consumption, and do not offer adequate accuracies in measuring low abundance 
transcripts [69], it is possible and necessary to investigate and develop a microfluidic 
device for qRT-PCR of cancer cells, incorporating all required steps on a microbead-based 
platform, such as trapping and lysis of single or small numbers of cells, capture, 
purification and reverse transcription (RT) of messenger RNA (mRNA), and quantitative 
real-time PCR (qPCR) using Taqman® assay. Meanwhile, the efficiency of cell lysis, 
mRNA capture and RT can be studied, and the feasibility of this fully integrated bead-
based approach can be further demonstrated by analyzing cells stimulated with different 
chemicals, leading to up- and/or down- regulation of some particular genes.  
184 
 
List of Publications Resulting from This Thesis 
Refereed Journal Publications 
 
1. Jing Zhu, Timothy Olsen, Renjun Pei, Milan Stojanovic and Qiao Lin, “A 
microfluidic device for cell specific aptamer development,” in preparation. 
2. Hao Sun, Jing Zhu, Brian Ponnaiya, Sally Amundson, David Brenner, Jianguo Tao 
and Qiao Lin, “A bead-based microfluidic device for gene expression analysis,” in 
preparation. 
3. Jing Zhu, Chunmei Qiu, Mirkó Palla, James Russo, Jingyue Ju and Qiao Lin, "A 
microfluidic device for multiplex single nucleotide polymorphism genotyping," RSC 
Advances, vol. 4, pp. 4269-4277, 2014. 
4. Jing Zhu, Junyi Shang, Timothy Olsen, Kun Liu, David Brenner and Qiao Lin, "A 
mechanically tunable microfluidic cell-trapping device," Sensor Actuat A-Phys, 
10.1016/j.sna.2013.10.016. 
5. Jing Zhu, Junyi Shang, Yuan Jia, Renjun Pei, Milan Stojanovic and Qiao Lin, 
"Spatially selective release of aptamer-captured cells by temperature mediation," IET 
Nanobiotechnol, doi: 10.1049/iet-nbt.2013.0028. 
6. Jing Zhu, Thaihuu Nguyen, Renjun Pei, Milan Stojanovic and Qiao Lin, "Specific 
capture and temperature-mediated release of cells in an aptamer-based microfluidic 
device," Lab Chip, 12: 3504-3513, 2012. 
7. Jing Zhu, Mirkó Palla, Stefano Ronca, Ronald Warpner, Jingyue Ju and Qiao Lin. "A 
MEMS-based approach to single nucleotide polymorphism genotyping," Sensor 
Actuat A-Phys, 195: 175-182, 2013. 
 
Refereed Conference Proceedings 
 
1. Jing Zhu, Timothy Olsen, Renjun Pei, Milan Stojanovic and Qiao Lin, “A 
microfluidic device for isolation of cell-targeting aptamers,” The 27th IEEE Int. Conf. 
on Micro Electro Mechanical Systems (MEMS '14), San Francisco, CA, pp. 242-245, 
2014. 
2. Yuan Jia, Bin Wang, Jing Zhu and Qiao Lin, “A polymer-based mems differential 
scanning calorimeter,” The 27th IEEE Int. Conf. on Micro Electro Mechanical 
Systems (MEMS '14), San Francisco, CA, pp. 306-309, 2014. 
3. Cheng Wang, Jinho Kim, Jing Zhu, Renjun Pei, Guohua Liu, James Hone, Milan 
185 
 
Stojanovic and Qiao Lin, “Graphene nanosensor for detection of small molecules,” 
The 27th IEEE Int. Conf. on Micro Electro Mechanical Systems (MEMS '14), San 
Francisco, CA, pp. 1075-1078, 2014. 
4. Jing. Zhu, Junyi. Shang, Yuan Jia, Kun Liu, David Brenner and Qiao Lin, "Physical 
modulation based cell manipulation in microfluidic devices," The 8th IEEE Int. Conf. 
on Nano/Micro Engineered and Molecular Systems (NEMS '13), Suzhou, China, pp. 
1226-1229, 2013. CM Ho Best Paper Award in Micro and Nanofluidics. 
5. Jing Zhu, Junyi Shang, David Brenner and Qiao Lin, "An elastomeric polymer 
microchip for mechanically tunable cell trapping," The 26th IEEE Int. Conf. on Micro 
Electro Mechanical Systems (MEMS '13), Taipei, Taiwan, pp. 945-948, 2013. 
6. Jaeyoung Yang, Jing Zhu and Qiao Lin, "A microfluidic aptasensor integrated with 
nanodrop generator for MALDI-TOF MS analysis in clinical applications," The 17th 
IEEE Int. Conf. on Solid-State Sensors, Actuators and Microsystems (Transducers 
'13), Barcelona, Spain, pp 2544-2547, 2013. 
7. Qiao Lin, Jinho Kim, Jing Zhu, Jaeyoung Yang, John Hilton, Thaihuu Nguyen, 
Renjun Pei, Kyungae. Yang and Milan Stojanovic, "Integrating aptamers and 
microfluidics for biological manipulation and sensing," The 8th IEEE Int. Conf. on 
Nano/Micro Engineered and Molecular Systems (NEMS '13), Suzhou, China, pp. 
1245-1248, 2013. 
8. Jinho Kim, John Hilton, Kyungae Yang, Renjun Pei, Jing Zhu, Milan Stojanovic and 
Qiao Lin, "Electrokinetically integrated microfluidic isolation and amplification of 
biomolecule- and cell-binding nucleic acids," The 26th IEEE Int. Conf. on Micro 
Electro Mechanical Systems (MEMS '13), Taipei, Taiwan, pp. 1007-1010, 2013. 
Outstanding Poster Paper Finalist. 
9. Jing Zhu, Mirkó Palla, Stefano Ronca, Ronald Warpner, Jingyue Ju and Qiao Lin, "A 
MEMS-based approach to detection of single nucleotide polymorphisms for genetic 
disorder diagnosis," The 25th IEEE Int. Conf. on Micro Electro Mechanical Systems 
(MEMS '12), Paris, France, pp. 754-756, 2012. 
10. Jing Zhu, Thaihuu Nguyen, Renjun Pei, Milan Stojanovic and Qiao Lin, "Specific 
capture and temperature mediated release of cells using aptamer-functionalized 
microfluidic surfaces," The 16th IEEE Int. Conf. on Solid-State Sensors, Actuators 
and Microsystems (Transducers '11), Beijing, China, pp. 751-754, 2011. 
11. Jing Zhu, Chunmei Qiu, Mirkó Palla, Thaihuu Nguyen, Jingyue Ju and Qiao Lin, "A 
microfluidic device for detection of single nucleotide polymorphisms by allele 
specific single base extension," The 15th Int. Conf. on Miniaturized Systems for 
Chemistry and Life Sciences (MicroTAS '11), Seattle, WA, pp. 1442-1444, 2011. 
186 
 
12. Jing Zhu, Thaihuu Nguyen, Renjun Pei, Milan Stojanovic and Qiao Lin, "Reusable 
microfluidic chip for cell capture and release using surface-immobilized aptamer," 
The 14th Int. Conf. on Miniaturized Systems for Chemistry and Life Sciences 





[1] G. M. Whitesides, "The Origins and the Future of Microfluidics," Nature, vol. 442, 
pp. 368-73, 2006. 
[2] J. W. Hong and S. R. Quake, "Integrated Nanoliter Systems," Nature 
Biotechnology, vol. 21, pp. 1179-1183, 2003. 
[3] D. B. Weibel, M. Kruithof, S. Potenta, S. K. Sia, A. Lee, and G. M. Whitesides, 
"Torque-Actuated Valves for Microfluidics," Analytical chemistry, vol. 77, pp. 
4726-4733, 2005. 
[4] N. T. Nguyen and Z. G. Wu, "Micromixers - a Review," Journal of 
Micromechanics and Microengineering, vol. 15, pp. R1-R16, 2005. 
[5] A. Gunther, M. Jhunjhunwala, M. Thalmann, M. A. Schmidt, and K. F. Jensen, 
"Micromixing of Miscible Liquids in Segmented Gas-Liquid Flow," Langmuir, vol. 
21, pp. 1547-1555, 2005. 
[6] P. Garstecki, M. A. Fischbach, and G. M. Whitesides, "Design for Mixing Using 
Bubbles in Branched Microfluidic Channels," Applied Physics Letters, vol. 86, 
2005. 
[7] D. J. Laser and J. G. Santiago, "A Review of Micropumps," Journal of 
Micromechanics and Microengineering, vol. 14, pp. R35-R64, 2004. 
[8] A. Manz, D. J. Harrison, E. M. J. Verpoorte, J. C. Fettinger, A. Paulus, H. Ludi, 
and H. M. Widmer, "Planar Chips Technology for Miniaturization and Integration 
of Separation Techniques into Monitoring Systems - Capillary Electrophoresis on 
a Chip," Journal of Chromatography, vol. 593, pp. 253-258, 1992. 
[9] A. Manz, N. Graber, and H. M. Widmer, "Miniaturized Total Chemical-Analysis 
Systems - a Novel Concept for Chemical Sensing," Sensors and Actuators B-
Chemical, vol. 1, pp. 244-248, 1990. 
[10] E. Livak-Dahl, I. Sinn, and M. Burns, "Microfluidic Chemical Analysis Systems," 
Annual Review of Chemical and Biomolecular Engineering, Vol 2, vol. 2, pp. 325-
353, 2011. 
[11] D. Janasek, J. Franzke, and A. Manz, "Scaling and the Design of Miniaturized 
Chemical-Analysis Systems," Nature, vol. 442, pp. 374-380, 2006. 
[12] E. W. K. Young and D. J. Beebe, "Fundamentals of Microfluidic Cell Culture in 




[13] S. M. Kim, S. H. Lee, and K. Y. Suh, "Cell Research with Physically Modified 
Microfluidic Channels: A Review," Lab on a Chip, vol. 8, pp. 1015-1023, 2008. 
[14] H. Andersson and A. van den Berg, "Microfluidic Devices for Cellomics: A 
Review," Sensors and Actuators B-Chemical, vol. 92, pp. 315-325, 2003. 
[15] P. Liu and R. A. Mathies, "Integrated Microfluidic Systems for High-Performance 
Genetic Analysis," Trends in Biotechnology, vol. 27, pp. 572-581, 2009. 
[16] K. M. Horsman, J. M. Bienvenue, K. R. Blasier, and J. P. Landers, "Forensic DNA 
Analysis on Microfluidic Devices: A Review," Journal of Forensic Sciences, vol. 
52, pp. 784-799, 2007. 
[17] G. H. W. Sanders and A. Manz, "Chip-Based Microsystems for Genomic and 
Proteomic Analysis," Trac-Trends in Analytical Chemistry, vol. 19, pp. 364-378, 
2000. 
[18] Y. H. Zhang and P. Ozdemir, "Microfluidic DNA Amplification-a Review," 
Analytica Chimica Acta, vol. 638, pp. 115-125, 2009. 
[19] X. D. Hoa, A. G. Kirk, and M. Tabrizian, "Towards Integrated and Sensitive 
Surface Plasmon Resonance Biosensors: A Review of Recent Progress," 
Biosensors & Bioelectronics, vol. 23, pp. 151-160, 2007. 
[20] J. Mairhofer, K. Roppert, and P. Ertl, "Microfluidic Systems for Pathogen Sensing: 
A Review," Sensors, vol. 9, pp. 4804-4823, 2009. 
[21] X. D. Fan, I. M. White, S. I. Shopova, H. Y. Zhu, J. D. Suter, and Y. Z. Sun, 
"Sensitive Optical Biosensors for Unlabeled Targets: A Review," Analytica 
Chimica Acta, vol. 620, pp. 8-26, 2008. 
[22] P. S. Dittrich and A. Manz, "Lab-on-a-Chip: Microfluidics in Drug Discovery," 
Nature Reviews Drug Discovery, vol. 5, pp. 210-218, 2006. 
[23] J. Pihl, M. Karlsson, and D. T. Chiu, "Microfluidic Technologies in Drug 
Discovery," Drug Discovery Today, vol. 10, pp. 1377-1383, 2005. 
[24] A. W. Chow, "Lab-on-a-Chip: Opportunities for Chemical Engineering," Aiche 
Journal, vol. 48, pp. 1590-1595, 2002. 
[25] D. Gonzalez de Castro, P. A. Clarke, B. Al-Lazikani, and P. Workman, 
"Personalized Cancer Medicine: Molecular Diagnostics, Predictive Biomarkers, 
and Drug Resistance," Clin Pharmacol Ther, vol. 93, pp. 252-9, 2013. 
[26] M. A. Hamburg and F. S. Collins, "The Path to Personalized Medicine," N Engl J 
Med, vol. 363, pp. 301-4, 2010. 
189 
 
[27] P. W. Gout and Y. Wang, "Drug Sensitivity Testing for Personalized Lung Cancer 
Therapy," J Thorac Dis, vol. 4, pp. 17-8, 2012. 
[28] K. J. Shaw, C. Birch, E. M. Hughes, A. D. Jakes, J. Greenman, and S. J. Haswell, 
"Microsystems for Personalized Biomolecular Diagnostics," Engineering in Life 
Sciences, vol. 11, pp. 121-132, 2011. 
[29] E. S. Lander, I. H. G. S. Consortium, L. M. Linton, B. Birren, C. Nusbaum, M. C. 
Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. 
Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. 
McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. 
Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-
Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. 
Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. 
Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, 
S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, 
L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, 
R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. 
McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, 
W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. 
Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. 
W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. 
Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, et al., 
"Initial Sequencing and Analysis of the Human Genome," Nature, vol. 409, pp. 
860-921, 2001. 
[30] J. Wang, W. Wang, R. Q. Li, Y. R. Li, G. Tian, L. Goodman, W. Fan, J. Q. Zhang, 
J. Li, J. B. Zhang, Y. R. Guo, B. X. Feng, H. Li, Y. Lu, X. D. Fang, H. Q. Liang, 
Z. L. Du, D. Li, Y. Q. Zhao, Y. J. Hu, Z. Z. Yang, H. C. Zheng, I. Hellmann, M. 
Inouye, J. Pool, X. Yi, J. Zhao, J. J. Duan, Y. Zhou, J. J. Qin, L. J. Ma, G. Q. Li, Z. 
T. Yang, G. J. Zhang, B. Yang, C. Yu, F. Liang, W. J. Li, S. C. Li, D. W. Li, P. X. 
Ni, J. Ruan, Q. B. Li, H. M. Zhu, D. Y. Liu, Z. K. Lu, N. Li, G. W. Guo, J. G. 
Zhang, J. Ye, L. Fang, Q. Hao, Q. Chen, Y. Liang, Y. Y. Su, A. San, C. Ping, S. 
Yang, F. Chen, L. Li, K. Zhou, H. K. Zheng, Y. Y. Ren, L. Yang, Y. Gao, G. H. 
Yang, Z. Li, X. L. Feng, K. Kristiansen, G. K. S. Wong, R. Nielsen, R. Durbin, L. 
Bolund, X. Q. Zhang, S. G. Li, H. M. Yang, and J. Wang, "The Diploid Genome 
Sequence of an Asian Individual," Nature, vol. 456, pp. 60-U1, 2008. 
[31] D. A. Wheeler, M. Srinivasan, M. Egholm, Y. Shen, L. Chen, A. McGuire, W. He, 
Y. J. Chen, V. Makhijani, G. T. Roth, X. Gomes, K. Tartaro, F. Niazi, C. L. 
Turcotte, G. P. Irzyk, J. R. Lupski, C. Chinault, X. Z. Song, Y. Liu, Y. Yuan, L. 
Nazareth, X. Qin, D. M. Muzny, M. Margulies, G. M. Weinstock, R. A. Gibbs, and 
J. M. Rothberg, "The Complete Genome of an Individual by Massively Parallel 
DNA Sequencing," Nature, vol. 452, pp. 872-U5, 2008. 
190 
 
[32] E. Check, "Human Genome: Patchwork People," Nature, vol. 437, pp. 1084-1086, 
2005. 
[33] H. Ellegren, "Comparative Genomics and the Study of Evolution by Natural 
Selection," Molecular Ecology, vol. 17, pp. 4586-4596, 2008. 
[34] K. E. Herold and A. Rasooly, Lab on a Chip Technology. Norfolk, UK: Caister 
Academic Press, 2009. 
[35] D. J. Harrison, K. Fluri, K. Seiler, Z. H. Fan, C. S. Effenhauser, and A. Manz, 
"Micromachining a Miniaturized Capillary Electrophoresis-Based Chemical-
Analysis System on a Chip," Science, vol. 261, pp. 895-897, 1993. 
[36] J. D. Watson and F. H. C. Crick, "Molecular Structure of Nucleic Acids - a Structure 
for Deoxyribose Nucleic Acid," Nature, vol. 171, pp. 737-738, 1953. 
[37] B. Alberts, Molecular Biology of the Cell, 4th ed. New York: Garland Science, 
2002. 
[38] F. Sanger and A. R. Coulson, "A Rapid Method for Determining Sequences in DNA 
by Primed Synthesis with DNA Polymerase," Journal of molecular biology, vol. 
94, pp. 441-8, 1975. 
[39] F. Sanger, G. M. Air, B. G. Barrell, N. L. Brown, A. R. Coulson, J. C. Fiddes, C. 
A. Hutchison, P. M. Slocombe, and M. Smith, "Nucleotide-Sequence of 
Bacteriophage Phichi174 DNA," Nature, vol. 265, pp. 687-695, 1977. 
[40] S. Brenner, M. Johnson, J. Bridgham, G. Golda, D. H. Lloyd, D. Johnson, S. J. Luo, 
S. McCurdy, M. Foy, M. Ewan, R. Roth, D. George, S. Eletr, G. Albrecht, E. 
Vermaas, S. R. Williams, K. Moon, T. Burcham, M. Pallas, R. B. DuBridge, J. 
Kirchner, K. Fearon, J. Mao, and K. Corcoran, "Gene Expression Analysis by 
Massively Parallel Signature Sequencing (Mpss) on Microbead Arrays," Nature 
Biotechnology, vol. 18, pp. 630-634, 2000. 
[41] J. Shendure, G. J. Porreca, N. B. Reppas, X. X. Lin, J. P. McCutcheon, A. M. 
Rosenbaum, M. D. Wang, K. Zhang, R. D. Mitra, and G. M. Church, "Accurate 
Multiplex Polony Sequencing of an Evolved Bacterial Genome," Science, vol. 309, 
pp. 1728-1732, 2005. 
[42] G. J. Porreca, "Genome Sequencing on Nanoballs," Nature Biotechnology, vol. 28, 
pp. 43-44, 2010. 
[43] M. Kircher and J. Kelso, "High-Throughput DNA Sequencing - Concepts and 
Limitations," Bioessays, vol. 32, pp. 524-536, 2010. 
191 
 
[44] C. P. Fredlake, D. G. Hert, C. W. Kan, T. N. Chiesl, B. E. Root, R. E. Forster, and 
A. E. Barron, "Ultrafast DNA Sequencing on a Microchip by a Hybrid Separation 
Mechanism That Gives 600 Bases in 6.5 Minutes," Proceedings of the National 
Academy of Sciences of the United States of America, vol. 105, pp. 476-481, 2008. 
[45] J. H. Aborn, S. A. El-Difrawy, M. Novotny, E. A. Gismondi, R. Lam, P. 
Matsudaira, B. K. Mckenna, T. O'Neil, P. Streechon, and D. J. Ehrlich, "A 768-
Lane Microfabricated System for High-Throughput DNA Sequencing," Lab on a 
Chip, vol. 5, pp. 669-674, 2005. 
[46] R. G. Blazej, P. Kumaresan, and R. A. Mathies, "Microfabricated Bioprocessor for 
Integrated Nanoliter-Scale Sanger DNA Sequencing," Proceedings of the National 
Academy of Sciences of the United States of America, vol. 103, pp. 7240-7245, 
2006. 
[47] A. J. Brookes, "The Essence of Snps," Gene, vol. 234, pp. 177-186, 1999. 
[48] R. Sachidanandam, D. Weissman, S. C. Schmidt, J. M. Kakol, L. D. Stein, G. 
Marth, S. Sherry, J. C. Mullikin, B. J. Mortimore, D. L. Willey, S. E. Hunt, C. G. 
Cole, P. C. Coggill, C. M. Rice, Z. Ning, J. Rogers, D. R. Bentley, P. Y. Kwok, E. 
R. Mardis, R. T. Yeh, B. Schultz, L. Cook, R. Davenport, M. Dante, L. Fulton, L. 
Hillier, R. H. Waterston, J. D. McPherson, B. Gilman, S. Schaffner, W. J. Van 
Etten, D. Reich, J. Higgins, M. J. Daly, B. Blumenstiel, J. Baldwin, N. Stange-
Thomann, M. C. Zody, L. Linton, E. S. Lander, and D. Altshuler, "A Map of Human 
Genome Sequence Variation Containing 1.42 Million Single Nucleotide 
Polymorphisms," Nature, vol. 409, pp. 928-33, 2001. 
[49] P. Y. Kwok, "Methods for Genotyping Single Nucleotide Polymorphisms," Annual 
review of genomics and human genetics, vol. 2, pp. 235-58, 2001. 
[50] J. Ragoussis, "Genotyping Technologies for Genetic Research," Annual review of 
genomics and human genetics, vol. 10, pp. 117-133, 2009. 
[51] M. Ota, H. Fukushima, J. K. Kulski, and H. Inoko, "Single Nucleotide 
Polymorphism Detection by Polymerase Chain Reaction-Restriction Fragment 
Length Polymorphism," Nature protocols, vol. 2, pp. 2857-64, 2007. 
[52] D. Botstein, R. L. White, M. Skolnick, and R. W. Davis, "Construction of a 
Genetic-Linkage Map in Man Using Restriction Fragment Length 
Polymorphisms," American Journal of Human Genetics, vol. 32, pp. 314-331, 
1980. 
[53] V. Lyamichev, A. L. Mast, J. G. Hall, J. R. Prudent, M. W. Kaiser, T. Takova, R. 
W. Kwiatkowski, T. J. Sander, M. de Arruda, D. A. Arco, B. P. Neri, and M. A. 
Brow, "Polymorphism Identification and Quantitative Detection of Genomic DNA 
192 
 
by Invasive Cleavage of Oligonucleotide Probes," Nature Biotechnology, vol. 17, 
pp. 292-6, 1999. 
[54] M. Olivier, "The Invader Assay for Snp Genotyping," Mutation research, vol. 573, 
pp. 103-10, 2005. 
[55] G. H. McGall and F. C. Christians, "High-Density Genechip Oligonucleotide Probe 
Arrays," Advances in biochemical engineering/biotechnology, vol. 77, pp. 21-42, 
2002. 
[56] H. Matsuzaki, H. Loi, S. Dong, Y. Y. Tsai, J. Fang, J. Law, X. Di, W. M. Liu, G. 
Yang, G. Liu, J. Huang, G. C. Kennedy, T. B. Ryder, G. A. Marcus, P. S. Walsh, 
M. D. Shriver, J. M. Puck, K. W. Jones, and R. Mei, "Parallel Genotyping of over 
10,000 Snps Using a One-Primer Assay on a High-Density Oligonucleotide Array," 
Genome research, vol. 14, pp. 414-25, 2004. 
[57] U. Landegren, R. Kaiser, J. Sanders, and L. Hood, "A Ligase-Mediated Gene 
Detection Technique," Science, vol. 241, pp. 1077-1080, 1988. 
[58] F. A. De La Vega, K. D. Lazaruk, M. D. Rhodes, and M. H. Wenz, "Assessment of 
Two Flexible and Compatible Snp Genotyping Platforms: Taqman (R) Snp 
Genotyping Assays and the Snplex (Tm) Genotyping System," Mutation Research-
Fundamental and Molecular Mechanisms of Mutagenesis, vol. 573, pp. 111-135, 
2005. 
[59] F. J. Steemers and K. L. Gunderson, "Whole Genome Genotyping Technologies on 
the Beadarray Platform," Biotechnology journal, vol. 2, pp. 41-9, 2007. 
[60] C. Jurinke, P. Oeth, and D. van den Boom, "Maldi-Tof Mass Spectrometry: A 
Versatile Tool for High-Performance DNA Analysis," Molecular biotechnology, 
vol. 26, pp. 147-64, 2004. 
[61] E. Paux, P. Sourdille, I. Mackay, and C. Feuillet, "Sequence-Based Marker 
Development in Wheat: Advances and Applications to Breeding," Biotechnology 
advances, vol. 30, pp. 1071-88, 2012. 
[62] K. Y. Lien and G. B. Lee, "Miniaturization of Molecular Biological Techniques for 
Gene Assay," The Analyst, vol. 135, pp. 1499-518, 2010. 
[63] D. Schmalzing, A. Belenky, M. A. Novotny, L. Koutny, O. Salas-Solano, S. El-
Difrawy, A. Adourian, P. Matsudaira, and D. Ehrlich, "Microchip Electrophoresis: 




[64] K. Hatakeyama, T. Tanaka, M. Sawaguchi, A. Iwadate, Y. Mizutani, K. Sasaki, N. 
Tateishi, and T. Matsunaga, "Microfluidic Device Using Chemiluminescence and 
a DNA-Arrayed Thin Film Transistor Photosensor for Single Nucleotide 
Polymorphism Genotyping of Pcr Amplicons from Whole Blood," Lab on a Chip, 
vol. 9, pp. 1052-1058, 2009. 
[65] P. J. Choi, L. Cai, K. Frieda, and S. Xie, "A Stochastic Single-Molecule Event 
Triggers Phenotype Switching of a Bacterial Cell," Science, vol. 322, pp. 442-446, 
2008. 
[66] L. Cai, N. Friedman, and X. S. Xie, "Stochastic Protein Expression in Individual 
Cells at the Single Molecule Level," Nature, vol. 440, pp. 358-362, 2006. 
[67] I. Dunham, A. Kundaje, S. F. Aldred, P. J. Collins, C. A. Davis, F. Doyle, C. B. 
Epstein, S. Frietze, J. Harrow, R. Kaul, J. Khatun, B. R. Lajoie, S. G. Landt, B. K. 
Lee, F. Pauli, K. R. Rosenbloom, P. Sabo, A. Safi, A. Sanyal, N. Shoresh, J. M. 
Simon, L. Song, N. D. Trinklein, R. C. Altshuler, E. Birney, J. B. Brown, C. Cheng, 
S. Djebali, X. Dong, J. Ernst, T. S. Furey, M. Gerstein, B. Giardine, M. Greven, R. 
C. Hardison, R. S. Harris, J. Herrero, M. M. Hoffman, S. Iyer, M. Kelllis, P. 
Kheradpour, T. Lassmann, Q. Li, X. Lin, G. K. Marinov, A. Merkel, A. Mortazavi, 
S. C. Parker, T. E. Reddy, J. Rozowsky, F. Schlesinger, R. E. Thurman, J. Wang, 
L. D. Ward, T. W. Whitfield, S. P. Wilder, W. Wu, H. S. Xi, K. Y. Yip, J. Zhuang, 
B. E. Bernstein, E. D. Green, C. Gunter, M. Snyder, M. J. Pazin, R. F. Lowdon, L. 
A. Dillon, L. B. Adams, C. J. Kelly, J. Zhang, J. R. Wexler, P. J. Good, E. A. 
Feingold, G. E. Crawford, J. Dekker, L. Elinitski, P. J. Farnham, M. C. Giddings, 
T. R. Gingeras, R. Guigo, T. J. Hubbard, M. Kellis, W. J. Kent, J. D. Lieb, E. H. 
Margulies, R. M. Myers, J. A. Starnatoyannopoulos, S. A. Tennebaum, Z. Weng, 
K. P. White, B. Wold, Y. Yu, J. Wrobel, B. A. Risk, H. P. Gunawardena, H. C. 
Kuiper, C. W. Maier, L. Xie, X. Chen, T. S. Mikkelsen, et al., "An Integrated 
Encyclopedia of DNA Elements in the Human Genome," Nature, vol. 489, pp. 57-
74, 2012. 
[68] J. S. Marcus, W. F. Anderson, and S. R. Quake, "Microfluidic Single-Cell Mrna 
Isolation and Analysis," Analytical chemistry, vol. 78, pp. 3084-9, 2006. 
[69] A. K. White, M. VanInsberghe, O. I. Petriv, M. Hamidi, D. Sikorski, M. A. Marra, 
J. Piret, S. Aparicio, and C. L. Hansen, "High-Throughput Microfluidic Single-Cell 
Rt-Qpcr," Proceedings of the National Academy of Sciences of the United States of 
America, vol. 108, pp. 13999-4004, 2011. 
[70] N. M. Toriello, E. S. Douglas, N. Thaitrong, S. C. Hsiao, M. B. Francis, C. R. 
Bertozzi, and R. A. Mathies, "Integrated Microfluidic Bioprocessor for Single-Cell 
Gene Expression Analysis," Proceedings of the National Academy of Sciences of 
the United States of America, vol. 105, pp. 20173-20178, 2008. 
194 
 
[71] J. D. Adams and H. T. Soh, "Perspectives on Utilizing Unique Features of 
Microfluidics Technology for Particle and Cell Sorting," Jala, vol. 14, pp. 331-340, 
2009. 
[72] H. Tsutsui and C. M. Ho, "Cell Separation by Non-Inertial Force Fields in 
Microfluidic Systems," Mechanics Research Communications, vol. 36, pp. 92-103, 
2009. 
[73] P. Chen, X. J. Feng, W. Du, and B. F. Liu, "Microfluidic Chips for Cell Sorting," 
Frontiers in Bioscience-Landmark, vol. 13, pp. 2464-2483, 2008. 
[74] D. Recktenwald and A. Radbruch, Cell Separation Methods and Applications. New 
York: M. Dekker, 1998. 
[75] X. Chen, D. Cui, C. Liu, H. Li, and J. Chen, "Continuous Flow Microfluidic Device 
for Cell Separation, Cell Lysis and DNA Purification," Analytica Chimica Acta, 
vol. 584, pp. 237-43, 2007. 
[76] S. K. Murthy, P. Sethu, G. Vunjak-Novakovic, M. Toner, and M. Radisic, "Size-
Based Microfluidic Enrichment of Neonatal Rat Cardiac Cell Populations," 
Biomedical microdevices, vol. 8, pp. 231-7, 2006. 
[77] L. R. Huang, E. C. Cox, R. H. Austin, and J. C. Sturm, "Continuous Particle 
Separation through Deterministic Lateral Displacement," Science, vol. 304, pp. 
987-990, 2004. 
[78] A. Jain and J. D. Posner, "Particle Dispersion and Separation Resolution of Pinched 
Flow Fractionation," Analytical chemistry, vol. 80, pp. 1641-8, 2008. 
[79] S. S. Kuntaegowdanahalli, A. A. S. Bhagat, G. Kumar, and I. Papautsky, "Inertial 
Microfluidics for Continuous Particle Separation in Spiral Microchannels," Lab on 
a Chip, vol. 9, pp. 2973-2980, 2009. 
[80] J. R. Rettig and A. Folch, "Large-Scale Single-Cell Trapping and Imaging Using 
Microwell Arrays," Analytical chemistry, vol. 77, pp. 5628-5634, 2005. 
[81] X. Wang, X. Gou, S. Chen, X. Yan, and D. Sun, "Cell Manipulation Tool with 
Combined Microwell Array and Optical Tweezers for Cell Isolation and 
Deposition," Journal of Micromechanics and Microengineering, vol. 23, pp. 
075006, 2013. 
[82] D. Di Carlo, N. Aghdam, and L. P. Lee, "Single-Cell Enzyme Concentrations, 
Kinetics, and Inhibition Analysis Using High-Density Hydrodynamic Cell Isolation 
Arrays," Analytical chemistry, vol. 78, pp. 4925-4930, 2006. 
195 
 
[83] A. M. Skelley, O. Kirak, H. Suh, R. Jaenisch, and J. Voldman, "Microfluidic 
Control of Cell Pairing and Fusion," Nature Methods, vol. 6, pp. 147-152, 2009. 
[84] T. B. Jones, Electromechanics of Particles. Cambridge ; New York: Cambridge 
University Press, 1995. 
[85] B. Kirby, "Micro- and Nanoscale Fluid Mechanics Transport in Microfluidic 
Devices." New York: Cambridge University Press, 2010. 
[86] H. A. Pohl, "The Motion and Precipitation of Suspensoids in Divergent Electric 
Fields," Journal of Applied Physics, vol. 22, pp. 869-871, 1951. 
[87] M. S. Pommer, Y. Zhang, N. Keerthi, D. Chen, J. A. Thomson, C. D. Meinhart, and 
H. T. Soh, "Dielectrophoretic Separation of Platelets from Diluted Whole Blood in 
Microfluidic Channels," Electrophoresis, vol. 29, pp. 1213-8, 2008. 
[88] X. Y. Hu, P. H. Bessette, J. R. Qian, C. D. Meinhart, P. S. Daugherty, and H. T. 
Soh, "Marker-Specific Sorting of Rare Cells Using Dielectrophoresis," 
Proceedings of the National Academy of Sciences of the United States of America, 
vol. 102, pp. 15757-15761, 2005. 
[89] F. Petersson, A. Nilsson, C. Holm, H. Jonsson, and T. Laurell, "Separation of Lipids 
from Blood Utilizing Ultrasonic Standing Waves in Microfluidic Channels," The 
Analyst, vol. 129, pp. 938-943, 2004. 
[90] F. Petersson, L. Aberg, A. M. Sward-Nilsson, and T. Laurell, "Free Flow 
Acoustophoresis: Microfluidic-Based Mode of Particle and Cell Separation," 
Analytical chemistry, vol. 79, pp. 5117-5123, 2007. 
[91] F. Petersson, A. Nilsson, C. Holm, H. Jonsson, and T. Laurell, "Continuous 
Separation of Lipid Particles from Erythrocytes by Means of Laminar Flow and 
Acoustic Standing Wave Forces," Lab on a Chip, vol. 5, pp. 20-22, 2005. 
[92] A. Ashkin, "Acceleration and Trapping of Particles by Radiation Pressure," 
Physical Review Letters, vol. 24, pp. 156-&, 1970. 
[93] S. Chu, J. E. Bjorkholm, A. Ashkin, and A. Cable, "Experimental-Observation of 
Optically Trapped Atoms," Physical Review Letters, vol. 57, pp. 314-317, 1986. 
[94] A. Ashkin, J. M. Dziedzic, and T. Yamane, "Optical Trapping and Manipulation of 
Single Cells Using Infrared-Laser Beams," Nature, vol. 330, pp. 769-771, 1987. 
[95] A. Ashkin and J. M. Dziedzic, "Optical Trapping and Manipulation of Viruses and 
Bacteria," Science, vol. 235, pp. 1517-1520, 1987. 
196 
 
[96] K. C. Neuman and S. M. Block, "Optical Trapping," Review of Scientific 
Instruments, vol. 75, pp. 2787-2809, 2004. 
[97] M. Werner, F. Merenda, J. Piguet, R. P. Salathe, and H. Vogel, "Microfluidic Array 
Cytometer Based on Refractive Optical Tweezers for Parallel Trapping, Imaging 
and Sorting of Individual Cells," Lab on a Chip, vol. 11, pp. 2432-2439, 2011. 
[98] C. Liberale, G. Cojoc, F. Bragheri, P. Minzioni, G. Perozziello, R. La Rocca, L. 
Ferrara, V. Rajamanickam, E. Di Fabrizio, and I. Cristiani, "Integrated Microfluidic 
Device for Single-Cell Trapping and Spectroscopy," Scientific Reports, vol. 3, 
2013. 
[99] B. Landenberger, H. Hofemann, S. Wadle, and A. Rohrbach, "Microfluidic Sorting 
of Arbitrary Cells with Dynamic Optical Tweezers," Lab on a Chip, vol. 12, pp. 
3177-3183, 2012. 
[100] X. L. Wang, S. X. Chen, M. Kong, Z. K. Wang, K. D. Costa, R. A. Li, and D. Sun, 
"Enhanced Cell Sorting and Manipulation with Combined Optical Tweezer and 
Microfluidic Chip Technologies," Lab on a Chip, vol. 11, pp. 3656-3662, 2011. 
[101] M. M. Wang, E. Tu, D. E. Raymond, J. M. Yang, H. C. Zhang, N. Hagen, B. Dees, 
E. M. Mercer, A. H. Forster, I. Kariv, P. J. Marchand, and W. F. Butler, 
"Microfluidic Sorting of Mammalian Cells by Optical Force Switching," Nature 
Biotechnology, vol. 23, pp. 83-87, 2005. 
[102] C. Janeway, Immunobiology : The Immune System in Health and Disease, 5th ed. 
New York: Garland Publishing., 2001. 
[103] S. I. Fox, Human Physiology, 7th ed. Boston: McGraw-Hill, 2002. 
[104] D. E. Koshland, "Application of a Theory of Enzyme Specificity to Protein 
Synthesis," Proceedings of the National Academy of Sciences of the United States 
of America, vol. 44, pp. 98-104, 1958. 
[105] E. Pavlovic, A. P. Quist, U. Gelius, and S. Oscarsson, "Surface Functionalization 
of Silicon Oxide at Room Temperature and Atmospheric Pressure," Journal of 
Colloid and Interface Science, vol. 254, pp. 200-203, 2002. 
[106] G. D. Sui, J. Y. Wang, C. C. Lee, W. X. Lu, S. P. Lee, J. V. Leyton, A. M. Wu, and 
H. R. Tseng, "Solution-Phase Surface Modification in Intact 




[107] W. J. Han, B. A. Allio, D. G. Foster, and M. R. King, "Nanoparticle Coatings for 
Enhanced Capture of Flowing Cells in Microtubes," Acs Nano, vol. 4, pp. 174-180, 
2010. 
[108] A. Sin, S. K. Murthy, A. Revzin, R. G. Tompkins, and M. Toner, "Enrichment 
Using Antibody-Coated Microfluidic Chambers in Shear Flow: Model Mixtures of 
Human Lymphocytes," Biotechnology and Bioengineering, vol. 91, pp. 816-826, 
2005. 
[109] S. Usami, H. H. Chen, Y. H. Zhao, S. Chien, and R. Skalak, "Design and 
Construction of a Linear Shear-Stress Flow Chamber," Annals of Biomedical 
Engineering, vol. 21, pp. 77-83, 1993. 
[110] S. Nagrath, L. V. Sequist, S. Maheswaran, D. W. Bell, D. Irimia, L. Ulkus, M. R. 
Smith, E. L. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. J. Balis, R. G. 
Tompkins, D. A. Haber, and M. Toner, "Isolation of Rare Circulating Tumour Cells 
in Cancer Patients by Microchip Technology," Nature, vol. 450, pp. 1235-9, 2007. 
[111] T. H. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "Demonstration and 
Characterization of Biomolecular Enrichment on Microfluidic Aptamer-
Functionalized Surfaces," Sensors and actuators. B, Chemical, vol. 155, pp. 58-66, 
2011. 
[112] C. Mannironi, A. Di Nardo, P. Fruscoloni, and G. P. Tocchini-Valentini, "In Vitro 
Selection of Dopamine Rna Ligands," Biochemistry, vol. 36, pp. 9726-34, 1997. 
[113] T. W. Wiegand, P. B. Williams, S. C. Dreskin, M. H. Jouvin, J. P. Kinet, and D. 
Tasset, "High-Affinity Oligonucleotide Ligands to Human Ige Inhibit Binding to 
Fc Epsilon Receptor I," Journal of Immunology, vol. 157, pp. 221-230, 1996. 
[114] D. Nieuwlandt, M. Wecker, and L. Gold, "In Vitro Selection of Rna Ligands to 
Substance P," Biochemistry, vol. 34, pp. 5651-9, 1995. 
[115] A. Geiger, P. Burgstaller, H. vonderEltz, A. Roeder, and M. Famulok, "Rna 
Aptamers That Bind L-Arginine with Sub-Micromolar Dissociation Constants and 
High Enantioselectivity," Nucleic acids research, vol. 24, pp. 1029-1036, 1996. 
[116] K. Harada and A. D. Frankel, "Identification of Two Novel Arginine Binding 
Dnas," The EMBO journal, vol. 14, pp. 5798-811, 1995. 
[117] J. K. Herr, J. E. Smith, C. D. Medley, D. H. Shangguan, and W. H. Tan, "Aptamer-
Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells," 
Analytical chemistry, vol. 78, pp. 2918-2924, 2006. 
198 
 
[118] A. Wochner, B. Cech, M. Menger, V. A. Erdmann, and J. Glokler, "Semi-
Automated Selection of DNA Aptamers Using Magnetic Particle Handling," 
Biotechniques, vol. 43, pp. 344-+, 2007. 
[119] W. James, "Aptamers in the Virologists' Toolkit," Journal of General Virology, vol. 
88, pp. 351-364, 2007. 
[120] S. C. B. Gopinath, "Methods Developed for Selex," Analytical and Bioanalytical 
Chemistry, vol. 387, pp. 171-182, 2007. 
[121] H. M. So, D. W. Park, E. K. Jeon, Y. H. Kim, B. S. Kim, C. K. Lee, S. Y. Choi, S. 
C. Kim, H. Chang, and J. O. Lee, "Detection and Titer Estimation of Escherichia 
Coli Using Aptamer-Functionalized Single-Walled Carbon-Nanotube Field-Effect 
Transistors," Small, vol. 4, pp. 197-201, 2008. 
[122] Z. Tang, D. Shangguan, K. Wang, H. Shi, K. Sefah, P. Mallikratchy, H. W. Chen, 
Y. Li, and W. Tan, "Selection of Aptamers for Molecular Recognition and 
Characterization of Cancer Cells," Analytical chemistry, vol. 79, pp. 4900-7, 2007. 
[123] S. D. Jayasena, "Aptamers: An Emerging Class of Molecules That Rival Antibodies 
in Diagnostics," Clinical Chemistry, vol. 45, pp. 1628-1650, 1999. 
[124] M. Cho, Y. Xiao, J. Nie, R. Stewart, A. T. Csordas, S. S. Oh, J. A. Thomson, and 
H. T. Soh, "Quantitative Selection of DNA Aptamers through Microfluidic 
Selection and High-Throughput Sequencing," Proceedings of the National 
Academy of Sciences of the United States of America, vol. 107, pp. 15373-15378, 
2010. 
[125] A. D. Ellington and J. W. Szostak, "In Vitro Selection of Rna Molecules That Bind 
Specific Ligands," Nature, vol. 346, pp. 818-22, 1990. 
[126] D. L. Robertson and G. F. Joyce, "Selection in Vitro of an Rna Enzyme That 
Specifically Cleaves Single-Stranded DNA," Nature, vol. 344, pp. 467-8, 1990. 
[127] C. Tuerk and L. Gold, "Systematic Evolution of Ligands by Exponential 
Enrichment: Rna Ligands to Bacteriophage T4 DNA Polymerase," Science, vol. 
249, pp. 505-10, 1990. 
[128] A. E. G. Cass and Y. Y. Zhang, "Nucleic Acid Aptamers: Ideal Reagents for Point-
of-Care Diagnostics?," Faraday Discussions, vol. 149, pp. 49-61, 2011. 
[129] S. D. Mendonsa and M. T. Bowser, "In Vitro Evolution of Functional DNA Using 
Capillary Electrophoresis," Journal of the American Chemical Society, vol. 126, 
pp. 20-21, 2004. 
199 
 
[130] W. S. Yao, K. Adelman, and J. A. Bruenn, "In Vitro Selection of Packaging Sites 
in a Double-Stranded Rna Virus," Journal of Virology, vol. 71, pp. 2157-2162, 
1997. 
[131] F. Zhang and D. Anderson, "In Vitro Selection of Bacteriophage Phi 29 Prohead 
Rna Aptamers for Prohead Binding," Journal of Biological Chemistry, vol. 273, pp. 
2947-2953, 1998. 
[132] R. Y. L. Tsai and R. R. Reed, "Identification of DNA Recognition Sequences and 
Protein Interaction Domains of the Multiple-Zn-Finger Protein Roaz," Molecular 
and Cellular Biology, vol. 18, pp. 6447-6456, 1998. 
[133] R. Stoltenburg, C. Reinemann, and B. Strehlitz, "Selex-a (R)Evolutionary Method 
to Generate High-Affinity Nucleic Acid Ligands," Biomolecular Engineering, vol. 
24, pp. 381-403, 2007. 
[134] R. K. Mosing and M. T. Bowser, "Microfluidic Selection and Applications of 
Aptamers," Journal of Separation Science, vol. 30, pp. 1420-1426, 2007. 
[135] J. C. Cox, P. Rudolph, and A. D. Ellington, "Automated Rna Selection," 
Biotechnology Progress, vol. 14, pp. 845-850, 1998. 
[136] J. C. Cox and A. D. Ellington, "Automated Selection of Anti-Protein Aptamers," 
Bioorganic & Medicinal Chemistry, vol. 9, pp. 2525-2531, 2001. 
[137] G. Hybarger, J. Bynum, R. F. Williams, J. J. Valdes, and J. P. Chambers, "A 
Microfluidic Selex Prototype," Analytical and Bioanalytical Chemistry, vol. 384, 
pp. 191-198, 2006. 
[138] P. Wilding, M. A. Shoffner, and L. J. Kricka, "Pcr in a Silicon Microstructure," 
Clinical Chemistry, vol. 40, pp. 1815-1818, 1994. 
[139] X. H. Lou, J. R. Qian, Y. Xiao, L. Viel, A. E. Gerdon, E. T. Lagally, P. Atzberger, 
T. M. Tarasow, A. J. Heeger, and H. T. Soh, "Micromagnetic Selection of Aptamers 
in Microfluidic Channels," Proceedings of the National Academy of Sciences of the 
United States of America, vol. 106, pp. 2989-2994, 2009. 
[140] K. M. Ahmad, S. S. Oh, S. Kim, F. M. McClellen, Y. Xiao, and H. T. Soh, "Probing 
the Limits of Aptamer Affinity with a Microfluidic Selex Platform," Plos One, vol. 
6, 2011. 
[141] S. S. Oh, K. M. Ahmad, M. Cho, S. Kim, Y. Xiao, and H. T. Soh, "Improving 
Aptamer Selection Efficiency through Volume Dilution, Magnetic Concentration, 
and Continuous Washing in Microfluidic Channels," Analytical chemistry, vol. 83, 
pp. 6883-6889, 2011. 
200 
 
[142] C. J. Huang, H. I. Lin, S. C. Shiesh, and G. B. Lee, "Integrated Microfluidic System 
for Rapid Screening of Crp Aptamers Utilizing Systematic Evolution of Ligands 
by Exponential Enrichment (Selex)," Biosensors & Bioelectronics, vol. 25, pp. 
1761-1766, 2010. 
[143] C. J. Huang, H. I. Lin, S. C. Shiesh, and G. B. Lee, "An Integrated Microfluidic 
System for Rapid Screening of Alpha-Fetoprotein-Specific Aptamers," Biosensors 
& Bioelectronics, vol. 35, pp. 50-55, 2012. 
[144] C. J. Easley, J. M. Karlinsey, J. M. Bienvenue, L. A. Legendre, M. G. Roper, S. H. 
Feldman, M. A. Hughes, E. L. Hewlett, T. J. Merkel, J. P. Ferrance, and J. P. 
Landers, "A Fully Integrated Microfluidic Genetic Analysis System with Sample-
in-Answer-out Capability," Proceedings of the National Academy of Sciences of 
the United States of America, vol. 103, pp. 19272-19277, 2006. 
[145] B. S. Ferguson, S. F. Buchsbaum, J. S. Swensen, K. Hsieh, X. H. Lou, and H. T. 
Soh, "Integrated Microfluidic Electrochemical DNA Sensor," Analytical chemistry, 
vol. 81, pp. 6503-6508, 2009. 
[146] R. H. Liu, J. N. Yang, R. Lenigk, J. Bonanno, and P. Grodzinski, "Self-Contained, 
Fully Integrated Biochip for Sample Preparation, Polymerase Chain Reaction 
Amplification, and DNA Microarray Detection," Analytical chemistry, vol. 76, pp. 
1824-1831, 2004. 
[147] J. Zhu, M. Palla, S. Ronca, R. Warpner, J. Ju, and Q. Lin, "A Mems-Based 
Approach to Detection of Single Nucleotide Polymorphisms for Genetic Disorder 
Diagnosis," 25th IEEE Int. Conf. Micro Electro Mechanical Systems, pp. 754-756, 
Paris, France, 2012. 
[148] J. Zhu, M. Palla, S. Ronca, R. Wapner, J. Y. Ju, and Q. Lin, "A Mems-Based 
Approach to Single Nucleotide Polymorphism Genotyping," Sensors and Actuators 
a-Physical, vol. 195, pp. 175-182, 2013. 
[149] R. Redon, S. Ishikawa, K. R. Fitch, L. Feuk, G. H. Perry, T. D. Andrews, H. Fiegler, 
M. H. Shapero, A. R. Carson, W. Chen, E. K. Cho, S. Dallaire, J. L. Freeman, J. R. 
Gonzalez, M. Gratacos, J. Huang, D. Kalaitzopoulos, D. Komura, J. R. MacDonald, 
C. R. Marshall, R. Mei, L. Montgomery, K. Nishimura, K. Okamura, F. Shen, M. 
J. Somerville, J. Tchinda, A. Valsesia, C. Woodwark, F. Yang, J. Zhang, T. Zerjal, 
L. Armengol, D. F. Conrad, X. Estivill, C. Tyler-Smith, N. P. Carter, H. Aburatani, 
C. Lee, K. W. Jones, S. W. Scherer, and M. E. Hurles, "Global Variation in Copy 
Number in the Human Genome," Nature, vol. 444, pp. 444-54, 2006. 
[150] J. Perkel, "Snp Genotyping: Six Technologies That Keyed a Revolution," Nature 
Methods, vol. 5, pp. 447-453, 2008. 
201 
 
[151] A. M. Glazier, J. H. Nadeau, and T. J. Aitman, "Finding Genes That Underlie 
Complex Traits," Science, vol. 298, pp. 2345-2349, 2002. 
[152] K. G. Becker, K. C. Barnes, T. J. Bright, and S. A. Wang, "The Genetic Association 
Database," Nature Genetics, vol. 36, pp. 431-432, 2004. 
[153] F. S. Collins, E. D. Green, A. E. Guttmacher, and M. S. Guyer, "A Vision for the 
Future of Genomics Research," Nature, vol. 422, pp. 835-47, 2003. 
[154] K. Offit, "Personalized Medicine: New Genomics, Old Lessons," Human genetics, 
vol. 130, pp. 3-14, 2011. 
[155] A. J. F. Griffiths, An Introduction to Genetic Analysis, 7th ed. New York: W.H. 
Freeman, 2000. 
[156] G. C. Kennedy, H. Matsuzaki, S. Dong, W. M. Liu, J. Huang, G. Liu, X. Su, M. 
Cao, W. Chen, J. Zhang, W. Liu, G. Yang, X. Di, T. Ryder, Z. He, U. Surti, M. S. 
Phillips, M. T. Boyce-Jacino, S. P. Fodor, and K. W. Jones, "Large-Scale 
Genotyping of Complex DNA," Nature biotechnology, vol. 21, pp. 1233-7, 2003. 
[157] F. M. De la Vega, K. D. Lazaruk, M. D. Rhodes, and M. H. Wenz, "Assessment of 
Two Flexible and Compatible Snp Genotyping Platforms: Taqman Snp Genotyping 
Assays and the Snplex Genotyping System," Mutation research, vol. 573, pp. 111-
35, 2005. 
[158] F. J. Steemers, W. Chang, G. Lee, D. L. Barker, R. Shen, and K. L. Gunderson, 
"Whole-Genome Genotyping with the Single-Base Extension Assay," Nature 
Methods, vol. 3, pp. 31-3, 2006. 
[159] J. Staaf, J. Vallon-Christersson, D. Lindgren, G. Juliusson, R. Rosenquist, M. 
Hoglund, A. Borg, and M. Ringner, "Normalization of Illumina Infinium Whole-
Genome Snp Data Improves Copy Number Estimates and Allelic Intensity Ratios," 
Bmc Bioinformatics, vol. 9, 2008. 
[160] J. B. Rampal, DNA Arrays : Methods and Protocols. Totowa, NJ: Human Press, 
2001. 
[161] E. Szantai and A. Guttman, "Genotyping with Microfluidic Devices," 
Electrophoresis, vol. 27, pp. 4896-4903, 2006. 
[162] Y. Wang, B. Vaidya, H. D. Farquar, W. Stryjewski, R. P. Hammer, R. L. McCarley, 
S. A. Soper, Y. W. Cheng, and F. Barany, "Microarrays Assembled in Microfluidic 
Chips Fabricated from Poly(Methyl Methacrylate) for the Detection of Low-
Abundant DNA Mutations," Analytical Chemistry, vol. 75, pp. 1130-1140, 2003. 
202 
 
[163] M. Noerholm, H. Bruus, M. H. Jakobsen, P. Telleman, and N. B. Ramsing, 
"Polymer Microfluidic Chip for Online Monitoring of Microarray Hybridizations," 
Lab on a Chip, vol. 4, pp. 28-37, 2004. 
[164] M. Bowden, L. N. Song, and D. R. Walt, "Development of a Microfluidic Platform 
with an Optical Imaging Microarray Capable of Attomolar Target DNA Detection," 
Analytical Chemistry, vol. 77, pp. 5583-5588, 2005. 
[165] Y. C. Chung, Y. C. Lin, C. D. Chueh, C. Y. Ye, L. W. Lai, and Q. Zhao, 
"Microfluidic Chip of Fast DNA Hybridization Using Denaturing and Motion of 
Nucleic Acids," Electrophoresis, vol. 29, pp. 1859-1865, 2008. 
[166] A. Russom, N. Tooke, H. Andersson, and G. Stemme, "Single Nucleotide 
Polymorphism Analysis by Allele-Specific Primer Extension with Real-Time 
Bioluminescence Detection in a Microfluidic Device," Journal of Chromatography 
A, vol. 1014, pp. 37-45, 2003. 
[167] W. Pusch, J. H. Wurmbach, H. Thiele, and M. Kostrzewa, "Maldi-Tof Mass 
Spectrometry-Based Snp Genotyping," Pharmacogenomics, vol. 3, pp. 537-548, 
2002. 
[168] S. Kim, H. D. Ruparel, T. C. Gilliam, and J. Y. Ju, "Digital Genotyping Using 
Molecular Affinity and Mass Spectrometry," Nature Reviews Genetics, vol. 4, pp. 
1001-1008, 2003. 
[169] S. Kim, J. R. Edwards, L. Y. Deng, W. Chung, and J. Y. Ju, "Solid Phase Capturable 
Dideoxynucleotides for Multiplex Genotyping Using Mass Spectrometry," Nucleic 
acids research, vol. 30, 2002. 
[170] L. P. Scheunemann and K. I. Ataga, "Delayed Hemolytic Transfusion Reaction in 
Sickle Cell Disease," American Journal of the Medical Sciences, vol. 339, pp. 266-
269, 2010. 
[171] Y. S. Shin, K. Cho, S. H. Lim, S. Chung, S. J. Park, C. Chung, D. C. Han, and J. K. 
Chang, "Pdms-Based Micro Pcr Chip with Parylene Coating," Journal of 
Micromechanics and Microengineering, vol. 13, pp. 768-774, 2003. 
[172] J. P. Hilton, T. H. Nguyen, M. Barbu, R. Pei, M. Stojanovic, and Q. Lin, "Pathogen 
Detection Using Microfluidic Bead-Based Polymerase Chain Reaction," 16th 
International Conference on Solid-State Sensors, Actuators and Microsystems, pp. 
190-193, Beijing, China, 2011. 
[173] J. Zhu, C. Qiu, M. Palla, T. Nguyen, J. Ju, and Q. Lin, "A Microfluidic Device for 
Detection of Single Nucleotide Polymorphisms by Allele Specific Single Base 
203 
 
Extension," Int. Conf. on Miniaturized Systems for Chemistry and Life Sciences 
(MicroTAS '11), pp. 1442-1444, Seattle, WA, 2011. 
[174] J. Zhu, C. Qiu, M. Palla, T. Nguyen, J. Russo, J. Ju, and Q. Lin, "A Microfluidic 
Device for Multiplex Single-Nucleotide Polymorphism Genotyping," RSC 
Advances, vol. 4, pp. 4269-4277, 2014. 
[175] G. Bollag, P. Hirth, J. Tsai, J. Zhang, P. N. Ibrahim, H. Cho, W. Spevak, C. Zhang, 
Y. Zhang, G. Habets, E. A. Burton, B. Wong, G. Tsang, B. L. West, B. Powell, R. 
Shellooe, A. Marimuthu, H. Nguyen, K. Y. Zhang, D. R. Artis, J. Schlessinger, F. 
Su, B. Higgins, R. Iyer, K. D'Andrea, A. Koehler, M. Stumm, P. S. Lin, R. J. Lee, 
J. Grippo, I. Puzanov, K. B. Kim, A. Ribas, G. A. McArthur, J. A. Sosman, P. B. 
Chapman, K. T. Flaherty, X. Xu, K. L. Nathanson, and K. Nolop, "Clinical Efficacy 
of a Raf Inhibitor Needs Broad Target Blockade in Braf-Mutant Melanoma," 
Nature, vol. 467, pp. 596-9, 2010. 
[176] P. T. C. Wan, M. J. Garnett, S. M. Roe, S. Lee, D. Niculescu-Duvaz, V. M. Good, 
C. G. Project, C. M. Jones, C. J. Marshall, C. J. Springer, D. Barford, and R. Marais, 
"Mechanism of Activation of the Raf-Erk Signaling Pathway by Oncogenic 
Mutations of B-Raf," Cell, vol. 116, pp. 855-867, 2004. 
[177] R. Kudchadkar, K. H. Paraiso, and K. S. Smalley, "Targeting Mutant Braf in 
Melanoma: Current Status and Future Development of Combination Therapy 
Strategies," Cancer journal, vol. 18, pp. 124-31, 2012. 
[178] D. Schleinitz, J. K. Distefano, and P. Kovacs, "Targeted Snp Genotyping Using the 
Taqman(R) Assay," Methods in molecular biology, vol. 700, pp. 77-87, 2011. 
[179] R. Palacios, D. Comas, J. Elorza, and P. Villoslada, "Genomic Regulation of Ctla4 
and Multiple Sclerosis," Journal of neuroimmunology, vol. 203, pp. 108-15, 2008. 
[180] Y. Zhang and P. Ozdemir, "Microfluidic DNA Amplification--a Review," 
Analytica chimica acta, vol. 638, pp. 115-25, 2009. 
[181] N. Beyor, L. Yi, T. S. Seo, and R. A. Mathies, "Integrated Capture, Concentration, 
Polymerase Chain Reaction, and Capillary Electrophoretic Analysis of Pathogens 
on a Chip," Analytical chemistry, vol. 81, pp. 3523-8, 2009. 
[182] R. H. Liu, M. J. Lodes, T. Nguyen, T. Siuda, M. Slota, H. S. Fuji, and A. McShea, 
"Validation of a Fully Integrated Microfluidic Array Device for Influenza a 




[183] J. K. K. Ng, H. H. Feng, and W. T. Liu, "Rapid Discrimination of Single-Nucleotide 
Mismatches Using a Microfluidic Device with Monolayered Beads," Analytica 
chimica acta, vol. 582, pp. 295-303, 2007. 
[184] R. D. Sochol, B. P. Casavant, M. E. Dueck, L. P. Lee, and L. Lin, "A Dynamic 
Bead-Based Microarray for Parallel DNA Detection," Journal of Micromechanics 
and Microengineering, vol. 21, 2011. 
[185] J. Chowdhury, G. V. Kagiala, S. Pushpakom, J. Lauzon, A. Makin, A. Atrazhev, 
A. Stickel, W. G. Newman, C. J. Backhouse, and L. M. Pilarski, "Microfluidic 
Platform for Single Nucleotide Polymorphism Genotyping of the Thiopurine S-
Methyltransferase Gene to Evaluate Risk for Adverse Drug Events," The Journal 
of molecular diagnostics : JMD, vol. 9, pp. 521-9, 2007. 
[186] J. Wang, M. Lin, A. Crenshaw, A. Hutchinson, B. Hicks, M. Yeager, S. Berndt, W. 
Y. Huang, R. B. Hayes, S. J. Chanock, R. C. Jones, and R. Ramakrishnan, "High-
Throughput Single Nucleotide Polymorphism Genotyping Using Nanofluidic 
Dynamic Arrays," BMC genomics, vol. 10, pp. 561, 2009. 
[187] M. Chan, M. W. Chan, T. W. Loh, H. Y. Law, C. S. Yoon, S. S. Than, J. M. Chua, 
C. Y. Wong, W. S. Yong, Y. S. Yap, G. H. Ho, P. Ang, and A. S. Lee, "Evaluation 
of Nanofluidics Technology for High-Throughput Snp Genotyping in a Clinical 
Setting," The Journal of molecular diagnostics : JMD, vol. 13, pp. 305-12, 2011. 
[188] Y. He, J. Wu, D. C. Dressman, C. Iacobuzio-Donahue, S. D. Markowitz, V. E. 
Velculescu, L. A. Diaz, Jr., K. W. Kinzler, B. Vogelstein, and N. Papadopoulos, 
"Heteroplasmic Mitochondrial DNA Mutations in Normal and Tumour Cells," 
Nature, vol. 464, pp. 610-4, 2010. 
[189] M. Gundry and J. Vijg, "Direct Mutation Analysis by High-Throughput 
Sequencing: From Germline to Low-Abundant, Somatic Variants," Mutation 
Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 729, pp. 
1-15, 2012. 
[190] S. Gabriel, L. Ziaugra, and D. Tabbaa, "Snp Genotyping Using the Sequenom 
Massarray Iplex Platform," Current protocols in human genetics / editorial board, 
Jonathan L. Haines ... [et al.], vol. Chapter 2, pp. Unit 2 12, 2009. 
[191] C. Qiu, S. Kumar, J. Guo, L. Yu, W. Guo, S. Shi, J. J. Russo, and J. Ju, "Design 
and Synthesis of Cleavable Biotinylated Dideoxynucleotides for DNA Sequencing 
by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectrometry," Analytical biochemistry, vol. 427, pp. 193-201, 2012. 
205 
 
[192] M. A. Unger, H. P. Chou, T. Thorsen, A. Scherer, and S. R. Quake, "Monolithic 
Microfabricated Valves and Pumps by Multilayer Soft Lithography," Science, vol. 
288, pp. 113-116, 2000. 
[193] M. Gonzalez, L. A. Bagatolli, I. Echabe, J. L. Arrondo, C. E. Argarana, C. R. 
Cantor, and G. D. Fidelio, "Interaction of Biotin with Streptavidin. Thermostability 
and Conformational Changes Upon Binding," J Biol Chem, vol. 272, pp. 11288-94, 
1997. 
[194] C. Qiu, S. Kumar, J. Guo, J. Lu, S. Shi, S. M. Kalachikov, J. J. Russo, A. B. Naini, 
E. A. Schon, and J. Ju, "Mitochondrial Single Nucleotide Polymorphism 
Genotyping by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectrometry Using Cleavable Biotinylated Dideoxynucleotides," Analytical 
biochemistry, vol. 427, pp. 202-10, 2012. 
[195] M. G. Pluskal, "Microscale Sample Preparation," Nature biotechnology, vol. 18, 
pp. 104-5, 2000. 
[196] C. E. C. A. Hop and R. Bakhtiar, "An Introduction to Electrospray Ionization and 
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry: Essential Tools 
in a Modern Biotechnology Environment," Biospectroscopy, vol. 3, pp. 259-280, 
1997. 
[197] J. White, "A Cfd Simulation on How the Different Sizes of Silica Gel Will Affect 
the Adsorption Performance of Silica Gel," Model. Simulat. Eng., vol. 2012, pp. 
Article ID 651434, 2012. 
[198] T. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "An Aptamer-Based Microfluidic 
Device for Thermally Controlled Affinity Extraction," Microfluidics and 
Nanofluidics, vol. 6, pp. 479-487, 2009. 
[199] J. Zhu, T. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "Specific Capture and 
Temperature Mediated Release of Cells Using Aptamer-Functionalized 
Microfluidic Surfaces," in IEEE Int. Conf. Solid-State Sensors, Actuators and 
Microsystems (Transducers '11). Beijing, China, 2011, pp. 751-754. 
[200] J. Zhu, T. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "Reusable Microfluidic Chip 
for Cell Capture and Release Using Surface-Immobilized Aptamer," in Int. Conf. 
on Miniaturized Chemical and Biochemical Analysis Systems (MicroTAS '10). 
Groningen, the Netherlands, 2010, pp. 920-922. 
[201] J. Zhu, T. Nguyen, R. Pei, M. Stojanovic, and Q. Lin, "Specific Capture and 
Temperature-Mediated Release of Cells in an Aptamer-Based Microfluidic 
Device," Lab on a chip, vol. 12, pp. 3504-13, 2012. 
206 
 
[202] S. K. Murthy, A. Sin, R. G. Tompkins, and M. Toner, "Effect of Flow and Surface 
Conditions on Human Lymphocyte Isolation Using Microfluidic Chambers," 
Langmuir, vol. 20, pp. 11649-11655, 2004. 
[203] P. Bianco and P. G. Robey, "Stem Cells in Tissue Engineering," Nature, vol. 414, 
pp. 118-21, 2001. 
[204] E. Gomez-Barrena, P. Rosset, I. Muller, R. Giordano, C. Bunu, P. Layrolle, Y. T. 
Konttinen, and F. P. Luyten, "Bone Regeneration: Stem Cell Therapies and Clinical 
Studies in Orthopaedics and Traumatology," Journal of cellular and molecular 
medicine, 2011. 
[205] D. S. Kompala and P. Todd, Cell Separation Science and Technology. Washington, 
DC: American Chemical Society, 1991. 
[206] A. Kumar and A. Bhardwaj, "Methods in Cell Separation for Biomedical 
Application: Cryogels as a New Tool," Biomedical Materials, vol. 3, pp. 034008, 
2008. 
[207] S. V. Hunt, Cell Separation Techniques Used in Immunology: John Wiley & Sons, 
Ltd, 2001. 
[208] J. D. Adams, U. Kim, and H. T. Soh, "Multitarget Magnetic Activated Cell Sorter," 
Proceedings of the National Academy of Sciences of the United States of America, 
vol. 105, pp. 18165-70, 2008. 
[209] A. A. S. Bhagat, H. Bow, H. W. Hou, S. J. Tan, J. Han, and C. T. Lim, 
"Microfluidics for Cell Separation," Medical & Biological Engineering & 
Computing, vol. 48, pp. 999-1014, 2010. 
[210] E. Chmela, R. Tijssen, M. T. Blom, H. J. Gardeniers, and A. van den Berg, "A Chip 
System for Size Separation of Macromolecules and Particles by Hydrodynamic 
Chromatography," Analytical chemistry, vol. 74, pp. 3470-5, 2002. 
[211] Y. Huang, S. Joo, M. Duhon, M. Heller, B. Wallace, and X. Xu, "Dielectrophoretic 
Cell Separation and Gene Expression Profiling on Microelectronic Chip Arrays," 
Analytical Chemistry, vol. 74, pp. 3362-71, 2002. 
[212] Z. Du, K. H. Cheng, M. W. Vaughn, N. L. Collie, and L. S. Gollahon, "Recognition 
and Capture of Breast Cancer Cells Using an Antibody-Based Platform in a 
Microelectromechanical Systems Device," Biomedical Microdevices, vol. 9, pp. 
35-42, 2007. 
[213] A. Hatch, G. Hansmann, and S. K. Murthy, "Engineered Alginate Hydrogels for 
Effective Microfluidic Capture and Release of Endothelial Progenitor Cells from 
207 
 
Whole Blood," Langmuir : the ACS journal of surfaces and colloids, vol. 27, pp. 
4257-64, 2011. 
[214] M. Stenberg and H. Nygren, "Kinetics of Antigen-Antibody Reactions at Solid-
Liquid Interfaces," Journal of Immunological Methods, vol. 113, pp. 3-15, 1988. 
[215] S. E. Lupold, B. J. Hicke, Y. Lin, and D. S. Coffey, "Identification and 
Characterization of Nuclease-Stabilized Rna Molecules That Bind Human Prostate 
Cancer Cells Via the Prostate-Specific Membrane Antigen," Cancer Res, vol. 62, 
pp. 4029-33, 2002. 
[216] D. Shangguan, Y. Li, Z. Tang, Z. C. Cao, H. W. Chen, P. Mallikaratchy, K. Sefah, 
C. J. Yang, and W. Tan, "Aptamers Evolved from Live Cells as Effective Molecular 
Probes for Cancer Study," Proc Natl Acad Sci U S A, vol. 103, pp. 11838-43, 2006. 
[217] D. Shangguan, L. Meng, Z. C. Cao, Z. Xiao, X. Fang, Y. Li, D. Cardona, R. P. 
Witek, C. Liu, and W. Tan, "Identification of Liver Cancer-Specific Aptamers 
Using Whole Live Cells," Anal Chem, vol. 80, pp. 721-8, 2008. 
[218] K. T. Guo, R. Schafer, A. Paul, G. Ziemer, and H. P. Wendel, "Aptamer-Based 
Strategies for Stem Cell Research," Mini Rev Med Chem, vol. 7, pp. 701-5, 2007. 
[219] D. Shangguan, Z. C. Cao, Y. Li, and W. Tan, "Aptamers Evolved from Cultured 
Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples," 
Clin Chem, vol. 53, pp. 1153-5, 2007. 
[220] D. Shangguan, Z. Tang, P. Mallikaratchy, Z. Xiao, and W. Tan, "Optimization and 
Modifications of Aptamers Selected from Live Cancer Cell Lines," Chembiochem 
: a European journal of chemical biology, vol. 8, pp. 603-6, 2007. 
[221] P. R. Bouchard, R. M. Hutabarat, and K. M. Thompson, "Discovery and 
Development of Therapeutic Aptamers," Annual review of pharmacology and 
toxicology, vol. 50, pp. 237-57, 2010. 
[222] J. A. Phillips, Y. Xu, Z. Xia, Z. H. Fan, and W. H. Tan, "Enrichment of Cancer 
Cells Using Aptamers Immobilized on a Microfluidic Channel," Analytical 
Chemistry, vol. 81, pp. 1033-1039, 2009. 
[223] Y. Xu, J. A. Phillips, J. Yan, Q. Li, Z. H. Fan, and W. Tan, "Aptamer-Based 
Microfluidic Device for Enrichment, Sorting, and Detection of Multiple Cancer 
Cells," Anal Chem, vol. 81, pp. 7436-42, 2009. 
[224] O. C. Farokhzad, A. Khademhosseini, S. Jon, A. Hermmann, J. Cheng, C. Chin, A. 
Kiselyuk, B. Teply, G. Eng, and R. Langer, "Microfluidic System for Studying the 
208 
 
Interaction of Nanoparticles and Microparticles with Cells," Anal Chem, vol. 77, 
pp. 5453-9, 2005. 
[225] U. Dharmasiri, S. Balamurugan, A. A. Adams, P. I. Okagbare, A. Obubuafo, and 
S. A. Soper, "Highly Efficient Capture and Enumeration of Low Abundance 
Prostate Cancer Cells Using Prostate-Specific Membrane Antigen Aptamers 
Immobilized to a Polymeric Microfluidic Device," Electrophoresis, vol. 30, pp. 
3289-300, 2009. 
[226] L. Chen, X. Liu, B. Su, J. Li, L. Jiang, D. Han, and S. Wang, "Aptamer-Mediated 
Efficient Capture and Release of T Lymphocytes on Nanostructured Surfaces," 
Advanced materials, vol. 23, pp. 4376-80, 2011. 
[227] H. Baumann and D. Doyle, "Effect of Trypsin on the Cell Surface Proteins of 
Hepatoma Tissue Culture Cells. Characterization of a Carbohydrate-Rich 
Glycopeptide Released from a Calcium Binding Membrane Glycoprotein," J Biol 
Chem, vol. 254, pp. 3935-46, 1979. 
[228] K. Jung, G. Hampel, M. Scholz, and W. Henke, "Culture of Human Kidney 
Proximal Tubular Cells - the Effect of Various Detachment Procedures on Viability 
and Degree of Cell Detachment," Cellular Physiology and Biochemistry, vol. 5, pp. 
353-360, 1995. 
[229] N. Fujioka, Y. Morimoto, K. Takeuchi, M. Yoshioka, and M. Kikuchi, "Difference 
in Infrared Spectra from Cultured Cells Dependent on Cell-Harvesting Method," 
Applied Spectroscopy, vol. 57, pp. 241-243, 2003. 
[230] T. Nguyen, R. J. Pei, D. W. Landry, M. N. Stojanovic, and Q. Lin, "Microfluidic 
Aptameric Affinity Sensing of Vasopressin for Clinical Diagnostic and Therapeutic 
Applications," Sensors and Actuators B-Chemical, vol. 154, pp. 59-66, 2011. 
[231] J. P. Hilton, T. H. Nguyen, R. J. Pei, M. Stojanovic, and Q. Lin, "A Microfluidic 
Affinity Sensor for the Detection of Cocaine," Sensors and Actuators a-Physical, 
vol. 166, pp. 241-246, 2011. 
[232] A. Shah and M. P. Coleman, "Increasing Incidence of Childhood Leukaemia: A 
Controversy Re-Examined," British journal of cancer, vol. 97, pp. 1009-12, 2007. 
[233] D. Parkin, E. Kramárová, G. Draper, E. Masuyer, J. Michaelis, J. Neglia, S. 
Qureshi, and S. CA., Eds., International Incidence of Childhood Cancer, Vol. Ii 
(Iarc Scientific Publication, No 144). Lyon, International Agency for Research on 
Cancer, 1998. 
[234] Y. Chen, M. B. O'Donoghue, Y. F. Huang, H. Kang, J. A. Phillips, X. Chen, M. C. 
Estevez, C. J. Yang, and W. Tan, "A Surface Energy Transfer Nanoruler for 
209 
 
Measuring Binding Site Distances on Live Cell Surfaces," J Am Chem Soc, vol. 
132, pp. 16559-70, 2010. 
[235] Q. Lin, F. K. Jiang, X. Q. Wang, Y. Xu, Z. G. Han, Y. C. Tai, J. Lew, and C. M. 
Ho, "Experiments and Simulations of Mems Thermal Sensors for Wall Shear-Stress 
Measurements in Aerodynamic Control Applications," Journal of Micromechanics 
and Microengineering, vol. 14, pp. 1640-1649, 2004. 
[236] G. Crescenzo, C. Boucher, Y. Durocher, and M. Jolicoeur, "Kinetic 
Characterization by Surface Plasmon Resonance-Based Biosensors: Principle and 
Emerging Trends," in Cellular and molecular bioengineering, vol. 1. New York: 
Springer, 2008, pp. 204-215. 
[237] M. N. Dickson, P. Tsinberg, Z. L. Tang, F. Z. Bischoff, T. Wilson, and E. F. 
Leonard, "Efficient Capture of Circulating Tumor Cells with a Novel 
Immunocytochemical Microfluidic Device," Biomicrofluidics, vol. 5, 2011. 
[238] R. H. Perry, D. W. Green, and Knovel (Firm), "Perry's Chemical Engineers' 
Handbook," 8th ed. New York: McGraw-Hill, 2008. 
[239] R. F. Hoernlein, T. Orlikowsky, C. Zehrer, D. Niethammer, E. R. Sailer, T. Simmet, 
G. E. Dannecker, and H. P. Ammon, "Acetyl-11-Keto-Beta-Boswellic Acid 
Induces Apoptosis in Hl-60 and Ccrf-Cem Cells and Inhibits Topoisomerase I," J 
Pharmacol Exp Ther, vol. 288, pp. 613-9, 1999. 
[240] C. B. Avci, C. Gunduz, Y. Baran, F. Sahin, S. Yilmaz, Z. O. Dogan, and G. Saydam, 
"Caffeic Acid Phenethyl Ester Triggers Apoptosis through Induction of Loss of 
Mitochondrial Membrane Potential in Ccrf-Cem Cells," Journal of Cancer 
Research and Clinical Oncology, vol. 137, pp. 41-47, 2011. 
[241] L. Lossi, S. Alasia, C. Salio, and A. Merighi, "Cell Death and Proliferation in Acute 
Slices and Organotypic Cultures of Mammalian Cns," Prog Neurobiol, vol. 88, pp. 
221-45, 2009. 
[242] J. P. Mather and P. E. Roberts, Introduction to Cell and Tissue Culture : Theory 
and Technique. New York: Plenum Press, 1998. 
[243] J. Zhu, J. Shang, Y. Jia, K. Liu, D. Brenner, and Q. Lin, "Physical Modulation 
Based Cell Manipulation in Microfluidic Devices," in IEEE Int. Conf. on 
Nano/Micro Engineered and Molecular Systems (NEMS '13). Suzhou, China, 2013, 
pp. 1226-1229. 
[244] J. Zhu, J. Shang, Y. Jia, R. Pei, M. Stojanovic, and Q. Lin, "Spatially Selective 
Release of Aptamer-Captured Cells by Temperature Mediation," IET 
Nanobiotechnology, doi: 10.1049/iet-nbt.2013.0028. 
210 
 
[245] S. Hou, H. C. Zhao, L. B. Zhao, Q. L. Shen, K. S. Wei, D. Y. Suh, A. Nakao, M. 
A. Garcia, M. Song, T. Lee, B. Xiong, S. C. Luo, H. R. Tseng, and H. H. Yu, 
"Capture and Stimulated Release of Circulating Tumor Cells on Polymer-Grafted 
Silicon Nanostructures," Advanced Materials, vol. 25, pp. 1547-1551, 2013. 
[246] A. A. Adams, P. I. Okagbare, J. Feng, M. L. Hupert, D. Patterson, J. Gottert, R. L. 
McCarley, D. Nikitopoulos, M. C. Murphy, and S. A. Soper, "Highly Efficient 
Circulating Tumor Cell Isolation from Whole Blood and Label-Free Enumeration 
Using Polymer-Based Microfluidics with an Integrated Conductivity Sensor," 
Journal of the American Chemical Society, vol. 130, pp. 8633-41, 2008. 
[247] H. L. Liu, X. L. Liu, J. X. Meng, P. C. Zhang, G. Yang, B. Su, K. Sun, L. Chen, D. 
Han, S. T. Wang, and L. Jiang, "Hydrophobic Interaction-Mediated Capture and 
Release of Cancer Cells on Thermoresponsive Nanostructured Surfaces," Advanced 
Materials, vol. 25, pp. 922-927, 2013. 
[248] P. Parekh, J. Martin, Y. Chen, D. Colon, H. Wang, and W. Tan, "Using Aptamers 
to Study Protein-Protein Interactions," Advances in biochemical 
engineering/biotechnology, vol. 110, pp. 177-94, 2008. 
[249] V. J. Ruigrok, M. Levisson, J. Hekelaar, H. Smidt, B. W. Dijkstra, and J. van der 
Oost, "Characterization of Aptamer-Protein Complexes by X-Ray Crystallography 
and Alternative Approaches," International journal of molecular sciences, vol. 13, 
pp. 10537-52, 2012. 
[250] J. P. Hilton, J. Kim, T. Nguyen, M. Barbu, R. Pei, M. Stojanovic, and Q. Lin, 
"Isolation of Thermally Sensitive Aptamers on a Microchip," IEEE Int. Conf. Micro 
Electro Mechanical Systems (MEMS '12) pp. 100-103, Paris, France, 2012. 
[251] J. Zhu, J. Shang, D. Brenner, and Q. Lin, "An Elastomeric Polymer Microchip for 
Mechanically Tunable Cell Trapping," The 26th IEEE International Conference on 
Micro Electro Mechanical Systems (MEMS '13), pp. 945-948, Taipei, Taiwan, 
2013. 
[252] J. Zhu, J. Shang, T. Olsen, K. Liu, D. Brenner, and Q. Lin, "A Mechanically 
Tunable Microfluidic Cell-Trapping Device," Sensor Actuat A-Phys, doi: 
10.1016/j.sna.2013.10.016. 
[253] B. Desoize and J. Jardillier, "Multicellular Resistance: A Paradigm for Clinical 
Resistance?," Critical reviews in oncology/hematology, vol. 36, pp. 193-207, 2000. 
[254] C. V. Rao, D. M. Wolf, and A. P. Arkin, "Control, Exploitation and Tolerance of 
Intracellular Noise," Nature, vol. 420, pp. 231-7, 2002. 
211 
 
[255] D. G. Spiller, C. D. Wood, D. A. Rand, and M. R. White, "Measurement of Single-
Cell Dynamics," Nature, vol. 465, pp. 736-45, 2010. 
[256] S. V. Avery, "Microbial Cell Individuality and the Underlying Sources of 
Heterogeneity," Nature reviews. Microbiology, vol. 4, pp. 577-87, 2006. 
[257] C. J. Wei, X. Xu, and C. W. Lo, "Connexins and Cell Signaling in Development 
and Disease," Annual review of cell and developmental biology, vol. 20, pp. 811-
38, 2004. 
[258] J. P. Himanen and D. B. Nikolov, "Eph Signaling: A Structural View," Trends in 
neurosciences, vol. 26, pp. 46-51, 2003. 
[259] S. Lindstrom and H. Andersson-Svahn, "Overview of Single-Cell Analyses: 
Microdevices and Applications," Lab on a chip, vol. 10, pp. 3363-72, 2010. 
[260] J. Nilsson, M. Evander, B. Hammarstrom, and T. Laurell, "Review of Cell and 
Particle Trapping in Microfluidic Systems," Analytica chimica acta, vol. 649, pp. 
141-57, 2009. 
[261] L. C. Taylor and D. R. Walt, "Application of High-Density Optical Microwell 
Arrays in a Live-Cell Biosensing System," Analytical biochemistry, vol. 278, pp. 
132-42, 2000. 
[262] J. P. Frimat, M. Becker, Y. Y. Chiang, U. Marggraf, D. Janasek, J. G. Hengstler, J. 
Franzke, and J. West, "A Microfluidic Array with Cellular Valving for Single Cell 
Co-Culture," Lab on a chip, vol. 11, pp. 231-237, 2011. 
[263] R. D. Sochol, M. E. Dueck, S. Li, L. P. Lee, and L. W. Lin, "Hydrodynamic 
Resettability for a Microfluidic Particulate-Based Arraying System," Lab on a chip, 
vol. 12, pp. 5051-5056, 2012. 
[264] A. Revzin, P. Rajagopalan, A. W. Tilles, F. Berthiaume, M. L. Yarmush, and M. 
Toner, "Designing a Hepatocellular Microenvironment with Protein Microarraying 
and Poly(Ethylene Glycol) Photolithography," Langmuir : the ACS journal of 
surfaces and colloids, vol. 20, pp. 2999-3005, 2004. 
[265] N. Li and C. M. Ho, "Photolithographic Patterning of Organosilane Monolayer for 
Generating Large Area Two-Dimensional B Lymphocyte Arrays," Lab on a chip, 
vol. 8, pp. 2105-12, 2008. 
[266] J. Y. Lee, C. Jones, M. A. Zern, and A. Revzin, "Analysis of Local Tissue-Specific 




[267] D. Wlodkowic, S. Faley, M. Zagnoni, J. P. Wikswo, and J. M. Cooper, 
"Microfluidic Single-Cell Array Cytometry for the Analysis of Tumor Apoptosis," 
Analytical Chemistry, vol. 81, pp. 5517-23, 2009. 
[268] L. Y. Wu, D. Di Carlo, and L. P. Lee, "Microfluidic Self-Assembly of Tumor 
Spheroids for Anticancer Drug Discovery," Biomedical microdevices, vol. 10, pp. 
197-202, 2008. 
[269] J. E. Molloy and M. J. Padgett, "Lights, Action: Optical Tweezers," Contemporary 
Physics, vol. 43, pp. 241-258, 2002. 
[270] T. Tonooka, T. Teshima, and S. Takeuchi, "Clustering Triple Microbeads in a 
Dynamic Microarray for Timing-Controllable Bead-Based Reactions," 
Microfluidics and Nanofluidics, vol. 14, pp. 1039-1048, 2013. 
[271] W. H. Tan and S. Takeuchi, "A Trap-and-Release Integrated Microfluidic System 
for Dynamic Microarray Applications," Proceedings of the National Academy of 
Sciences of the United States of America, vol. 104, pp. 1146-1151, 2007. 
[272] B. Z. Yang and Q. Lin, "A Planar Compliance-Based Self-Adaptive Microfluid 
Variable Resistor," Journal of Microelectromechanical Systems, vol. 16, pp. 411-
419, 2007. 
[273] D. Huh, K. L. Mills, X. Y. Zhu, M. A. Burns, M. D. Thouless, and S. Takayama, 
"Tuneable Elastomeric Nanochannels for Nanofluidic Manipulation," Nature 
Materials, vol. 6, pp. 424-428, 2007. 
[274] W. Liu, L. Li, J. C. Wang, Q. Tu, L. Ren, Y. Wang, and J. Wang, "Dynamic 
Trapping and High-Throughput Patterning of Cells Using Pneumatic 
Microstructures in an Integrated Microfluidic Device," Lab on a chip, vol. 12, pp. 
1702-9, 2012. 
[275] E. M. Arruda and M. C. Boyce, "A 3-Dimensional Constitutive Model for the Large 
Stretch Behavior of Rubber Elastic-Materials," Journal of the Mechanics and 
Physics of Solids, vol. 41, pp. 389-412, 1993. 
[276] T. K. Kim, J. K. Kim, and O. C. Jeong, "Measurement of Nonlinear Mechanical 
Properties of Pdms Elastomer," Microelectronic Engineering, vol. 88, pp. 1982-
1985, 2011. 
[277] M. Liu and Q. F. Chen, "Characterization Study of Bonded and Unbonded 
Polydimethylsiloxane Aimed for Bio-Micro-Electromechanical Systems-Related 
Applications," Journal of Micro-Nanolithography MEMS and Moems, vol. 6, 2007. 
213 
 
[278] J. Zhu, T. Olsen, R. Pei, M. Stojanovic, and Q. Lin, "A Microfluidic Device for 
Isolation of  Cell-Targeting Aptamers," The 27th IEEE International Conference 
on Micro Electro Mechanical Systems (MEMS '14), pp. 242-245, San Francisco, 
CA, 2014. 
[279] M. Rajendran and A. D. Ellington, "Selection of Fluorescent Aptamer Beacons 
That Light up in the Presence of Zinc," Analytical and bioanalytical chemistry, vol. 
390, pp. 1067-75, 2008. 
[280] H. P. Hofmann, S. Limmer, V. Hornung, and M. Sprinzl, "Ni2+-Binding Rna 
Motifs with an Asymmetric Purine-Rich Internal Loop and a G-a Base Pair," RNA, 
vol. 3, pp. 1289-300, 1997. 
[281] E. N. Brody and L. Gold, "Aptamers as Therapeutic and Diagnostic Agents," 
Journal of biotechnology, vol. 74, pp. 5-13, 2000. 
[282] E. Gilboa, J. McNamara, 2nd, and F. Pastor, "Use of Oligonucleotide Aptamer 
Ligands to Modulate the Function of Immune Receptors," Clinical cancer research 
: an official journal of the American Association for Cancer Research, vol. 19, pp. 
1054-62, 2013. 
[283] C. Ravelet, C. Grosset, and E. Peyrin, "Liquid Chromatography, 
Electrochromatography and Capillary Electrophoresis Applications of DNA and 
Rna Aptamers," Journal of chromatography. A, vol. 1117, pp. 1-10, 2006. 
[284] E. N. Brody, M. C. Willis, J. D. Smith, S. Jayasena, D. Zichi, and L. Gold, "The 
Use of Aptamers in Large Arrays for Molecular Diagnostics," Molecular diagnosis 
: a journal devoted to the understanding of human disease through the clinical 
application of molecular biology, vol. 4, pp. 381-8, 1999. 
[285] S. M. Nimjee, C. P. Rusconi, and B. A. Sullenger, "Aptamers: An Emerging Class 
of Therapeutics," Annual Review of Medicine, vol. 56, pp. 555-583, 2005. 
[286] H. J. Lee, A. W. Wark, and R. M. Corn, "Microarray Methods for Protein 
Biomarker Detection," The Analyst, vol. 133, pp. 975-83, 2008. 
[287] S. Fredriksson, J. Horecka, O. T. Brustugun, J. Schlingemann, A. C. Koong, R. 
Tibshirani, and R. W. Davis, "Multiplexed Proximity Ligation Assays to Profile 
Putative Plasma Biomarkers Relevant to Pancreatic and Ovarian Cancer," Clinical 
chemistry, vol. 54, pp. 582-9, 2008. 
[288] R. Chen, S. Pan, E. C. Yi, S. Donohoe, M. P. Bronner, J. D. Potter, D. R. Goodlett, 
R. Aebersold, and T. A. Brentnall, "Quantitative Proteomic Profiling of Pancreatic 
Cancer Juice," Proteomics, vol. 6, pp. 3871-9, 2006. 
214 
 
[289] S. Nishizuka, "Profiling Cancer Stem Cells Using Protein Array Technology," 
European journal of cancer, vol. 42, pp. 1273-82, 2006. 
[290] K. Sefah, Z. W. Tang, D. H. Shangguan, H. Chen, D. Lopez-Colon, Y. Li, P. 
Parekh, J. Martin, L. Meng, J. A. Phillips, Y. M. Kim, and W. H. Tan, "Molecular 
Recognition of Acute Myeloid Leukemia Using Aptamers," Leukemia, vol. 23, pp. 
235-44, 2009. 
[291] K. Sefah, D. Shangguan, X. Xiong, M. B. O'Donoghue, and W. Tan, "Development 
of DNA Aptamers Using Cell-Selex," Nature protocols, vol. 5, pp. 1169-85, 2010. 
[292] C. H. Weng, I. S. Hsieh, L. Y. Hung, H. I. Lin, S. C. Shiesh, Y. L. Chen, and G. B. 
Lee, "An Automatic Microfluidic System for Rapid Screening of Cancer Stem-Like 
Cell-Specific Aptamers," Microfluidics and Nanofluidics, vol. 14, pp. 753-765, 
2013. 
[293] J. Kim, J. Hiltion, K. Yang, R. Pei, J. Zhu, M. Stojanovic, and Q. Lin, 
"Electrokinetically Integrated Microfluidic Isolation and Amplification of 
Biomolecule- and Cell-Binding Nucleic Acids," IEEE Int. Conf. on Micro Electro 
Mechanical Systems (MEMS '13), pp. 1007-1010, Taipei, Taiwan, 2013. 
[294] T. Nagel, N. Resnick, W. J. Atkinson, C. F. Dewey, Jr., and M. A. Gimbrone, Jr., 
"Shear Stress Selectively Upregulates Intercellular Adhesion Molecule-1 
Expression in Cultured Human Vascular Endothelial Cells," J Clin Invest, vol. 94, 
pp. 885-91, 1994. 
[295] V. F. Veiga, L. Nimrichter, C. A. Teixeira, M. M. Morales, C. S. Alviano, M. L. 
Rodrigues, and C. Holandino, "Exposure of Human Leukemic Cells to Direct 
Electric Current: Generation of Toxic Compounds Inducing Cell Death by 
Different Mechanisms," Cell Biochem Biophys, vol. 42, pp. 61-74, 2005. 
[296] A. K. Naik, M. S. Hanay, W. K. Hiebert, X. L. Feng, and M. L. Roukes, "Towards 
Single-Molecule Nanomechanical Mass Spectrometry," Nat Nanotechnol, vol. 4, 
pp. 445-50, 2009. 
[297] M. B. Elowitz, A. J. Levine, E. D. Siggia, and P. S. Swain, "Stochastic Gene 
Expression in a Single Cell," Science, vol. 297, pp. 1183-6, 2002. 
 
